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ABSTRACT 
This research work consists of two independent studies. The first study is the 
development of a synthetic route to plakortethers A−E along with possible derivatives. 
The second study focuses on the synthetic applications of rhodium-catalyzed 
intramolecular C–H insertion on diazosulfonates.  
Plakortethers (A–G) represent a set of marine natural products, which contain of a 
characteristic tetrasubstituted tetrahydrofuran fragment. This group of compounds was 
isolated from the Caribbean sponge Plakortis simplex. Their selective cytotoxic activity 
against the RAW 264−7 cell lines (murine macrophage) makes them promising 
candidates for biological studies and, along with their unusual structure, warrants the 
synthesis of these natural products. In the approach to plakortethers A−E, the key efforts 
were directed at the assembly of the important structural element: the tetrasubstituted 
tetrahydrofuran ring with three stereocenters. To achieve this goal, initially, it was 
intended to use trans-annular iodocyclization to obtain the embedded tetrasubstituted 
tetrahydrofuran backbone in plakortethers. Due to the synthetic difficulties encountered 
in preparation of the necessary intermediates, the construction of the tetrahydrofuran ring 
was proposed to be achieved via an acyclic intermediate using cyclization of an 
episulfonium ion onto an alcohol to control stereochemistry. Construction of the key 
precursor to the episulfonium ion with desired stereochemistry was envisioned from a 
xx 
 
six-membered lactone (valerolactone) intermediate. The requisite lactones were prepared 
via enolate alkylation for the future studies of the episulfonium ion cyclization step.  
The second study focuses on the use of rhodium-catalyzed intramolecular C–H 
insertion on diazosulfonates as a tool for the synthesis of organic molecules. Dirhodium-
induced intramolecular C–H insertion on diazo carbonyl compounds is a relatively well-
studied reaction. In a wide variety of cases it lead to the preferential formation of five-
membered cycles. In the earlier work in our lab, it was found that sulfone and sulfonate 
diazocompounds undergo intramolecular C−H insertion to form predominantly six-
membered cyclic sulfones and sulfonates (δ-sultones) over their five-membered 
counterparts. δ-Sultones can serve as viable synthetic intermediates. Preliminary work on 
the transformations of these compounds done in our research group has identified that, 
upon treatment with THBP and t-BuOK, δ-sultones undergo oxidative desulfonation to 
form five-membered lactones (γ-butyrolactones). Butyrolactones are a common fragment 
in natural compounds and are valuable as synthetic intermediates. In the current study, 
the conditions for this oxidative desulfonation of δ-sultones to γ-butyrolactones were 
optimized, along with testing of the scope of this transformation. Optimization studies 
resulted in satisfactory yields of γ-butyrolactones from δ-sultones with 5 eq of THBP and 
6 eq of t-BuOK in THF or DME as a solvent at room temperature. These conditions have 
been utilized to synthesize a γ-butyrolactone key intermediate that was used in the 
previously reported total synthesis of natural product (−)-eburnamonine.  
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CHAPTER I 
POLYKETIDES FROM SPONGES OF GENUS PLAKORTIS 
1.1 Introduction and background of the chemistry in oceans 
Nature provides us with a considerable number of highly functionalized natural 
products with great structural divergence. Oceans, which cover almost 75% of the Earth’s 
surface, contain a variety of fauna and flora species, which have no terrestrial 
counterparts.1 These marine species, unexploited prior to 1980,1 are an endless source of 
compounds with interesting pharmacological activity.2 Marine organisms have attracted 
enormous interest from scientists in recent decades. The large numbers of structurally 
diverse compounds that were obtained from marine organisms have been populating the 
ever-expanding library of natural products.3, 4   
Among marine organisms, the chance of finding bioactive compounds is 
remarkably higher in slow moving or sessile invertebrates such as sponges, coelenterates 
(e.g., soft corals), ascidians (e.g., sea squirts), mollusks (e.g., sea hares) and bryozoans.3, 5 
Many of the organisms in these phyla are brightly colored, lacking a spine or protective 
shell and often lacking any physical defense from predators. Therefore, many of the 
bioactive compounds are involved in their defensive mechanisms as a chemical weapon.1  
About one third of all marine natural products have been isolated from sponges.1 
Sponges are among the most studied marine organisms,3, 4  making them currently the 
most popular source of novel compounds. Among the different classes of 
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bioactive natural products isolated from sponges, a group of compounds known as 
polyketides plays an essential role in terms of structural diversity and biological activity.  
 
1.2 Polyketides from oceans 
Polyketides have been isolated from bacteria, fungi, sponges, plants, and animals. 
These isolates are usually biosynthesized through the decarboxylation condensation of 
acetyl-CoA-derived starter units and malonyl-CoA-derived extender units.6, 7  Although 
they are also known to be produced by bacteria and fungi, marine sponges are the major 
source of polyketides. This group of compounds exhibits a bewildering structural 
diversity and a broad array of biological activities, including antibiotic (e.g., 
erythromycin), antitumor (e.g., bryostatins) and immunosuppressant (e.g., rapamycin) 
actions.8 These numerous polyketides isolated from marine sponges can occur as simple 
small molecules and also as complex large molecules.9 Some examples of polyketides are 
shown in Figure 1, ranging from such simple compounds like 6-methylsalicylic acid 
(F1.1)9 and butenolide F1.210 to elaborate amphothericin B (F1.4)11 and brevetoxin A 
(F1.6).12 The biological activity of these compounds also ranges widely as antibiotics 
(F1.1), insecticides (F1.2), potential drugs towards polio and hepatitis (F1.3),13 
fungicides (F1.4), and antimalarial drugs (F1.5)14 and neurotoxins (F1.6).   
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Figure 1. Examples of polyketides isolated from various marine sources.9−14 
 
 
1.3 Polyketides isolated from genus Plakortis 
Marine sponges of the genus Plakortis (family Plakinidae, class Demospongiae, 
order Homosclerophorida) are known to be rich sources of structurally unique and 
biologically active isolates.15 They are well known for their prolific production of 
bioactive polyketides, such as a large number of cyclic peroxides (F2.1−F2.7),16  α-,γ-
pyrones (F2.8−F2.12), butenolides (F2.13−F2.15), cyclic furan esters (F2.16−F2.18), 
and bicyclic lactones (F2.19−F2.21).17−19 Thousands of compounds isolated from this 
vastly diverse group (genus Plakortis) have been found to exhibit a range of biological 
activities. Examples encompass anti-tumor (F2.2−F2.5, F2.8−F2.21)15, 20−30 anti-fungal 
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(F2.20),20 anti-malarial (F2.1, F2.6),28, 31 anti-bacterial (F2.14, F2.15),17, 21, 32 anti-
leishmanial (F2.15, F2.18, F2.19)33 and other important pharmacological activities, 
including promotion of Ca2+  uptake in the cardiac sarcoplasmic reticulum (F2.7, 
F2.19).33−35  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Selected bioactive polyketides isolated from genus Plakortis. 
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In addition to the aforementioned polyketides, plakortethers A–G isolated from 
the Caribbean sponge Plakortis simplex, exhibit unusual structure bearing a 
polysubstituted tetrahydrofuran ring. Biological studies on plakortethers A−G have 
concluded that the plakortethers A, B, D, and E are cytotoxic against the RAW 264−7 
cell line with IC50 values of 7.9, 10.0, 8.4 and 11.6 µg/mL, respectively.2  
  
 
 
 
Figure 3. Plakortethers A−G from Plakortis simplex.2 
 
 
1.4 Synthetic progress towards the construction of polysubstituted tetrahydrofuran 
rings of polyketides from genus Plakortis 
 
Even when showing promising and potent pharmacological activities, natural 
compounds isolated from marine organisms rarely raise the interest of pharmaceutical 
companies, because they are difficult to acquire in sufficient amounts for clinical use. 
Obtaining such compounds from natural resources means excessive harvesting of the 
marine organisms and destruction of the nature balance. The problem is to conciliate 
expansion requirements for human beings and protection of the marine environment and 
biodiversity. Oceans are showing increasing signs of overexploitation and degradation, 
ensuing in loss of both productivity and biodiversity. In this circumstance, an enormous 
collection of marine organisms producing compounds of industrial concern appears 
impractical, and total synthesis is one of the best possible ways to address this problem.  
This chapter presents a review of reported synthetic advances made towards the 
total synthesis of selected polyketides, which bear a polysubstituted tetrahydrofuran ring, 
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along with the reported syntheses of plakortethers F and G (F9.1−F9.7). Further 
elaboration of different approaches towards the construction of polysubstituted 
tetrahydrofuran ring will be highlighted.  
 
1.4.1 Total synthesis of plakortone D 
 
 Hayes et al.36 were the first to report the total synthesis of plakortone D (F2.19). 
The authors clarified the uncertain structural and stereochemical features of this 
compound and also enabled the acquisition of other plakortones and analogues of the 
correct stereochemical series. The key disconnection is at C7-C8 thus providing lactone 
S1.2 along with the side chain unit S1.1, which require control at C10 and eventually an 
E-double bond (C11-C12). The main focus of the total synthesis of plakortone D is to 
incorporate quaternary centers at C-4 and C-6 in the 2,6-dioxabicyclo[3.3.0]octan-3-one 
moiety of the plakortone core S1.2 (Scheme 1). 
 
 
 
Scheme 1. Retrosynthetic analysis of plakortone D.36 
 
The total synthesis is initiated by protection of 3-butyn-1-ol S2.1 and conversion 
of the resulted alkyne to alkene S2.2 (Scheme 2). Asymmetric dihydroxylation of 
compound S2.2 by AD mix-β followed by deprotection, oxidation, and addition steps 
provided the sensitive triol S2.4 as a mixture of diastereomers. The isomers is subjected 
to the Pd(II)-mediated lactone forming reaction cascade (hydroxycyclization, 
O
O O
H
F2.19
X
S1.1
O
O O
S1.2
HO
+
4
6
7
8
11
12
6
4
7 
 
carbonylation and lactonization), which resulted in the desired key intermediate S2.5a 
along with S2.5b in a separable mixture.36−38  
 
 
 
 
 
 
 
 
Scheme 2. Synthesis of the bicyclic lactones S2.5a and S2.5b.36 
 
Sulfone S3.2 is constructed via five steps starting from the γ,δ-unsaturated ester 
S3.1 (Scheme 3). The previously prepared hydroxymethyl lactone S2.5a (Scheme 3) is 
oxidized to the corresponding aldehyde, which is immediately coupled with the anion of 
sulfone S3.2 affording lactone S3.3. The key diol S3.4 is obtained by removal of 
acetonide, followed by hydrogenation. Generation of the C11-C12 E-double bond is 
achieved by the stereospecific syn removal of the 1,2-diol using triethyl orthoformate. 
This afforded an orthoester, which provided plakortone D F2.19, after heating at  
180 oC for 1 h.36   
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Scheme 3. Synthesis and structural confirmation of plakortone D.36  
 
1.4.2 Total synthesis of Plakortone E 
Although plakortone E (S2.21) has a bicyclic lactone moiety similar to plakortone 
D (F2.19), Akiyama et al. followed a different approach to construct the lactone rings for 
total synthesis of plakortone E.27 The authors initiated the synthesis with Evans 
asymmetric alkylation of the chiral imide S4.1 with crotyl bromide to get compound S4.2 
(Scheme 4). The chiral auxiliary in alkene S4.2 is removed by hydrolytic cleavage with 
lithium hydroperoxide followed by iodolactonization of the resultant carboxylic acid to 
produce iodolactones S4.3a and S4.3b in a 2:1 ratio.  Iodolactone S4.3a is separated from 
the mixture and reduced to the corresponding lactone, which is then treated with LiAlH4 
to furnish the diol S4.4. The resulted diol S4.4 is transferred to alcohol S4.5 via five 
steps. 
 Compound S4.5 is then oxidized with IBX to the corresponding ketone, which on 
reaction with lithiotrimethylsilyldiazomethane in THF afforded dihydrofuran via C−H 
insertion reaction of the alkylidene carbene. Allylic oxidation of the dihydrofuran with 
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CrO3 and 3, 5-dimethylpyrazole constructed lactone S4.6 with proper stereochemistry. 
Reduction of S4.6 with DIBAL-H followed by treatment of the resultant hemiacetal with 
methyl (triphenylphosphoranylidene)acetate is produced diastereomeric methyl esters 
S4.7a and S4.7b as a 1:1 mixture. The undesired ester S4.7b is converted into S4.7a 
through epimerization process. Finally, ester S4.7a is converted to the target plakortone E 
F2.21 through four steps as shown in Scheme 4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4. Asymmetric synthesis of plakortone E.27 
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1.4.3 Total synthesis of Plakortone G 
Kowashi et al. have reported the successful total synthesis of plakortone G 
(F2.13).29 The authors used intramolecular aldol reaction to construct an α,β-unsaturated-
γ-lactone moiety as indicated in Scheme 5. Selective E-olefination is approached via a 
Julia olefination. Introduction of the C-4 and C-8 chiral centers is performed before 
construction of S5.1 by the Julia coupling reaction between the sulfone unit S5.2 and the 
aldehyde unit S5.3 (Scheme 5). 
 
 
 
 
 
 
 
Scheme 5. Retrosynthetic analysis of plakortone G.29 
  
 The synthesis of pakortone G required two major precursors, sulfone S6.2 and 
aldehyde S5.3 (Scheme 6). The authors prepared sulfone S6.2 in six steps, starting with 
the acyl oxazolidinone derivative S6.1. Interlocution of the first chiral center (S6.4) is 
performed by exposing alkene S6.3 to the asymmetric dihydroxylation conditions. The 
resulted diol S6.4 is converted to the target aldehyde S5.3 in five steps.  
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Scheme 6. [A] Preparation of precursor S6.2; [B] Preparation of precursor S5.3.29  
 
The modified Julia coupling reaction of sulfone S6.2 with the aldehyde unit S5.3 
produced alkene S7.1 as a mixture of the geometric isomers (Scheme 7). Diol S7.2 is 
prepared in seven steps from compound S7.1. Oxidation of the primary alcohol in S7.2, 
and successive acylation afforded S7.3, a precursor of the intramolecular aldol reaction. 
Cyclization of compound S7.3 with LiHMDS followed by dehydration with MsCl/Et3N 
gave desired plakortone G (F2.13).29  
 
 
 
  
           
 
 
Scheme 7. Total synthesis of plakortone G.29  
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1.4.4 Total synthesis of plakortethers F and G 
 A retrosynthetic plan for the syntheses of plakortethers F (F3.6) and G (F3.6) is 
designed in Dr. Novikov’s group by recognizing the symmetry of intermediate S8.1.18 
The disconnection of the 3-hydroxyester via acetate aldol condensation and the 
tetrahydrofuran ring via iodocyclization lead to the C2-symmetric intermediate S8.1. This 
intermediate is assembled via a bis-alkylation of allylic dihalide by a chiral auxiliary-
modified butyrate (Scheme 8). 
 
 
 
 
 
Scheme 8. Retrosynthetic analysis of plakortethers F and G.18 
  
 The total synthesis is initiated with bis-alkylation of 3-iodo-2-(iodomethyl)prop-
1-ene S9.2 with the enolate of oxazolidinone S9.1 (Scheme 9). Peroxide-assisted 
hydrolysis followed by cyclization with trifluoroacetic acid at room temperature resulted 
in diastereomeric lactonic acids S9.4a and S9.4b as a separable mixture in a ratio of 
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S9.5a (minor) and S9.5b (major) is accomplished in two steps.  
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corresponding alcohols S9.9a and S9.9b. Reduction of the minor diastereomer S9.5a 
followed by treatment with para-toluenesulfonic acid in methanol yielded in alcohols 
S9.9a and S9.9b as a 1:1 mixture. Diastereomers S9.9a and S9.9b are isolated as pure 
compounds after separation.18 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 9. Preparation of the key intermediates S9.9a and S9.9b.18  
 
 
The separated diastereomers S9.9a and S9.9b are independently converted to 
plakortether F (F3.6) and plakortether G (F3.7). Alcohols S9.9a and S9.9b are 
independently subjected to the Swern oxidation followed by SmI2-iodide mediated 
Reformatsky reaction, hydrolysis, and esterification. This reaction sequence is provided 
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methyl esters S3.6 and S3.7 (Scheme 10). Successful synthesis of plakortether F is 
confirmed by matching the synthesized plakortether F with reported physical data of the 
compound.18   
 
 
 
 
 
 
 
 
 
Scheme 10. Completion of the synthesis of plakortether F (S3.6) and plakortether G 
(S3.7).18  
 
 
1.4.5 Progress towards the synthesis of plakortether B through a zinc-mediated 
homologation 
 
 In the synthesis of plakortethers F (S3.6) and G (S3.7) by John et al., the resulted 
cyclized key product S9.4 from acid-mediated cyclization step is poorly 
diastereoselective.18 Zercher and co-workers intended to address this issue by utilizing 
the tandem homologation-aldol reaction as the key step to construct the plakortether core 
during the approach towards plakortether B (S3.2). Although the synthetic trials 
performed to establish proper stereocenters at the tetrahydrofuran ring using such 
homologation method were not successful, the method starting with L-proline is 
synthetically interesting and hence, it is worth to discuss.39 
 As shown in Scheme 11, the methyl ester of commercially available L-proline 
(S11.2) is obtained via an acid-catalyzed esterification of the amino acid S11.1 in 
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refluxed in toluene for three days. The expected product β-keto amide S11.3 is isolated 
only in low yields after purification. The β-keto amide is subjected to tandem 
homologation-aldol reaction conditions. The resulting crystal structure of the major 
isomer S11.4 revealed that the homologation-aldol reaction of β-keto amides is syn-
selective. Even though L-proline-induced stereocontrol provided the incorrect absolute 
configuration for the formation of naturally occurring plakortether B, the authors decided 
to perform subsequent model studies using the synthesized intermediate. 
 
 
 
 
 
 
 
 
 
Scheme 11. Synthesis of chiral β-keto amide S11.4.39 
 
 As shown in Scheme 12, the advanced intermediate S12.2 is synthesized by 
reductive allylation of the previously prepared enantiopure hemiketal S11.4 exploiting 
the substituted allylsilane (S12.1) and BF3·Et2O.  
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Scheme 12. Reductive allylation of compound S11.4.39 
 
 
 The authors concluded the synthesis by providing several important suggestions 
as follows. The amide moiety of S12.2 can be reduced chemoselectively using Wittig 
reaction followed by a selective reduction of the terminal alkene, which would afford the 
ethyl moiety embedded in plakortether B. The authors have also suggested that it would 
be possible to obtain the enantiomer of plakortether B by performing a diastereoselective 
hydroboration-oxidation of the trisubstituted alkene. Finally, the authors pointed out the 
importance and possibility of utilizing D-proline instead of L-proline, to obtain the 
plakortether core with correct stereochemistry during the tandem homologation-aldol 
reaction.39 
 
1.4.6 Diastereoselective Pd-catalyzed carboetherification reaction to establish 
polysubstituted tetrahydrofuran in simplakidine A 
 
Even though there are developed synthetic methodologies to construct 
polysubstituted tetrahydrofuran rings, this research area is still challenging, due to low 
efficiency of the available methods. Ward et al.40 were trying to discourse this issue by 
consuming a Pd-catalyzed carboetherification reaction developed in their research group 
to establish polysubstituted tetrahydrofuran rings. The authors demonstrated high 
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efficiency of the developed method in constructing polysubstituted tetrahydrofuran ring 
of Simplakidine A (S13.1).40  
Simplakidine A (S13.1) is a unique 4-alkyl substituted pyridinium alkaloid 
isolated from the Caribbean sponge Plakortis simplex and also an unique example of a 
trigonelline nucleus substituted at position C-4 with a complex polyketide-derived 
moiety. Although Simplakidine A exhibits weak cytotoxicity due to its high polarity, this 
molecule is synthetically important since it shares its basic backbone and the 
polysubstituted tetrahydrofuran ring with that of plakortethers A−G.41, 42   
As shown in Scheme 13, the authors envisioned the retrosynthetic analysis by 
generating tetrahydrofuran core through a Pd-catalyzed carboetherification between a 
tertiary alcohol bearing a pendant E-alkene S13.2 and a suitably substituted 4-
bromopyridine derivative (S13.3). The construction of the desired stereocenters at C9 and 
C10 is intended to be accomplished via a ring-closing reaction.40  
 
 
 
 
Scheme 13. Strategy for the synthesis of Simplakidine A (S13.1).40 
 
Ward et al. assumed that the two substituents on C6 of Simplakidine A (Scheme 
13) are approximately close in size (e.g., Me vs i-Bu).40 Due to this reason, it is suggested 
that the diastereotopic face selectivity of the alkene carboetherification reaction could 
likely be controlled by the stereochemical configuration at C8 of substrate S13.2 rather 
than C6. Hence, the simple tertiary alcohol S14.1 is chosen to be a reasonable 
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approximation to S13.2 for the model study. The Pd/S-Phos-catalyzed coupling of 
alcohol S14.1 with 4-bromopyridine hydrochloride resulted in the desired moiety S14.3 
with 15:1 dr in 67% yield (Scheme 14).  
  
 
 
 
Scheme 14.  Model scheme to study the developed transformation towards 
polysubstituted tetrahydrofuran ring in Simplakidine A. 
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CHAPTER II 
          AN APPROACH TO THE TOTAL SYNTHESIS OF PLAKORTETHERS A−E 
Successful syntheses of plakortethers F (F3.6) and G (F3.7) were carried out in 
our research group by taking advantage of the C2 symmetry in the structure (discussed in 
Chapter I, Section 1.4.4).18 However, there are no reports on the synthesis of 
plakortethers A−E (F3.1−F3.5). Because of the above reason and their biological activity 
(Section 1.3, Scheme 3), our research was extended to develop a synthetic route to 
plakortethers A−E along with possible derivatives.  
 
2.1 Synthetic approach towards plakortethers A−E via trans-annular 
iodocyclization 
 
Synthesis of plakortethers A−E is more challenging than that of the F and G 
counterparts, and it requires construction of a tetrasubstituted tetrahydrofuran ring with 
the correct stereochemistry of the chiral centers at both C-6 and C-9 positions. To address 
this challenge, initially it was envisioned to use trans-annular iodocyclization to obtain 
the embedded tetrasubstituted tetrahydrofuran ring in plakortethers (Scheme 15).43 
 
   
 
 
 
 
 
Scheme 15. Retrosynthetic analysis of plakortethers A−E. 
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Bicyclic lactone S16.4 was proposed as the key intermediate of the synthesis of 
the targeted plakortether core via trans-annular iodocyclization. As shown in Scheme 16, 
the key intermediate S16.4 was intended to be obtained by coupling acid S16.1 with 
alcohol S16.2 followed by ring-closure metathesis (RCM). Iodocyclization of 
macrolactone S16.3 would produce bicyclic lactone S16.4, which could be converted to 
plakortethers A−E. The synthesis of starting acid S16.4 was successful, while preparation 
of the desired alcohol S16.2 demonstrated synthetic difficulties. Therefore, the synthetic 
route towards plakortether core through such key intermediate was closed.43  
 
 
 
 
 
 
 
Scheme 16. Synthetic plan towards plakortethers A−E via trans-annular iodocyclization.   
 
 
 
2.2 Synthetic approach towards plakortethers A−E based on episulfonium ion 
 
2.2.1 Key step of the reactions: assembly of the tetrasubstituted tetrahydrofuran ring 
 
The aforementioned situation prompted us to explore an alternate synthetic 
pathway to construct the tetrasubstituted tetrahydrofuran ring, which does not rely on 
trans-annular iodocyclization. As a result, assembly of the tetrasubstituted 
tetrahydrofuran ring was proposed to be achieved through stereoselective cyclization 
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promoted by reacting episulfonium ion S17.2 with hydroxyl group in the same molecule 
(Scheme 17).  
 
 
 
 
 
Scheme 17. Synthetic plan to assemble the tetrasubstituted tetrahydrofuran ring S17.3.  
 
The episulfonium ion can be generated from diol S17.1, which is readily available 
from six-membered lactone S18.2 (valerolactone). Therefore, our initial goal was to 
synthesize valerolactones. The sequence outlined in Scheme 18 was used for an approach 
towards lactones. 
 
 
 
 
 
 
 
Scheme 18. Assembly of the tetrasubstituted tetrahydrofuran ring in compound S18.3. 
 
2.2.2 Attempt to synthesize the valerolactone 
The approach was initiated by establishing chiral centers in S19.2 through direct 
asymmetric aldol self-condensation of propanaldehyde using L-proline as a catalyst in 
dimethylformamide (Scheme 19).44 Resulting aldehyde S19.2 was reduced to diol S19.3 
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with LiAlH4.   Subsequently, the primary hydroxyl group of diol S19.3 was tosylated 
followed by Steglich esterification of the secondary alcohol with 2-
(ethoxycarbonyl)acetic acid, DCC and DMAP, which gave ester S19.4. Lactonization 
was carried out by exposing the obtained ester S19.4 to potassium carbonate and 
dimethylsufoxide. The 1H NMR data of the crude product did not prove the formation of 
lactone S19.5. This provoked us to modify the synthetic scheme mainly by changing the 
conditions for the cyclization step.  
 
 
 
 
 
 
 
Scheme 19. Attempt to prepare valerolactone S19.5. 
 
Preparation of valerolactone S20.2 (Scheme 20), in turn, would require diol 
S19.3, which was previously prepared (Scheme 19).  Monotosylation of the primary 
alcohol in diol S19.3, then acetylation of the secondary alcohol followed by detosylation 
with iodine resulted in compound S20.1 (Scheme 20).  Cyclization of S20.1 was tried in 
the presence of NaHMDS and freshly prepared LDA with and without DMPU.45 The 
trials without DMPU ended up giving the starting material or unidentified products. 
When reactions were carried out under the same conditions (with NaHMDS or freshly 
prepared LDA) in the presence of DMPU, 1H NMR of the resulting compound was 
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compatible with that of valerolactone S20.2 shown in Scheme 20. This shows that the 
polar aprotic solvent significantly assists the reaction. A satisfactory purification method 
has yet to be developed due to the volatility of the valerolactone.    
 
 
 
 
 
 
Scheme 20. Attempt to prepare valerolactone S20.2 via different cyclization conditions. 
 
Meanwhile different approaches were carried out to obtain valerolactone S20.2 as 
shown in Schemes 21 and 22. The primary hydroxyl group of diol S19.3 was tosylated 
and the secondary OH moiety was protected by TBS followed by substitution with iodide 
resulting in compound S21.1. The TBS-protected iodide S21.1 was exposed to diethyl 
malonate in the presence of potassium carbonate and dimethyl sulfoxide to produce 
S21.2. Valerolactone S19.5 was obtained from S21.2 with Dowex 50 and methanol and 
then subjected to the Krapcho decarboxylation46, 47 conditions (lithium chloride in 
dimethyl sulfoxide at 195−205°C). 1H NMR spectrum showed some significant peaks to 
prove the formation of the desired valerolactone S20.2. Once again the purification 
method has to be improved due to the volatility of valerolactone.    
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Scheme 21. A synthesis of valerolactone S20.2. 
 
Diethyl malonate used in Scheme 21 was replaced with the dimethyl malonate 
analogue in Scheme 22 due to the possibility of decarboxylation of methyl ester at lower 
temperatures (135 °C rather than 195 °C) in the presence of dimethylformamide and 
lithium chloride. These conditions also resulted in a crude product with trace amounts of 
valerolactone S20.2. This could be mainly due to the high temperatures applied during 
decarboxylation.  
 
 
 
 
Scheme 22. Modified reaction pathway by replacing diethyl malonate with dimethyl 
malonate.  
 
Parallel to the reaction sequence shown in Scheme 22, preparation of the cyclic 
compound S23.3 as a part of the assembly of the tetrasubstituted tetrahydrofuran ring in 
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diazomalonate (preparation was carried out with MsN3 and DBU on diethyl malonate) to 
obtain compound S23.2.48 Cyclization of crude S23.2 was attempted in the presence of 
potassium carbonate and dimethyl sulfoxide. Unexpectedly, the signals of 
tetrahydrofuran ring S23.3 were not detected in the 1H NMR spectrum of the reaction 
mixture.  
 
 
 
 
 
 
Scheme 23. Attempt to obtain cyclize compound S23.5 using diethyl diazomalonate. 
 
 Due to the complications encountered during the preparation of valerolactone, 
diethyl and dimethyl malonates were replaced with phenylsulfonylacetate S24.5 (Scheme 
24) to ensure easier handling during the synthesis, by elevating the boiling point of the 
resulting valerolactone S24.2. To prepare sulfone S24.5, halide S24.3 was subjected to 
nucleophilic substitution by thiophenol in the presence of potassium carbonate and 
catalytic amounts of sodium iodide in refluxing acetone. The resulting ethyl 2-
(phenylthio)acetate S24.4 was oxidized to phenylsulfonylacetate S24.5 by using excess 
m-CPBA in dichloromethane.49 
The TBS-protected S21.1 was exposed to phenylsulfonylacetate S24.5 in the 
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and methanol. Cyclization also attempted on compound S24.1 using p-TsOH and ethanol 
in dichloromethane; however, this transformation provided only unidentified products. 
From the observations it is clear that the main challenge of the proposed synthetic scheme 
comes from the cyclization step. This could be due to improper orientation of the reaction 
sites. This hypothesis was achieved by changing the positions of the substitute sites 
(Scheme 25).     
 
 
 
 
 
 
 
Scheme 24. Attempt to prepare valerolactone S24.2 using phenylsulfonylacetate S24.5.  
 
 
The cyclization was attempted using an alternative synthetic route as shown in 
Scheme 25. The previously prepared alcohol S23.1 was esterified using DCC, DMAP 
and carboxylic acid S25.2 (prepared by hydrolysis of ester S24.5 as shown in Scheme 
25).50 Sulfone S25.1 was exposed to potassium carbonate and dimethyl sulfoxide, which 
yielded a mixture of unidentified products and no trace of the desired compound was 
found in the 1H NMR spectrum of the crude product. Similar results were obtained in the 
preparation of valerolactone S24.2 from compound S25.1, sodium hydride in 
tetrahydrofuran.   
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Scheme 25. Attempt to prepare valerolactone S24.2 following an alternative synthetic 
route. 
 
2.2.3 A plan for further use of the prepared lactone 
As explained in the previous sections, decarboxylation of S19.5 was problematic 
due to the formation of the highly volatile valerolactone S20.2. Bearing a substituent on 
valerolactone S26.1 would help reduce volatility during the decarboxylation step. 
Therefore, Scheme 26 was suggested, a modification of Scheme 19 to obtain a 
valerolactone with a substituent R at 4th position, which would ensure easier handling of 
the substrate.   
 
 
 
 
 
 
 
Scheme 26. A proposed synthetic pathway to obtain a substituted tetrahydrofuran ring.  
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Valerolactone S19.5 could be alkylated to obtain its derivative S26.1. 
Decarboxylation with lithium chloride in DMSO at 195−205 °C followed by the PhS 
group substitution in the presence of Ph2S2 and LDA should result in the formation of 
PhS-substituted valerolactone S26.2. LAH reduction of valerolactone S26.2 should form 
S26.3, which is expected to be converted to the five-membered key intermediate S26.4. 
 
2.3 Preparation of the unified substrate for synthesis of plakortethers A−E 
Although the above discussed synthetic routes were planned only to proceed 
towards plakortether B, the proposed valerolactone S28.6 (Scheme 28) would be a 
potential intermediate in the synthesis of plakortethers A−E. Its preparation, in turn, 
requires enantiopure alcohol S28.3, which can be prepared using a chiral auxiliary.  
The auxiliary S27.3, developed in Evans’ group, was selected for this purpose.51, 
52
 It was prepared from commercially available phenylalanine S27.1. Alcohol S27.2 was 
obtained by reducing carboxylic acid S27.1 with LAH. The Evans oxazolidinone S27.3 
was successfully synthesized by refluxing alcohol S27.2 for 48 h with dimethyl carbonate 
in the presence of potassium carbonate as a base.53 Oxazolidinone S27.3 was then 
acylated with butyryl chloride using sodium hydride to result in the acylated chiral 
auxiliary S27.4.43 
 
 
 
 
Scheme 27. Synthesis of acylated chiral auxiliary S27.4. 
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The oxazolidinone derivative S28.1 was obtained by aldol condensation of S27.4 
with cinnamaldehyde in the presence of MgBr2·ethyl etherate, triethylamine, TMSCl and 
ethyl acetate.54 TBS-protection of the alcohol by TBSCl and imidazole in 
dimethylformamide followed by reductive cleavage of the chiral auxiliary resulted in 
alcohol S28.3.  This compound was converted to the iodinated derivative S28.4 using 
PPh3, imidazole and iodine in dichloromethane.55 Since it is difficult to remove PPh3 
from the reaction mixture during the purification process, an alternative method was 
followed to prepare iodinated compound S28.4. Alcohol S28.3 was first tosylated in the 
presence of p-TsCl and pyridine followed by detosylation with iodine (acetone, sodium 
iodide at 40 oC), which also resulted in S28.4 with a compatible yield. Iodide S28.4 was 
exposed to ester S24.5 to produce sulfone S28.5. Initial purification using column 
chromatography on silica gel gave a mixture of products. Therefore, the optimization of 
the purification method is necessary for this step.  
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Scheme 28. Attempt to prepare the unified substrate S28.6 for the synthesis of 
plakortethers A−E. 
 
2.4 Conclusion 
In summary, during the approach to plakortethers A−E, the key efforts were 
directed at assembling the tetrahydrofuran ring containing two stereocenters at positions 
C-6 and C-9. This was proposed to be achieved through stereoselective cyclization of the 
episulfonium ion into an alcohol. In the initial synthetic plan, preparation of δ-
varerolatones were studied, as they are important intermediates in the synthesis of 
plakortethers A−E. An approach to the preparing δ-varerolatones by enolate alkylation 
was evaluated and several reaction conditions were examined. Due to the problems 
encountered during the purification process and volatility of the lactone, low yields were 
obtained. This issue can be overcome by modifying the substrate with a suitable 
substituent as proposed in Scheme 26. Even though the plakortether core could not 
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achieved during the study, the target δ-varerolatone was constructed.  Future endeavors 
should be focused on optimizing the yields of this and other low-yielding synthetic steps, 
which would provide building blocks for the construction of the plakortether core.    
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CHAPTER III 
EXPERIMENTAL SECTION FOR APPROACH TO THE TOTAL SYNTHESIS 
OF PLAKORTETHERS A−E 
 
3.1 General information and instrumentation 
1H and 13C NMR spectra were recorded on a Bruker AVANCE 500 NMR 
spectrometer. All spectra were obtained in deuterochloroform (CDCl3). Chemical shifts 
are reported in ppm relative to tetramethylsilane (TMS). Spin-spin coupling constants, J, 
are reported in hertz (Hz). Infrared (IR) spectra were acquired on a Perkin Elmer 
Spectrum 400 FT-IR/FT-FIR spectrometer. Analytical thin layer chromatography (TLC) 
was performed on silica gel 60 F254 (E. Merck no. 5715−7) pre-coated plates. 
Purification by column chromatography was performed using 40−63 µm silica gel 
(Merck, Geduran, no.11567-1) as the stationary phase. THF was distilled over sodium-
benzophenone under nitrogen before use. CH2Cl2 was distilled over calcium hydride 
under nitrogen atmosphere. All other chemicals were used as purchased without further 
purification, unless mentioned. 
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3.2 Procedures and physical data for compounds from Scheme 19 
(2S,3S)-2-Ethyl-3-hydroxyhexanal (S19.2). A solution of freshly 
distilled propanaldehyde (1.00 g, 17.0 mmol) and L-proline (157 
mg, 1.40 mmol) in DMF was stirred at 4 °C for 10 h. The resulting  
solution was diluted with diethyl ether (10 mL) and washed successively with water and 
brine. The combined aqueous layers were extracted with diethyl ether (3 × 10 mL), dried 
over anhydrous magnesium sulfate, filtered and the crude product was concentrated under 
vacuum. Purification by column chromatography on silica gel (5:2, pentane-DEE) 
yielded aldehyde S19.2 (1.60 g, 65%) as a clear liquid. Rf = 0.55 (5:1, pentane-DEE): The 
physical data of S19.2 match with its previously reported data of the compound.56  
 
(2R,3S)-2-Ethylhexane-1,3-diol (S19.3). Aldehyde S19.2       
(50.0 mg, 0.294 mmol) and 50 mL of diethyl ether was added to a 
round bottom flask under nitrogen and the mixture was  
cooled to 0 °C. LAH (27.0 mg, 0.734 mmol) was then added to the reaction mixture, and 
stirred for 16 h at rt. The reaction mixture was cooled to 0 °C and quenched with water 
(0.1 mL) followed by 0.1 mL of 15% aqueous solution of KOH and additional 30 µL of 
water. The resulting mixture was stirred for 1 h at rt and then with anhydrous magnesium 
sulfate for another 1 h, followed by filtration through a short Celite plug. The solid on the 
Celite plug was washed several times with diethyl ether. Volatiles were removed under 
vacuum and the resulting residue was purified by column chromatography on silica gel 
(1:3, EtOAc-hexane) affording 254 mg (81%) of diol S19.3 as a colorless viscous liquid. 
OH O
S19.2
OH OH
S19.3
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Rf = 0.45 (1:1, EtOAc-hexane). The physical data of S19.3 match with its previously 
reported data of the compound.57 
 
(2R,3S)-3-[2-(Ethoxycarbonyl)acetoyloxy]-2-ethylhexyl 
4-methylbenzenesulfonate (S19.4). A solution of  
2-(phenylsulfonyl)acetic acid (15.9 mg, 0.120 mmol) and 
DCC  (49.5 mg, 0.240 mmol) in dichloromethane (2.5 mL)  
was stirred for 30 min under nitrogen at rt. Then DMAP (9.8 mg, 0.080 mmol) and 
alcohol S19.3 (20.0 mg, 0.0800 mmol) was added to the reaction mixture and stirred for 
16 h at rt. The reaction mixture was diluted with 1:1 mixture of ethyl acetate and hexane  
(10 mL). The organic layer was washed with a 1 N aqueous solution of HCl (10 mL), 
saturated aqueous solution of sodium bicarbonate (10 mL), and brine. Purification by 
column chromatography on silica gel (1:7, EtOAc-hexane) provided 20.0 mg (67%) of 
compound S19.4 as a pale yellow oil. Rf = 0.30 (1:5, EtOAc-hexane). 1H NMR (CDCl3, 
500 MHz): δ 0.80 (t, J = 7.0 Hz, 6H), 1.20 (t, J = 7.6 Hz, 3H), 1.20−1.50 (m, 6H), 1.70 
(m, 1H), 3.90−4.10 (m, 4H), 3.20 (s, 3H), 4.95 (m, 1H), 7.30 (d, J = 6.4 Hz, 2H), 7.70 (d, 
J = 7.1 Hz, 2H).  
 
Ethyl (5R,6S)-5-ethyl-2-oxo-6-propyltetrahydro-2H- 
pyran-3-carboxylate (S19.5). A flame-dried round bottom  
flask was charged with compound S19.4 (25.0 mg, 
0.0700 mmol), potassium carbonate (27.9 mg, 0.200 mmol)  
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and with 2 mL of anhydrous DMSO under nitrogen.  The reaction mixture was stirred for 
18 h at rt. Upon completion, the reaction was quenched with water and the product was 
extracted with 1:1 mixture of ethyl acetate and hexane (10 mL). The organic layer was 
further washed with water (2 × 10 mL) and the resulting organic layer was dried with 
anhydrous magnesium sulfate, filtered and concentrated under vacuum. Purification by 
chromatography on silica gel (1:7, EtOAc-hexane) provided 15.2 mg (62%) of the 
valerolactone S19.5 as a colorless viscous liquid. Rf = 0.35 (1:5, EtOAc-hexane). 1H 
NMR (CDCl3, 500 MHz): δ 0.85 (t, J = 6.9 Hz, 3H), 0.90 (t, J = 7.0 Hz, 3H), 1.28 (t, J = 
6.8 Hz, 3H), 1.30 (m, 2H), 1.33 (m, 2H), 1.53 (m, 2H), 1.70 (m, 1H),  2.09 (dd, J = 14.0, 
7.7 Hz, 1H), 2.15 (dd, J = 14.0, 7.4 Hz, 1H), 3.30 (dd, J = 13.9, 7.0 Hz, 1H), 3.40 (t, J = 
14.0 Hz, 1H), 4.20 (q, J = 7.0 Hz, 2H).   
 
3.3 Procedures and physical data for compounds from Scheme 20 
(3S,4S)-3-(Iodomethyl)heptan-4-yl acetate (S20.1). A round  
bottom flask was charged with diol S19.3 (360 mg, 2.47 mmol) in  
25 mL of pyridine. The resulting solution was cooled to 0 oC  
followed by addition of p-tosyl chloride (470 mg, 2.47 mmol) and the reaction mixture 
was stirred at 0 oC for 15 h. Upon completion, acetic anhydride (503 mg, 4.93 mmol) was 
added to the reaction mixture at 0 oC. The reaction mixture was stirred for 24 h and 
diluted with 25 mL of ethyl acetate. The organic layer was washed with saturated 
aqueous solution of sodium bicarbonate (15 mL), water (15 mL) and brine. The resulting 
organic layer was dried with anhydrous magnesium sulfate, filtered and concentrated 
under reduced pressure. The obtained mixture was added to a round bottom flask along 
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with sodium iodide (1.17 g, 7.83 mmol) followed by 20 mL of acetone. Then the reaction 
mixture was refluxed at 40−50 °C for 24 h. Upon completion, volatiles of the reaction 
mixture were removed under reduced pressure and the resulting residue was dissolved in 
1:1 mixture of ethyl acetate and hexane (20 mL). The organic layer was then washed with 
water (20 mL) and brine, then dried over anhydrous magnesium sulfate and filtered. The 
volatiles were removed under reduced pressure. Purification by column chromatography 
on silica gel (0.5:9.5, EtOAc-hexane) yielded 650 mg (89% over two steps) of compound 
S20.1 as a pale yellow oil. Rf = 0.55 (1:9, EtOAc-hexane). 1H NMR (CDCl3, 500 MHz): δ 
0.80 (t, J = 6.5 Hz,  3H), 0.90 (t, J = 7.0 Hz, 3H), 1.30−1.35 (m, 4H), 1.45 (m, 2H), 1.95 
(s, 3H), 2.00 (m, 1H), 3.10 (dd, J = 12.5, 6.5 Hz, 1H), 3.20 (dd, J = 13.0, 6.8 Hz, 1H), 4.8 
(m, 1H).  
 
Preparation of S20.2 following method 1 
(5R,6S)-5-Ethyl-6-propyltetrahydro-2H-pyran-2-one (S20.2). A  
solution of diispropylamine (41.1 mg, 0.410 mmol) in 1 mL of  
anhydrous THF was cooled to −78 °C. To this solution,  
n-butyllithium (0.16 mL, 0.40 mmol of a 2.5 M solution in hexane) was added. After 
stirring the mixture for 15 min at −78 °C, a solution of compound S20.1 (100 mg, 0.340 
mmol) and DMPU (50 µL, 0.40 mmol) in 2 mL of THF was added dropwise over 2 h 
period. Upon completion of the reaction, 5 mL of saturated aqueous solution of 
ammonium chloride was added and the reaction mixture was brought to rt. The resulting 
reaction mixture was diluted with 20 mL of diethyl ether. The organic layer was then 
washed with water (2 × 10mL) and brine. The organic layer was dried over anhydrous 
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magnesium sulfate and filtered. Volatiles were removed under reduced pressure. 
Purification of the resulting residue by column chromatography on silica gel (1:5, DEE-
petroleum ether) afforded 5.0 mg (9%) of crude valerolactone S20.2 as a colorless liquid. 
Due to the low yield and volatility of valerolactone S20.2, the crude product was not 
subjected to purification. The 1H NMR spectrum of the crude product of the compound 
S20.2 exhibited some significant peaks relevant to S20.2.  
 
Preparation of S20.2 following method 2  
(5R,6S)-5-Ethyl-6-propyltetrahydro-2H-pyran-2-one (S20.2). A solution of compound 
S20.1 (100 mg, 0.340 mmol) and DMPU (40 µL, 0.34 mmol) in 2 mL of THF was cooled 
to −78 °C under nitrogen. Then a solution of NaHMDS (1.06 mL, 0.740 mmol) was 
added dropwise to the reaction. The mixture was stirred for 7 h. Upon completion, the 
reaction mixture was quenched with 5 mL of saturated aqueous solution of ammonium 
chloride and brought to rt. The resulting mixture was diluted with 20 mL of diethyl ether 
and washed with water (2 × 10mL) and brine. Then the organic layer was dried over 
anhydrous magnesium sulfate and filtered. Volatiles were removed under reduced 
pressure. Purification of the resulting residue by column chromatography on silica gel 
(1:5, DEE-petroleum ether) afforded 3.0 mg (5%) of compound S20.2 as a colorless 
liquid. The 1HNMR spectrum of the crude product of S20.2 exhibited some significant 
peaks compatible with previously prepared S20.2. 
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3.4 Procedures and physical data for compounds from Scheme 21 
tert-Butyl[(3S,4S)-3-(iodomethyl)heptan-4-yloxy]dimethylsilane  
(S21.1). A flame-dried round bottom flask was charged with  
compound S21.1 (20.0 mg, 0.800 mmol) in 2 mL of anhydrous  
dichloromethane, followed by addition of imidazole (13.5 mg, 0.200 mmol) and TBSCl 
(15.1 mg, 0.100 mmol). After a white precipitate formed, the reaction mixture was stirred 
for 2 h at rt under nitrogen atmosphere. The reaction mixture was then quenched with 
saturated aqueous solution of sodium bicarbonate and the crude product was extracted 
with ethyl acetate (3 × 10 mL). The combined organic layers were dried over anhydrous 
magnesium sulfate, filtered and concentrated under reduced pressure. The crude product 
of the TBS-protected compound was added to a round bottom flask along with sodium 
iodide (84.7 mg, 0.565 mmol) followed by 10 mL of acetone. The reaction mixture was 
refluxed at 40−50 °C for 24 h. Upon completion of the reaction, volatiles were removed 
under reduced pressure and the crude product was dissolved in a 1:1 mixture of ethyl 
acetate and hexane (10 mL). The organic layer was subsequently washed with water (10 
mL) and brine. The resulting organic layer was dried over anhydrous magnesium sulfate, 
filtered and concentrated under reduced pressure. Purification by column chromatography 
on silica gel (1:9, EtOAc-hexane) provided 27 mg (90% over two steps) of compound 
S21.1 as a pale yellow oil. Rf = 0.50 (1:9, EtOAc-hexane). 1H NMR (CDCl3, 500 MHz): δ 
0.00 (s, 6H), 0.80 (s, 9H), 0.85 (t, J = 6.9, 6.5 Hz, 3H), 0.90 (t, J = 7.0 Hz, 3H), 1.20 (m, 
2H), 1.30 (m, 2H), 1.45 (m, 2H), 1.50 (m, 1H),  3.30 (m, 1H), 3.06 (dd, J = 11.5, 6.7 Hz, 
1H), 3.25 (dd, J = 12.0, 7.0 Hz, 1H).  
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Diethyl 2-[(2R,3S)-3-(tert-butyldimethylsilyloxy)-2- 
ethylhexyl]malonate (S21.2). A flame dried round bottom  
flask was charged with compound S21.1 (25.0 mg,  
0.0700 mmol) and with potassium carbonate (27.9 mg, 0.200 mmol) under nitrogen. 2 
mL of anhydrous DMSO was added to the solid mixture followed by diethyl malonate 
(16.1 mg, 0.100 mmol). The reaction mixture was then stirred for 18 h at rt. Upon 
completion, the reaction was quenched with water and the product was extracted with a 
1:1 mixture of ethyl acetate and hexane (10 mL). The organic layer was further washed 
with water (2 × 10 mL) and the resulting organic layer was dried with anhydrous 
magnesium sulfate, filtered and concentrated under vacuum. Purification by 
chromatography on silica gel (1:7, EtOAc-hexane) provided 15.2 mg (62%) of compound 
S21.2 as a colorless viscous liquid. Rf = 0.50 (1:5, EtOAc-hexane). 1H NMR (CDCl3, 500 
MHz): δ 0.00 (s, 6H), 0.80 (s, 9H), 0.85 (t, J = 6.9, 6.5 Hz, 6H), 0.90 (t, J = 7.0 Hz, 3H), 
1.25 (t, J = 6.8 Hz, 6H), 1.40 (m, 2H), 1.30 (m, 2H), 1.40 (m, 1H), 1.50 (m, 2H),  1.95(m, 
2H), 3.40 (t, J = 7.0 Hz, 3H), 3.55 (m, 2H), 4.18 (q, J = 7.0 Hz, 4H). 13C NMR (CDCl3, 
125 MHz): δ −5.0 (CH3), 13.0 (CH3), 13.2 (CH3), 14.5 (CH3), 20.0 (CH2), 26.0 (CH3), 
28.8 (CH2), 37.0 (CH2), 36.0 (CH2), 43.0 (CH), 50.5(CH), 61.5 (CH2), 62(CH2), 74(CH), 
170.0 (C).  
 
Ethyl (5R,6S)-5-ethyl-2-oxo-6-propyltetrahydro-2H-
pyran-3-carboxylate (S19.5).  Compound S21.2 (25.0 mg, 
0.0700 mmol) was dissolved in 1 mL of anhydrous 
methanol and catalytic amount of Dowex 50 was added to  
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the reaction mixture. The reaction mixture was stirred for 24 h at rt. Upon completion, the 
mixture was filtered through a thin Celite plug and the volatiles were removed under 
reduced pressure. Purification of the crude product by column chromatography on silica 
gel (1:7, EtOAc-hexane) afforded 7.5 mg (44%) of compound S19.5 as a colorless liquid. 
Rf = 0.35 (1:5, EtOAc-hexane). The physical data of S19.5 match with its previously 
reported data of the compound.  
 
Diethyl 2-[(2R,3S)-3-(tert-butyldimethylsilyloxy)-2- 
ethylhexyl]malonate (S20.2). A round bottom flask was charged 
with compound S19.5 (15.0 mg, 0.0600 mmol), lithium chloride  
(7.9 mg, 0.19 mmol) and 2 mL of DMSO. After addition of 2−3  
drops of water, the reaction was refluxed for 7 h at 195−205 °C under nitrogen. Then the 
mixture was cooled to rt and the product was extracted with diethyl ether (10 mL). The 
organic layer was washed with water (2 × 10mL) and brine. The resulting organic extract 
was dried with anhydrous magnesium sulfate, filtered and volatiles were removed under 
reduced pressure. Purification of the resulting residue by column chromatography on 
silica gel (1:5, DEE-petroleum ether) afforded 2 mg (3.5%) of compound S20.2 as a 
colorless liquid. Rf = 0.30 (1:5, DEE-petroleum ether). 1H NMR spectrum of the crude 
product of S20.2 exhibited some significant peaks match with its previously reported data 
of the compound S20.2. 
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3.5 Procedures and physical data for compounds from Scheme 22 
  Dimethyl 2-[(2R,3S)-3-(tert-butyldimethylsilyloxy)-2- 
ethylhexyl]malonate (S22.1). The compound S22.1 was  
obtained using the procedure described for compound  
S21.2. Purification by column chromatography on silica gel (1:7, EtOAc-hexane) yielded 
19.5 mg (68%) of compound S22.1 as a colorless viscous liquid. Rf = 0.52 (1:5, EtOAc-
hexane). 1H NMR (CDCl3, 500 MHz): δ 0.00 (s, 6H), 0.85 (s, 12H), 1.15 (t, J = 7.3 Hz, 
3H), 1.20−1.50 (m, 6H), 1.55 (m, 1H), 1.99 (m, 2H), 3.15 (dd, J = 13.8, 6.8 Hz, 1H), 3.20 
(m, 1H), 3.57 (s, 6H).   
 
Methyl (5R,6S)-5-ethyl-2-oxo-6-propyltetrahydro-2H- 
pyran-3-carboxylate (S22.2). The compound S22.2 was  
obtained using the same procedure described for compound  
S19.5. Purification by column chromatography on silica gel 
(1:7, EtOAc-hexane) yielded 19.5 mg (68%) of the compound S22.2 as a colorless 
viscous liquid. Rf = 0.35 (1:5, EtOAc-hexane). 1H NMR (CDCl3, 500 MHz): δ 0.85 (t, J = 
6.5 Hz, 3H), 0.90 (m, 2H), 1.15 (t, J = 7.3 Hz, 3H), 1.40 (m, 4H), 1.50 (m, 2H), 1.85 (m, 
1H), 2.20−2.40 (m, 2H), 3.40 (dd, J = 14, 5.9 Hz, 1H), 3.90 (s, 3H). 
 
3.6 Procedures and physical data for compounds from Scheme 23 
(2R,3S)-2-Ethyl-3-hydroxyhexyl 4-methylbenzenesulfonate  
(S23.1). A solution of diol S19.3 (100 mg, 0.690 mmol) in pyridine  
(5 mL) was cooled to 0 °C. Tosyl chloride (131 mg, 0.690 mmol) 
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was then added to the reaction mixture and stirred overnight at 0 °C. Upon completion of 
the reaction, it was diluted with 10 mL of ethyl acetate. The reaction mixture was then 
washed with water (10 mL), 1 N aqueous solution of HCl (10 mL) and again with water 
(10 mL). The organic layer was dried with anhydrous magnesium sulfate, filtered and 
volatiles were removed under reduced pressure. Purification of the crude product by 
column chromatography on silica gel (1:9, DEE-petroleum ether) yielded 150 mg (88%) 
of compound S23.1 as a viscous liquid. Rf = 0.3 (1:9 DEE-petroleum ether). 1H NMR 
(CDCl3, 500 MHz): δ 0.85 (t, J = 7.5 Hz, 3H), 0.9 (t, J = 6.7 Hz, 3H), 1.20−1.50 (m, 5H), 
1.90 (broad s, 1H), 2.45 (s, 3H), 3.50 (m, 1H), 4.22 (dd, J = 11.0, 5.5 Hz, 1H), 4.10 (dd, J 
= 11.5, 6.0 Hz, 1H), 7.40 (d, J = 7.6 Hz, 2H), 8.20 (d, J = 7.5 Hz, 2H). 13C NMR (CDCl3, 
125 MHz): δ 11.7 (CH3), 14.2 (CH3), 19.4 (CH2), 19.8 (CH3), 21.2 (CH2), 37.2 (CH2), 
45.0 (CH), 70.2 (CH2), 71.3(CH), 128.3 (CH), 130.3 (CH), 133.2 (C), 145.2 (C).  
 
(2S,3S)-3-(Di(ethoxycarbonyl)methyl)-2-ethylhexyl 4- 
methylbenzenesulfonate (S23.2) A solution of alcohol  
S23.1 (50.0 mg, 0.200 mmol) and diethyl diazomalonate  
(S23.5) (36.9 mg, 0.200 mmol) in 2.5 mL of anhydrous  
Benzene was heated at 65 °C for 1 h, with catalytic amounts of rhodium acetate (0.01 mol 
%) under nitrogen. The solvent was evaporated under reduced pressure and the resulting 
residue was dissolved in 10 mL of ethyl acetate. The insoluble material was filtered 
through a Celite plug and the resulting organic layer was washed with saturated aqueous 
solution of sodium bicarbonate (10 mL) and then with water (2 × 10 mL). The organic 
layer was dried with anhydrous magnesium sulfate and filtered. Volatiles were 
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evaporated under reduced pressure.  Purification of the residue by column 
chromatography on silica gel (1:7, EtOAc-hexane) afforded 60 mg (68%) of compound 
S23.2 as a pale yellow oil with a yield of. Rf = 0.35 (1:7, EtOAc-hexane). 1H NMR 
(CDCl3, 500 MHz): δ 0.7 (t, J = 7.5 Hz, 3H), 0.80 (t, J = 7.2 Hz, 3H), 1.20 (t, J = 6.9 Hz, 
3H), 1.20−1.50 (m, 6H), 1.70 (m, 1H), 2.38 (s, 3H), 3.44 (m, 1H), 3.95 (dd, J = 11.5, 6.0 
Hz, 1H), 4.12 (dd, J = 12.0, 6.7 Hz, 1H), 4.15 (q, J = 13.8 Hz, 2H), 4.30 (s, 1H), 7.3 (d, J 
= 7.5 Hz, 2H), 7.7 (d, J = 7.0 Hz, 2H).  
 
Diethyl diazopropanedioate (S23.5) A solution of diethyl  
malonate ester (1.00 g, 6.00 mmol) in 10 mL of THF was  
cooled to −45 °C and charged with mesyl azide (2.18 g, 
18.0 mmol). DBU (1.4 mL, 9.0 mmol) was then added dropwise over 2−3 min period to 
the reaction mixture. After stirring at −45 °C for 1 h, the reaction mixture was brought to 
rt over 15−20 min period and diluted with 10 mL of half saturated aqueous solution of 
ammonium sulfate. The product was extracted with dichloromethane (3 × 10 mL) and the 
combined organic layers were dried over anhydrous magnesium sulfate, filtered and 
volatiles were removed under reduced pressure. Purification of the resulting residue by 
column chromatography on silica gel (1:7, EtOAc-hexane) afforded 850 mg (73%) of 
compound S23.5 as a colorless liquid. Rf = 0.40 (1:5, EtOAc-hexane). 1H NMR (CDCl3, 
500 MHz): δ 1.15 (t, J = 12.5 Hz, 6H), 4.15 (q, J = 11.5 Hz, 4H). IR (CH2Cl2, cm-1, ν): 
2175.80, 1725.54.   
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3.7 Procedures and physical data for compounds from Scheme 24 
(4R,5S)-Ethyl 5-(tert-butyldimethylsilyloxy)-4-ethyl-2- 
(phenylsulfonyl)octanoate (S24.1). Compound S24.1  
was obtained using the procedure described for compound  
S19.5, replacing diethyl malonate with ethyl 2-(phenylsulfonyl)acetate (S24.5). 
Purification by column chromatography on silica gel (1:7, EtOAc-hexane) provided 16 
mg (86%) of compound S24.1 as a colorless viscous liquid. Rf = 0.50 (1:5, EtOAc-
hexane). 1H NMR (CDCl3, 500 MHz): δ 0.00 (s, 6H), 0.85 (s, 9H), 09. (t, J = 15.4 Hz, 
3H), 1.10 (t, J = 12.7 Hz, 3H), 1.15 (t, J = 11.9 Hz, 3H), 1.20−1.50 (m, 6H), 1.90 (m, 
1H), 2.20 (m, 2H), 3.20 (m, 2H), 3.50 (m, 1H), 4.10 (q, J = 13.6 Hz, 2H).  
 
Ethyl 2-(phenylthio)acetate (S24.4). Ethyl bromoacetate (2.00 g,  
12.0 mmol) was added to a round bottom flask along with 10 mL 
of acetone under nitrogen environment. Sodium iodide (0.09 g, 
5 mol %) and potassium carbonate (2.49 g, 18.0 mmol) were then added. After stirring 
the reaction mixture for 10 min, thiophenol (1.2 mL, 12 mmol) was added. The reaction 
mixture was refluxed overnight, the acetone was evaporated and the residue was diluted 
with 50 mL of ethyl acetate.  The organic layer was washed with water (2 × 10mL) and 
brine followed by drying with anhydrous magnesium sulfate and filtering. Volatiles were 
removed under reduced pressure and 2.35 g (100%) of crude product was obtained as a 
pale yellow oil. Rf = 0.50 (1:7, EtOAc-hexane). The physical data of compound S24.4 
match with its previously reported data of the compound.58   
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Ethyl 2-(phenylsulfonyl)acetate (S24.5). A round bottom flask  
was charged with crude compound S24.4 (2.35 g, 12.0 mmol) and 
20 mL of anhydrous dichlormethane. The resulting reaction  
mixture was cooled to 0 °C, m-CPBA (5.18 g, 30.0 mmol) was added and was stirred for 
12 h at rt under nitrogen. Once the reaction was completed, the reaction mixture was 
taken up in 50 mL of dichloromethane and washed successively with saturated aqueous 
solution of sodium sulfite (10 mL), saturated aqueous solution of sodium bicarbonate (10 
mL) and brine. The organic layer was then dried with anhydrous magnesium sulfate, 
filtered and volatiles were evaporated under reduced pressure. Purification of the crude 
product by column chromatography on silica gel (1:5, EtOAc-hexane) yielded 2.46 g 
(90%) of compound S24.5 as a pale yellow liquid. Rf = 0.20 (1:3, EtOAc-hexane): The 
physical data of S24.5 match with its previously reported data of the compound.58 
   
3.8 Procedures and physical data for compounds from Scheme 25 
(2R,3S)-3-[2-(Phenylsulfonyl)acetoyloxy]-2-ethylhexyl 4- 
methylbenzenesulfonate (S25.1). A solution of 2- 
(phenylsulfonyl)acetic acid (S25.2) (52.9 mg, 0.260 mmol) and 
DCC  (163 mg, 0.790 mmol) in dichloromethane (2.5 ml) was  
stirred for 30 min under nitrogen environment at rt. DMAP (35.3 mg, 0.260 mmol) and 
alcohol S19.3 (66.0 mg, 0.260 mmol) were then added and stirred for 16 h at rt. The 
reaction mixture was diluted with a 1:1 mixture of ethyl acetate and hexane (10 mL). The 
organic layer was washed with a 1 N aqueous solution of HCl (10 mL), saturated aqueous 
solution of sodium bicarbonate (10 mL), and brine. Volatiles were removed under 
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reduced pressure. Purification of the resulting crude product by column chromatography 
on silica gel (1:7, EtOAc-hexane) provided 50 mg (40%) of compound S25.1 as a 
colorless viscous liquid. Rf = 0.40 (1:5, EtOAc-hexane). 1H NMR (CDCl3, 500 MHz): δ 
0.75 (t, J = 6.4 Hz, 6H), 1.20−1.50 (m, 6H), 2.38 (s, 3H), 2.40 (m,  1H), 3.50 (s, 2H), 
3.80 (dd, J = 10.2, 5.1 Hz, 1H), 4.00 (dd, J = 11.0, 6.3 Hz, 1H), 4.90 (m, 1H), 7.00−7.50 
(m, 10H). 13C NMR (CDCl3, 125 MHz): δ 11.6 (CH3), 11.8 (CH3), 18.6 (CH2), 19.8 
(CH3), 22.2 (CH2), 32.7 (CH), 34.1 (CH), 43.1 (CH2), 69.4 (CH2), 69.8 (CH), 128.4 
(CH), 129.5 (CH), 129.9 (CH), 130.3 (CH), 133.1 (C), 135.4 (C), 138.8 (C), 145.2 (C), 
169.5 (C).   
 
2-(Phenylsulfonyl)acetic acid (S25.2). A round bottom flask was  
charged with ester S24.5 (100 mg, 0.440 mmol), potassium  
hydroxide (123 mg, 2.19 mmol) and methanol (5 mL). The  
reaction mixture was refluxed overnight at 70−80 °C. Upon completion of the reaction, 
the volatiles were removed under reduced pressure. The remaining residue was dissolved 
in 10 mL of water and organic impurities were extracted with a 1:1 mixture of ethyl 
acetate and hexane (15 mL). The aqueous layer was acidified with an aqueous solution of 
1N hydrochloric acid, and the resulting carboxylic acid was extracted with ethyl acetate 
(2 × 10 mL). The combined organic layers were then dried with anhydrous magnesium 
sulfate and filtered. Evaporation of volatiles under reduced pressure resulted in 84 mg 
(97%) of pure compound S25.2 as a colorless liquid. Rf = 0.10 (1:5, EtOAc-hexane). The 
physical data of S25.2 match with its previously reported data of the compound.58   
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3.9 Procedures and physical data for compounds from Scheme 27 
(R)-2-Amino-3-phenylpropan-1-ol (S27.2). L-Phenylalanine  
(4.00 g, 24.4 mmol) and LAH (2.77 g, 73.2 mmol) were added to a  
round bottomed flask under nitrogen environment. 60 mL of THF  
was added and the reaction mixture was refluxed for 24 h under nitrogen. The reaction 
mixture was slowly cooled to 0 °C and quenched with deionized water (9 mL) followed 
by addition of 9 mL of a 15% aqueous solution of KOH and additional 3 mL of deionized 
water. The resulting mixture was stirred for 1 h, filtered and dried with anhydrous 
magnesium sulfate, then filtered through a Celite plug and washed the Celite with excess 
dichloromethane. Volatiles were removed under vacuum yielding alcohol S27.2 (3.50 g, 
95%) as a white solid. Rf = 0.25 (1:1, EtOAc-hexane). The physical data of S27.2 match 
with its previously reported data of the compound.53   
 
(R)-4-Benzyloxazolidin-2-one (S27.3).  A mixture of acetonitrile  
(50.0 mL) and dimethyl carbonate (8.3 mL, 99 mmol) was added to a  
round bottomed flask containing a mixture of amine S27.2 (3.00 g, 
19.8 mmol) and potassium carbonate (16.44 g, 119.0 mmol). The reaction  
mixture was refluxed for 48 h under nitrogen environment and then cooled to room 
temperature. The reaction mixture was filtered through a Celite plug and was washed 
with a 1:1 mixture of ethyl acetate and hexane (25 mL). The organic layer was 
concentrated under vacuum and resulting residue was purified by column 
chromatography on silica gel (1:2−1:9, EtOAc-hexane) to afford 2.62 g (73 %) of 
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compound S27.3 as a white solid. Rf = 0.35 (1:1, EtOAc-hexane). The physical data of 
S27.3 match with its previously reported data of the compound.53   
 
(R)-4-Benzyl-3-butyryloxazolidin-2-one (S27.4). (R)-4-
benzyloxazolidin-2-one (S27.3) (2.00 g, 12.1 mmol) and sodium hydride 
(0.43 g, 18 mmol) were added to a round bottomed flask. The mixture was 
dissolved in THF (40 mL) and butyryl chloride (1.30 g, 12.1 mmol) was  
then added to the mixture, followed by stirring for 1 h under nitrogen atmosphere. Upon 
completion, the reaction mixture was quenched with a solution of saturated ammonium 
chloride and the compound was extracted with ethyl acetate. The organic extract was then 
washed with a solution of saturated ammonium chloride (10 mL), deionized water (10 
mL) and brine (10 mL). The organic layer was dried over anhydrous magnesium sulfate, 
filtered and concentrated under reduced pressure. Purification of the resulting residue by 
column chromatography on silica gel (1:5, EtOAc-hexane) provided 2.15 g (72%) of 
compound S27.4 as a pale yellow oil. Rf = 0.50 (1:3, EtOAc-hexane): The physical data 
of S27.4 match with its previously reported data of the compound.53   
 
3.10 Procedures and physical data for compounds from Scheme 28 
(R)-4-Benzyl-3-[(2R,3R,E)-2-ethyl-3-hydroxy-5- 
phenylpent-4-enoyl]oxazolidin-2-one (S28.1). Compound  
S27.4 (1.00 g, 4.00 mmol) was added to MgBr2·Et2O  
(103 mg, 0.400 mmol) in a round bottom flask and flushed with nitrogen. 10 mL of ethyl 
acetate was added to the mixture followed by a subsequent addition of triethylamine (1.1 
O N
Ph
O O
S27.4
NO
O
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O
Ph
OH
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mL, 8.0 mmol), cinnamaldehyde (0.6 mL, 5 mmol) and TMSCl (0.8 mL, 6 mmol). The 
reaction mixture was stirred at 23 °C for 24 h. Upon completion, the resulting yellow 
slurry was pushed through a plug of silica with diethyl ether. Volatiles were removed 
under vacuum, and to the remaining residue, 15 mL of methanol was added along with 
4−5 drops of trifluoroacetic acid. The mixture was stirred at rt for 30 min and volatiles 
were removed under reduced pressure. Purification of the resulting crude product by 
column chromatography on silica gel (1:7, EtOAc-hexane) afforded 1.53 g (87%) of 
compound S28.1 as a pale yellow oil. Rf = 0.40 (1:5, EtOAc-hexane). 1H NMR (CDCl3, 
500 MHz): δ 0.9 (t, J = 11.5 Hz, 3H), 1.75 (m, 2H), 2.6 (dd, J = 11.7, 6.8 Hz, 1H), 2.6 
(dd, J = 11.9, 7.0 Hz, 1H), 3.00 (dd, J = 12.1, 6.9 Hz, 1H),  3.30 (dd, J = 12.0, 6.8 Hz, 
1H),  4.12 (t, J = 12.8 Hz, 1H), 4.15 (dd, J = 14.5, 7.3 Hz, 1H), 4.35 (dd, J = 14.6, 6.8 Hz, 
1H), 4.75 (m, 1H), 6.35 (dd, J = 15.5, 3.6 Hz 1 H), 6.70 (d, J = 16.0 Hz, 1H), 7.15−7.35 
(m, 10H).  
 
(R)-4-Benzyl-3-[(2R,3R,E)-3-(tert-
butyldimethylsilyloxy)-2-ethyl-5-phenylpent-4-
enoyl]oxazolidin-2-one (S28.2). A flame-dried round  
bottom flask was charged with compound S28.1 (1.50 g, 3.04 mmol) and anhydrous 
DMF (10 mL). Imidazole (518 mg, 7.60 mmol) and TBSCl (572 mg, 3.80 mmol) were 
successively added to the solution. After a white precipitate formed, the reaction mixture 
was stirred overnight at rt. The reaction mixture was quenched with saturated aqueous 
solution of sodium bicarbonate (25 mL) and the compound was extracted with ethyl 
acetate (3 × 20 ml). The combined organic extracts were dried over anhydrous 
NO
O
Ph
O
Ph
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magnesium sulfate, filtered and concentrated under reduced pressure. Purification of the 
resulted crude product by column chromatography on silica gel (1:7, EtOAc-hexane) 
afforded 1.70 g (87%) of compound S28.2 as a pale yellow oil. Rf = 0. 32 (1:5, EtOAc-
hexane). 1H NMR (CDCl3, 500 MHz): δ 0.00 (s, 6H), 0.70 (s, 9H), 0.75 (t, J = 12.7 Hz, 
3H), 1.59 (m, 2H), 2.50 (m, 1H), 3.35 (dd, J = 10.6, 4.1 Hz, 1H), 4.12 (m, 1H), 4.18 (dd, 
J = 14.0, 6.9 Hz, 1H), 4.43 (dd, J = 13.50, 7.4 Hz, 1H), 4.60 (m, 1H), 6.25 (dd, J = 16.2, 
7.3 Hz, 1H), 6.62 (d, J = 16.6 Hz, 1H), 7.10−7.40 (m, 10H). 
 
(2S,3R,E)-3-(tert-Butyldimethylsilyloxy)-2-ethyl-5- 
phenylpent-4-en-1-ol (S28.3). Compound S28.2 (175 mg, 
0.350 mmol) was dissolved in 3 mL of abs. ethanol and the  
solution was cooled to 0 °C. Sodium borohydride (67.0 mg, 1.77 mmol) was then added 
to the solution at 0 °C followed by stirring for 24 h at rt. The reaction mixture was 
quenched with saturated aqueous solution of sodium bicarbonate (10 mL) at 0 °C and 
was warmed up to rt. The product was extracted with 20 mL of dichloromethane and the 
organic layer was successively washed with water (2 × 10 mL) and brine.  The organic 
layer was dried over anhydrous magnesium sulfate, filtered and concentrated under 
reduced pressure. Purification of the resulted crude by column chromatography on silica 
gel (1:7, EtOAc-hexane) afforded 85 mg (75%) of compound S28.3 as a colorless oil. Rf 
= 0.35 (1:5, EtOAc-hexane). 1H NMR (CDCl3, 500 MHz): δ 0.00 (s, 6H), 0.75 (t, J = 6.9 
Hz, 3H), 0.9 (s, 9H), 2.00 (m, 1H), 1.40 (m, 1H), 2.90 (s, 1H), 3.50 (dd, J = 10.8, 4.8 Hz, 
1H), 3.80 (dd, J = 9.5, 4.5 Hz, 1H), 4.30 (t, J = 4.0 Hz, 1H), 6.10 (dd, J = 16.1, 3.6 Hz, 
1H), 6.40 (dd, J = 15.7, 6.8 Hz, 1H), 7.10− 7.40 (m, 5H). 13C NMR (CDCl3, 125 MHz): δ 
HO Ph
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5.0 (CH3), 13.35 (CH3), 19.0 (CH2), 26.41 (CH3), 48.27 (CH), 63.2 (CH2), 78.4 (CH), 
126.9 (CH), 128.1 (CH), 129.0 (C), 131.0 (CH), 132. 2 (CH), 137.1 (C). 
 
[(E,3R,4R)-4-(Iodomethyl)-1-phenylhex-1-en-3-yloxy](tert- 
Butyl)dimethylsilane (S28.4). A round bottom flask was  
charged with compound S28.3 (35.0 mg, 0.109 mmol) and  
dichloromethane (1 mL) at 0 °C followed by successive addition of imidazole (14.9 mg, 
0.218 mmol), triphenylphosphine (57.2 mg, 0.220 mmol) and iodine (55.3 mg, 0.220 
mmol). After stirring for 20 min, the reaction mixture was diluted with hexane, filtered 
through a celite plug followed by rinsing thoroughly with hexane. The filtrate was 
concentrated under reduced pressure and the resulting residue was purified using column 
chromatography on silica gel (1:7, EtOAc-hexane) yielding 39 mg (83%)  of compound 
S28.4 as a pale yellow oil. Rf = 0.50 (1:5, EtOAc-hexane). 1H NMR (CDCl3, 500 MHz): δ  
0.00 (s, 6H), 0.75 (t, J = 6.9 Hz, 3H), 0.85 (s, 9H), 1.30 (m, 2H), 1.50 (m, 1H), 3.30 (dd, 
J = 10.7, 4.6 Hz, 1H), 3.50 (dd, J = 9.7, 4.5 Hz, 1H), 4.10 (t, J = 4.0 Hz, 1H), 6.10 (dd, J 
= 16.0, 7.6 Hz, 1H), 6.10 (d, J = 16.7, 1H), 7.20−7.40 (m, 5H). 13C NMR (CDCl3, 125 
MHz): δ 4.0 (CH3), 11.89 (CH2), 18.5 (CH3), 23.43 (CH2), 47.79 (CH), 76.5 (CH), 126.9 
(CH), 128.1 (CH), 129.0 (C), 131.5 (CH), 132. 1 (CH), 137.1 (C).    
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CHAPTER IV 
BACKGROUND OF THE RHODIUM CATALYZED INTRAMOLECULAR C−H 
INSERTION ON DIAZOSULFONATES AND ITS SYNTHETIC APPLICATIONS 
 
4.1 Introduction and background on C−C bond formation through activation of 
C−H bonds 
 
Controlling product selectivity in carbon−hydrogen (C−H) bond functionalization 
reactions represents one of the great challenges in modern synthetic chemistry.59 Over the 
years, conventional approaches towards the synthesis of organic molecules have 
neglected sp3 C–H bonds, which are highly abundant in organic molecules and are 
usually the most ubiquitous “functional group”.60−61 The sp3 C–H bond has a bond length 
of 1.09 Å, bond energy of 413 kJ/mol, and a small difference in electronegativity 
between carbon and hydrogen, making this C−H bond nonpolar.59, 62, 63 In general, C−H 
bonds are considered inert due to the absence of empty orbitals of low energy or filled 
orbitals of high energy that can readily facilitate chemical reactions.64, 65 The inertness 
and ubiquitous nature of sp3 C–H bonds make the development of synthetically useful 
reactions challenging. Efficient and selective C–H bond functionalization strategies could 
lead to more effective carbon–carbon (C–C) bond formation reactions and address 
important unsolved synthetic challenges.66−68 Towards this end, unique reagents are 
needed that are reactive enough to cleave the relatively stable C–H bonds but, at the same 
time, selectively discriminate the different types of C–H bonds in organic molecules.69−74
The sp3 C–H bonds adjacent to heteroatoms or functional groups are considered to 
be activated sp3 C–H bonds. Since such C–H bonds are weaker and thus more reactive 
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than their unactivated counterparts, these bonds can be selectively functionalized.  At the 
same time, the selective activation of sp3 hybridized C–H bonds is known to be both 
kinetically and thermodynamically unfavorable. Nevertheless, much progress has been 
made in recent years to selectively activate these bonds as shown by the work of many 
researchers.65, 75−84  
Traditionally, C−C bond formation via activation of C−H bond was entirely 
dependent on radical reactions.85−86 The high abundance of C–H bonds in organic 
substrates and the complications associated with controlling radical reactions limited the 
applications of these type of reactions. However, over the past two decades there has 
been an explosive growth in the development of methodologies for C–H functionalization 
and the application of these technologies for the synthesis of complex targets such as 
natural products and pharmaceutical agents. As a result, a variety of regio- and 
stereoselective C–H functionalization methods became available for the assembly of 
complex molecules. These tools can streamline multi-step chemical routes by eliminating 
unnecessary functional group transformations. Thanks to many contributors in the field, 
C−H functionalization has reached an era in which certain C–H bond can now be 
considered a synthon for both C–C and C–heteroatom moieties.87 
Out of the reactions available, two significant transition metal-based 
methodologies have emerged for C–H bond functionalization, specifically with respect to 
new C–C bond formation.65, 67, 78, 88 The first of these conversions is direct C–H 
activation, requiring a reactive transition metal complex (Ru, Ir, Rh or Pd) to transform a 
relatively strong C–H bond (90−105 kcal/mol) to a weaker carbon–metal bond (50−80 
kcal/mol), followed by subsequent C–C bond formation (Scheme 29).75, 89−91 Shilov,92 
54 
 
Bercaw,65 Bergman,82 Crabtree,93, 94 Murai77 and Goldman95 are the pioneers of this direct 
C−H insertion methodologies, which date back to the 1970s and 1980s. 
 
 
 
 
 
 
 
 
 
Scheme 29. Direct C−H activation mechanism, “R” represents a nucleophile and MLn 
represents a reactive transition metal complex.88 
 
 
Direct activation of C−H bonds generally involves harsh reaction conditions. 
Such conditions may not be tolerated by other functional groups in the substrate. In 
addition, the reactive transition metal complex may bind too tightly to the C–H bond by 
limiting the use of this transformation for synthetic purposes.65, 91, 96 Unlike the above 
method of transition-metal-based transformations for functionalizing C–H bonds, metal 
carbenoid C–H insertion proceeds under relatively mild conditions and tolerates many 
functional groups.  
 
 
 
4.2 Rhodium(II) complexes in carbenoid C–H insertion 
During the initial efforts of functionalizing C−H bonds using metal carbenoids, 
copper complexes were employed with different levels of success. However, due to the 
high electrophilicity of copper, copper carbenoids tend to be too reactive to undergo 
selective C−H activation reactions.88  
C H
MLn
C
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M
H
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"R"
55 
 
Introduction of dirhodium complexes has greatly enlarged the spectrum of metal 
carbenoid-mediated C–H insertion reactions. Rh(II) complexes are among the most 
effective and versatile catalysts and have been used in a variety of synthetically useful 
transformations.97−105 The major factor behind the superiority of Rh(II) complexes is 
thought to be the formation of a dirhodium bridge caged within a ‘lantern’ 
structure.106−107 It is believed that only one of the two Rh atoms actually binds to the 
carbene; the other unbound atom assists as an electron pool to increase the 
electrophilicity of the carbenoid moiety and facilitates the cleavage of Rh–C bond upon 
completion of the reaction.69, 108  
More recently, dirhodium carboxylates and dirhodium carboxamides have 
emerged as the most effective and most widely used catalysts for C−H insertion 
reactions.88, 109, 110 Some of the commonly used catalysts are Rh2(OAc)4 (F4.1, rhodium 
acetate), Rh2(tfa)4 (F4.2, rhodium trifluoroacetate), Rh2(esp)2 {F4.3, 
[bis(rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)]}, and Rh2(acam)4 
(F4.4, rhodium acetamide) (Figure 4) among others. Electron-withdrawing ligands tend 
to increase the reactivity of the catalyst towards diazo decomposition, while electron-
donating ligands tend to decrease the reactivity of the catalyst towards diazo 
decomposition. Out of the catalysts listed, rhodium acetamide, F4.4, is considered to be 
the least reactive and most selective. 
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Figure 4. Common Rh-catalysts used for the C−H insertion reaction of diazo 
compounds.88, 109, 110 
 
 
 
4.2.1 Rhodium-catalyzed C–H insertion mechanism 
In the 80s, Doyle was the first to propose a widely accepted mechanism for 
Rh(II)-catalyzed transformations of diazo compounds.69 According to his mechanism, the 
catalytic cycle of Rh-catalyzed C–H insertion reactions proceeds through three main 
steps: Rh-assisted nitrogen extrusion from the diazo compound, activation of the C–H 
bond and C–C bond formation.108, 111, 112 In this method, the reactive transition metal 
complex inserts into a C–H bond to create a three-membered cyclic transition state, 
which directly provides the functionalized products (Scheme 30).88 If the metal carbenoid 
is highly electrophilic, competing side reactions become an issue. On the other hand, if 
the electrophilicity is insufficient, the metal carbenoid lacks reactivity to insert into an 
unactivated C–H bond.66, 88 
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Scheme 30. Catalytic cycle for C−H functionalization by metal carbenoid insertion from 
diazo compounds.88 
 
The author of this work suggested a transition state for the C−H bond activation 
based on the literature preferences and their own experimental data.69 They suggested 
that after nitrogen extrusion, there is an overlap of the carbenoids p-orbital with the σ-
orbital of the reacting C–H bond to form a three-membered concerted transition state 
(Scheme 31).112 The author also have proposed that the C–C bond formation with the 
carbenoid carbon proceeds at the same time as the ligated metal dissociates, but not to the 
same extent. Although Doyle’s catalytic cycle is generally accepted, the sequence of C−H 
activation and C−C bond formation steps has been a subject of considerable speculation.  
 
 
 
 
 
Scheme 31. Proposed transition state by Doyle for Rh-catalyzed C−H insertion from 
diazo precursors.112 
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As an extension for the study by Doyle, a mechanism for the intramolecular C−H 
insertion reaction of α-diazoesters with Rh2(OAc)4 has been proposed by Taber et al.73 
(Scheme 32). During the initial studies, the authors were able to use a computational 
approach to reliably predict the major diastereomers formed in Rh-mediated cyclization 
of α-diazoesters to acylcyclopentanes. According to this model, coordination of α-
diazoester S32.1 to the open axial position of Rh2(OAc)4, F4.1, affords complex S32.2. 
Back donation of electron density from Rh to the adjacent carbon with simultaneous 
extrusion of nitrogen give carbenoid S32.3, which may also be depicted as an inverted 
ylide S32.4.  The reversible formation of a three-center two-electron bond affords 
complex S32.5. For bond formation to proceed, a four-membered transition state (TS) 
S32.6 is needed, in which the Rh–C bond is aligned with the target C–H bond. Provided 
sufficient overlap exists, the electron pair of the C–H bond moves to form a new C–C 
bond, and synchronously, the electron pair of the Rh–C bond moves to form a new C–H 
bond. This results in formation of product S32.7 and regeneration of catalyst F4.1.73, 113 
 
 
 
 
 
 
 
 
Scheme 32. Proposed mechanism by Taber et al. for Rh-catalyzed C–H insertion from 
diazo precursors.73 
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In 2002, Nakamura et al.108 proposed a transition state model of Rh(II)-catalyzed 
C−H activation, which confirmed the TS model proposed by Doyle.69 Using B3LYP 
density functional theory on dirhodium tetracarboxylate-catalyzed C–H bond activation, 
the authors discovered the energetics, geometry of important intermediates and TS in the 
catalytic cycle, thereby providing a more accurate TS model. Based on the analysis, the 
authors proposed that the reaction is initiated by formation of a complex between the Rh 
catalyst F4.1 and the diazo compound S33.1 (Scheme 33). Back donation of electrons 
from Rh(II) 4dxz orbital to the C–N σ*-orbital provides the driving force for nitrogen 
extrusion to form the Rh carbenoid S33.3. The Rh carbenoid is highly electrophilic 
because of its empty 2p orbital. As such, C–H activation and formation of the C–C bond 
proceed in a single step via a three-membered hydride transfer-like TS (S33.5 and S33.6) 
with small activation energy.  
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Scheme 33. Proposed mechanism by Nakamura et al. for Rh-catalyzed C–H insertion 
from diazo precursors.108 
 
 
4.2.2 Synthetic utility of rhodium-induced intramolecular C–H insertion 
In the last three decades, a significant increase in the utilization of diazocarbonyl 
compounds as precursors in C−C bond formation reactions has been witnessed. Rh-
induced carbene insertion into C–H bonds has emerged as a powerful and valuable 
synthetic method, thanks to the pioneering works of Davis,114−118 Doyle,112, 119 Du 
Bois,120 Taber121, 122 and other. These Rh-induced insertion reactions can either be 
intermolecular or intramolecular.123−127 Intermolecular versions have certain limitations. 
Obtaining desired regioselectivity and high yields in intermolecular C−H insertion 
reactions has proven challenging mainly due to competing side reactions (e.g., carbene 
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dimerization). With the exception of a few selected substrates, only intramolecular C−H 
insertion is deemed synthetically useful.72, 124, 125, 128−135  
In general, Rh(II) carboxamidates are considered to be one of the best classes of 
catalyst for Rh-induced intramolecular C–H insertions.136 The intramolecular C−H 
insertion reaction has demonstrated an overwhelming preference for the formation of 
five-membered rings and a reactivity order of tertiary > secondary >> primary in regards 
to the insertion into the pertinent C−H bond.137, 138 This inherent preference can be 
occasionally overridden by conformational and steric effects in the substrate. The nature 
of the ligands on Rh-catalyst also influences the size of the ring (e.g., four- and six-
membered rings may be formed) and on the regio- and stereochemical outcome of the 
product.106, 139, 140  
Competing influences may give rise to a mixture of insertion products, as 
illustrated in the case of β- (S34.6) and γ-lactam (S34.7) formation from the C−H 
insertion reaction of α-diazoacetamides (S34.1, Scheme 34).139, 141 The formation of a β-
lactam is favored by the influence of the amide nitrogen and a strong electron-
withdrawing substituent (e.g., X = COMe) attached to the carbene carbon. Presence of a 
strong electron-withdrawing substituent presumably disallows an early transition state 
(S34.4), leading directly to the β-lactam product S34.7. In the absence of a strong 
electron-withdrawing substituent (when X = PhSO2 or PO(EtO)2), later transition state 
S34.5 is reached and γ-lactam S34.7 is formed. 
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Scheme 34. Formation of β- and γ-lactams by intramolecular Rh-catalyzed insertion.139 
  
4.2.3 Application of rhodium-induced intramolecular C–H insertion towards natural 
product synthesis 
 
Synthetic methodologies are the main essential force of total synthesis. 
Impressive simplification of total synthesis of complex natural product using Rh-
catalyzed intramolecular C−H insertion as a powerful synthetic methodology will be 
discussed under this section.  
As mentioned, the majority of studies involving Rh-mediated intramolecular C−H 
insertion have observed the preferential five-membered ring formation. Nevertheless, the 
first application of C−H insertion to natural product synthesis reported by Cane and 
Thomas, involved a six-membered ring formation (Scheme 35).142 The authors were able 
to synthesize methyl esters of pentalenolactone E S35.4 and F S35.5. The synthesis was 
carried out via a route based on the intramolecular C−H insertion of α-acyldiazo S35.2 
yielding the key intermediate, γ-lactone S35.3.    
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Scheme 35. Synthesis of pentalenolactone E and F.142  
 
Taber and Schuchardt143 synthesized the previously discussed pentalenolactone E 
S35.4, using an alternative route in which a five-membered ring is constructed (Scheme 
36).143 In the key step, tricyclic ketone S36.3 is furnished by Rh2(OAc)4-catalyzed 
intramolecular C–H insertion of α-diazo-β-ketoester S36.2, which contains two chiral 
center. The ester is converted to tricyclic ketone S36.3 with high asymmetric induction 
resulting in two additional chiral centers. The total synthesis of pentalenolactone E S36.4 
is then completed with five more steps. 
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Scheme 36. Use of intramolecular Rh-catalyzed C−H insertion in the synthesis of 
pentalenolactone E by Taber and co-workers.143 
 
 
Another notable feature of intramolecular C–H insertion is its inherent ability to 
convert an acyclic tertiary chiral center into a quaternary chiral center with retention of 
absolute configuration.103, 113, 144 This phenomenon has been exploited by Taber and co-
workers in the synthesis of (+)-α-cuparenone S37.4 (Scheme 37)103 and (−)-hamigeran B 
S38.3 (Scheme 38).144 The synthesis of (+)-α-cuparenone is initiated with diazo transfer 
of β-ketoester S37.1 to afford α-diazo-β-ketoester S37.2 in 75% yield (Scheme 37). Rh-
catalyzed decomposition of α-diazo-β-ketoester S37.2 affords the key intermediate 
cyclopentanone S37.3 in 67% yield with retention of configuration at the newly 
constructed quaternary center. Additional four steps resulted in the target product. 
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Scheme 37. Intramolecular C−H insertion in the synthesis of (+)-α-cuparenone S37.4 
reported by Taber and co-workers.103 
 
In 2008, the same authors reported the synthesis of (−)-hamigeran B S38.3, using 
a similar approach. In this case, a mixture of diastereomers is obtained because of the 
stereogenic center adjacent to the carbonyl moiety. The compound with the desired 
configuration is conveniently obtained by equilibrating the mixture in the presence of 
acid catalyst. Subsequent steps furnished the product (−)-hamigeran B S38.3 as shown in 
Scheme 38.144 
 
 
 
 
 
Scheme 38. Intramolecular Rh-catalyzed insertion applied to the synthesis of  
(−)-hamigeran B.144  
 
Preparation of the key chiral cyclopentanone intermediates (S39.3 and S39.7) of 
(−)-2-pupukeanone S39.4145 and (+)-morphine S39.8146 demonstrate the effectiveness of 
the C−H insertion reaction during the construction of C−C bonds in strained fused-ring 
systems. The synthesis of (−)-2-pupukeanone S39.4 was initiated with 6-methyl carvone 
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S39.1. In the presence of Rh2(tfa)4, diazoketone S39.2 affords fused cyclopentanone 
S39.3 (55%), and the synthesis of (−)-2-pupukeanone is completed with additional seven 
more steps. The synthesis of (+)-morphine S39.8 is initiated with an acid derivative of 
isovanillin S39.5. Treatment of diazoketone S39.6 with Rh2(OAc)4 affords 50% yield of 
the strained fused cyclopentanone S39.7, which is converted in nine steps to  (+)-
morphine.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 39. Intramolecular C−H insertion in the synthesis of (−)-2-pupukeanone S39.4 
and (+)-morphine S39.8.145, 146 
 
 
Intramolecular C–H insertion has been broadly used in the synthesis of γ-
butyrolactones and γ-lactams. The synthesis of (R)-baclofen·HCl S40.4 and (R)-rolipram 
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S40.8 can be considered as notable examples (Scheme 40).147, 148 The synthesis of (R)-
baclofen.HCl is initiated with p-chlorophenethyl alcohol S40.1. The Rh2(S-MPPIM)4-
catalyzed intramolecular C–H insertion reaction of diazoacetate S40.2 affords the γ-
butyrolactone S40.3 in 81% yield and 99% ee, and the desired product S40.4 is obtained 
in 60% overall yield.149 Hu and co-workers have described the synthesis of (−)-rlipram, 
S40.8 starting from isovanillin S40.5.150 Utilizing cumyl (2,2-dimethylbenzyl) as an N-
protecting group, the Rh2(MEOX)4-catalyzed intramolecular C–H insertion reaction of α-
diazoacetamide S34.6 affords the γ-lactum S40.7 in 64% yield and 46% ee. Removal of 
the cumyl protecting group furnished the final target compound S40.8 in 15% overall 
yield.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 40. Synthesis of γ-butyrolactones and γ-lactams by intramolecular Rh-catalyzed 
insertion.147, 148  
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The C−H insertion reaction has also been used in the formation of a chiral γ-
lactone precursor for naturally occurring indole alkaloid (−)-eburnamonine S41.4 
(Scheme 41).99 Starting with N-butanoyloxazolidinone S41.1, diazoester S41.2 is 
prepared in three steps, which upon treatment with Rh2(OAc)4, affords chiral γ-lactone 
intermediate S41.3 in 90% yield.  
 
 
 
 
 
 
 
 
 
 
Scheme 41. Intramolecular C−H insertion to form a quaternary chiral center in the 
synthesis of (−)-eburnamonine S41.4.99 
 
 
4.3 Rhodium-catalyzed intramolecular C−H insertion on disulfones and disulfonates 
Rh-catalyzed intramolecular C−H insertion of α-diazosulfones is a relatively well-
studied reaction. In a wide variety of cases it leads to the preferential formation of five-
membered cyclic sulfones.151, 152 However, Espino et al.120 have reported the formation of 
six-membered cyclic sulfamates via Rh-catalyzed intramolecular N–H insertion of Rh-
nitrenoids generated from the corresponding sulfamate esters. The authors have 
suggested that the difference in bond lengths and bond angles around the sulfur atom is 
responsible for this preference towards six-membered ring formation.153−156 In 2007, 
branching off the Du Bois’s work, John and Novikov49 demonstrated that the preferential 
formation of cyclic six-membered sulfones and sulfonates can also be achieved through 
Rh-catalyzed intramolecular carbene C–H insertion reactions of aliphatic α-diazosulfones 
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and α-diazosulfonates (Table 2). Using this method, available chiral starting materials 
(T2.1−T2.5) can be easily converted into useful synthetic intermediates. Bequette et al.157  
have demonstrated the potential of this approach by converting the δ-sultone from (−)-
citronellol to (+)-bakuchiol, a natural product with various biological activities.  
 
Table 1. Formation of six-membered rings from α-diazosulfones and  
α-diazosulfonates reported by John and Novikov.49 
 
 
 
 
a: Isolated as a single isomer. 
b: Diastereomeric ratio varied from experiment to experiment, ranging from complete to 2:1 in favor of the 
same diastereomer.  
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A complimentary report by Wolckenhauer et al. has also confirmed the 
preferential formation of δ-sultones (T3.1−T3.8) from α-diazosulfonate substrates (Table 
3).158 Notably, the preference for a six-membered ring is maintained even when 
formation of a strained system is required, as evidenced by the reactions of substrates 
T3.5−T3.8. 
 
Table 2. Formation of δ-sultones from the C−H insertion reaction of α-diazosulfonates 
reported by Wolckenhauer et al.158  
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Table 2. Cont.  
 
 
 
Although the formation of δ-sultones as the major products from intramolecular 
Rh-catalyzed C−H insertion on alkylsulfonyl diazoacetate substrates was observed by  
John et al. in their first report,49 a later, more detailed analysis by Jungong et al.159 has 
revealed this preference is sensitive to the substrate structure and the catalyst used (Table 
4). As discussed in previous sections, intramolecular C−H insertion is favored at sites that 
stabilize positive charges. For example, substrate T4.4 (R3 = Me) favored primarily the 
six-membered product P.1, whereas substrate T4.1 (R3 = H) afforded primarily the five-
membered product P.2. Presumably, this is due to the lesser substitution at the C−H 
insertion site. Trimethyl-substituted substrate T4.8 (R1, R2, R3 = Me) also afforded 
primarily the five-membered product P.2, as compared to substrate T4.4 (R1, R2 = H, R3 
= Me). In this case, the steric compression of the angle at the sulfonyl group likely favors 
S R P Yield (%)  
T3.6  
 
 
60d 
 
T3.7 
 
 68a 
 
T3.8 
 
 
 
77a 
Rh catalyst: a = Rh2(OAc)4, b = Rh2(esp)2, c = Rh2(O2CCPh3)4, d = Rh2(tfa)4 
O
S
CO2Et
O
O
Ph
O
S CO2Et
Ph
O O
O
S CO2Et
O O
72 
 
the formation of a five-membered ring. The catalyst also influences the outcome of the 
reaction as evidenced by the effect of a strongly electron-withdrawing ligand, (pfb). 
Reactions catalyzed by a Rh(II) complex with this ligand tend to favor the formation of 
five-membered rings, while those with electron-donating ligands tend to favor six-
membered rings. This suggests that the electronic environment on the metal center is 
another critical factor in determining selectivity.  
 
Table 3. Formation of five-membered versus six-membered rings from C−H insertion 
reaction of diazosulfones reported by Jungong et al.159 
 
 
 
S R1 R2 R3 catalyst Yield of P.1
a 
(%) 
Yield of P.2a 
(%) 
T4.1 H H H Rh2(OAc)4 2 25 
T4.2 H H H Rh2(esp)2 4 45 
T4.3 H H H Rh2(pfb)2 Not detected 80 
T4.4 H H Me Rh2(OAc)4 65 9 
T4.5 Me H Me Rh2(OAc)4 40 24 
T4.6 Me H Me Rh2(esp)2 26 34 
T4.7 Me H Me Rh2(pfb)2 8 60 
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Table 3. Cont.  
S R1 R2 R3 catalyst Yield of P.1
a 
(%) 
Yield of P.2a 
(%) 
T4.8 Me Me Me Rh2(OAc)4 5 75 
T4.9 Me Me Me Rh2(pfb)2 Not detected 64 
a: Isolated yields, combined for both diastereomers.  
 
4.4 Synthetically useful intermediates from cyclic six-membered sulfones and 
sulfonates 
 
The chemistry of the novel cyclic six-membered sulfones and sulfonates as 
synthetic intermediates remains largely unexplored.160 Only a few cases have been 
reported in the literature where cyclic six-membered sulfones and sulfonates have been 
converted into synthetically viable intermediates. Particularly, it has been shown by Du 
Bois’s research group158 that the carbon–oxygen bond of δ-sultones S42.2 can be 
displaced with nucleophiles such as NaCN, NaN3, NaOAc, and thiolates to form 
analogues of the  sulfonate salt S42.3. Direct extrusion of SO3 from the subsequent salts 
under a variety of conditions proved ineffective, but the salts could be effectively 
converted to acyclic esters by a two-step sequence (Scheme 42).  
 
 
 
 
 
 
Scheme 42. Nucleophilic substitution reactions of δ-sultones reported by Wolckenhauer 
et al.158  
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Wolckenhauer et al.158 have also observed the desulfonation of δ-sultones under 
oxidative conditions to furnish five-membered lactol S43.2. The conversion is reported to 
involve an oxygen transfer followed by a C–S bond cleavage to afford α-keto ester, 
which is trapped internally by the awaiting hydroxyl group (Scheme 43).  
 
 
 
 
Scheme 43. Desulfonation of δ-sultones to form substituted lactones reported by 
Wolckenhauer et al.158  
 
 There are many examples of reductive desulfonation of α-arylsulfonyl 
esters.161−163 However, the aryl group on the sulfur atom is essential for this 
transformation. δ-Sultones did not react in the presence of known reducing agents such as 
Al/Hg,164 Na/Hg,165 Mg-MeOH,162 and SmI2-MeOH,161 which are routinely used for 
desulfonation of aryl sulfonyl compounds. Duffy et al.163 reported desulfonation of 
fluoroalkylsulfonyl oxindoles by using SmI2 with prolonged reaction times. However, 
there are no such examples for α-alkoxysulfonyl substituted esters. Jungong et al.164 have 
successfully used the modified reaction conditions used by Duffy et al.163 by combining 
DMPU along with SmI2, which slowly react with δ-sultones to afford γ-valerolactones 
(Table 4).164 
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Table 4. SmI2 reduction of δ-sultones to form γ-valerolactone reported by Jungong et 
al.164  
 
 
 
 
 
 
Following the example of oxidative desulfonation of -sultones reported by 
Wolckenhauer et al.,158 studies in our lab have found that the δ-sultone exposed to tert-
butyl hydrogen peroxide (TBHP) in the presence of a suitable base, undergoes. oxidative 
desulfonation along with decarboxylation leading to formation of γ-butyrolactone.166 
Common bases such as NaH, DBU, K2CO3, KOH, t-TEA, NaHMDS, and KHMDS have 
been surveyed in efforts to identify an appropriate base for the desulfonation process. It is 
found that KHMDS and t-BuOK are effective bases for this purpose. Several examples of 
oxidative desulfonation of δ-sultones with ranging yields were found (Scheme 44). 
S Time P Yield (%)  
 
45 min 
 
 
 
47 
 
3 h 
 
 
45 
 
 
 
 
3 h 
 
 
 
85 
 
O
S
O O
COOEt
O
S
O O
COOEt
S
O
O
O
COOEt
H
O
O
O
O
O
H
O
H
O
S
O O
R2
R1
S
SmI2, DMPU
THF, rt, 3 h
O
R2
R1
P
O
OEt OEt
O O
76 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 44. TBHP oxidative desulfonation of δ-sultones to γ-butyrolactones.166  
 
Presumably, the product formation would proceed through three steps: formation 
of the enolate, subsequent oxidation and cyclization. Formation of potassium enolate 
S45.2 with t-BuOK followed by the deprotonation of TBHP would form a t-butyl 
hydroperoxide nucleophile, which after reaction would give a potassium alkoxide ring 
structure (S45.3). C−S bond cleavage would result in S45.4, and it is possible that S45.4 
would further be oxidized through Baeyer-Villiger type oxidation providing mixed 
anhydride S45.6. SO2 extrusion of anhydride S45.6 followed by cyclization would 
furnish the desired five-membered lactone S45.7. 
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Scheme 45. Proposed mechanism of TBHP oxidative desulfonation of δ-sultones to  
γ-butyrolactones.166 
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CHAPTER V 
 
RHODIUM-CATALYZED INTRAMOLECULAR C−H INSERTION ON 
DIAZOSULFONATES AND THEIR SYNTHETIC APPLICATIONS 
 
As an extension and optimization of the previous work done in our research group 
on C−H insertion of diazosulfones and diazosulfonates,49, 157, 159, 160, 164 other synthetic 
intermediates from common precursors were explored. Such intermediates include six-
membered sulfones (F5.1 and F5.2), δ-sultones (T5.1a−T5.1h) and γ-butyrolactones 
(T5.2a−T5.2h).167  
Since reactions towards diazosulfone T4.5 provided good diastereoselectivity, as 
reported in early studies by Jungong et al., it was intended to synthesize six-membered 
cyclic sulfones F5.1 and F5.2, which are structurally similar to the previously 
synthesized sulfone.164 This way sulfone substrates with 1,3 (F5.1) and 1,2 (F5.2) chiral 
centers could be conveniently assembled.167   
 
 
 
 
 
 
 
Figure 5. Six-membered sulfones as synthetic targets.
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Synthesis of δ-sultones T5.1a and T5.1b was planned from easily available chiral 
starting materials isomethol and (−)-borneol, respectively. Preparation of δ-sultone T5.1c 
and benzyl-protected δ-sultoneT5.1d was intended due to their potential towards the 
construction of γ-butyrolactones T5.2c and T5.2d, which can serve as key intermediates 
in the synthesis of (−)-eburnamonine S41.4 (Scheme 54).168 Remaking of the already 
reported δ-sultones T5.1e−T5.1h49, 157 was planned to optimize the oxidative 
desulfonation of δ-sultone substrates to γ-butyrolactone. Synthesis of the above mention 
six-membered sulfones (F5.1 and F5.2) and δ-sultones (T5.1a−T5.1h) requires their 
corresponding diazo substrates; their preparation will be discussed under Section 5.1.1 
and 5.1.2.  
 
Table 5. δ-Sultones and γ-butyrolactones as synthetic targets. 
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Table 5. Cont. 
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5.1 Results and discussion 
5.1.1 Preparation of diazosulfones 
 Synthesis of diazo sulfones F5.1 and F5.2 required the corresponding starting 
alcohols T6.1a and T6.1b.  
LAH reduction of 2-methyl-2-pentenal to its corresponding alcohol followed by 
hydrogenation with H2/Pt successfully resulted in desired alcohol T6.1a. Conversion of 
2-amino-3-methylpentanoic acid to 2-chloro-3-methylpentanoic acid in the presence of 
HCl and NaNO2, followed by LAH reduction yielded alcohol T6.1b. 
The required diazosulfones were prepared according to the method shown in 
Table 6, using alcohols T6.1a and T6.1b as starting materials. Alcohol T6.1 was treated 
with p-TsCl using pyridine as a solvent at room temperature to yield tosylated compound 
T6.2, which was then converted to its corresponding sulfide T6.3 by reacting with ethyl 
mercaptoacetate and K2CO3 in acetone at rt. Sulfone T6.4 obtained from the Oxone 
oxidation of sulfide T6.3, was then treated with MsN3 in the presence of DBU to yield 
the desired diazosulfone T6.5 (Table 6).  
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Table 6. Preparation of diazosulfones.49, 167 
 
 
 
 
 
5.1.2 Preparation of alcohol substrates for diazosulfonates 
Several commercially available alcohols (T7.1a, T7.1b, T7.1e, T7.1g and T7.1h) 
and some easily prepared alcohols (T7.1c, T7.1d and T7.1f) were used as substrates for 
diazosulfonates. The synthesis of alcohols T7.1c, T7.1d and T7.1f will be discussed in 
the following section.  
Alcohol T7.1f was prepared by oxidation of isopentanol via Swern oxidation169 
followed by exposure to methylmagnesium iodide in diethyl ether at −78 oC. The 
enantiopure alcohol T7.1c was prepared as a potential precursor to the natural product 
(−)-eburnamonine. To obtain alcohol T7.1c as a single enantiomer, the camphor auxiliary 
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S46.4 was selected. The latter was prepared from commercially available and optically 
pure camphorsulfonic acid S46.1. Compound S46.2 yielded upon treatment with thionyl 
chloride followed by ammonium hydroxide (Scheme 46). The resulting camphor 
sulfonamide was cyclized to furnish compound S46.3 by heating it in a 0.5 N solution of 
HCl. It was further reduced to the desired chiral auxiliary S46.4 by NaBH4 in MeOH.170 
 
 
 
 
Scheme 46. Synthesis of camphor auxiliary S46.4.170  
 
 
The camphor auxiliary S46.4 upon treatment with (E)-pent-2-enoic acid in the 
presence of triethylamine, lithium chloride and pivaloyl chloride resulted in compound 
S47.1.171 Compound S47.1 yielded the acylated product S47.2 upon treatment with 3-
butenylmagnesium bromide. The hydrolytic cleavage of the auxiliary followed by LAH 
reduction resulted in alcohol T7.1c.172 
 
 
 
 
 
 
 
Scheme 47. Synthesis of enantiopure alcohol T7.1c using a camphor auxiliary. 
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 The preparation of enantiopure alcohol T7.1d is necessary in order to prepare a 
single enantiomer of key intermediate S49.2 for the synthesis of (−)-eburnamonin S41.4 
(Scheme 49).168 Prior to the preparation of enantiopure T7.1d, racemic alcohol S48.7 was 
prepared to investigate the feasibility of the proposed reaction scheme (Scheme 48). 
Synthesis of racemic alcohol S48.7 was initiated with diol S48.1. Swern oxidation of 
monobenzylated diol S48.2169 resulted in aldehyde S48.3, which was subjected to the 
Horner–Wadsworth–Emmons reaction with triethylphosphonoacetate in the presence of 
sodium hydride at 0 oC to produceα,β-unsaturated ester S48.5.173 Ester S48.6 was 
obtained via Michael type 1,4 addition of ethylmagnesium bromide in the presence of  
copper bromide, lithium chloride and trimethylsilyl chloride. Resulted ester S48.6 was 
reduced with LAH to furnish racemic alcohol S48.7. In order to obtain key intermediate 
S49.2 in Scheme 49, it is necessary to establish a corresponding stereocenter on ester 
S48.6. Preparation of ester S48.6 with high enantiomeric excess will be shown in Scheme 
49.  
 
 
 
 
 
 
 
 
Scheme 48. Synthesis of racemic alcohol S48.7.  
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5.1.3 Coupling of the substrates with chiral molecules to study enantioselectivity 
The chiral center of the ester S49.1 was established by regio- and enantioselective 
addition of a Grignard reagent to α,β-unsaturated ester S48.5, employing commercially 
available chiral catalyst tol-BINAP. This catalyst along with copper iodide promote the 
regio- and enantioselective addition.174 Therefore, the synthesis of chiral ester S49.1 was 
carried out in t-BuOMe as a solvent at −40 oC with ethylmagnesium bromide and copper 
iodide in the presence of chiral catalyst (R)-tol-BINAP.174 LAH reduction of the resulting 
ester S49.1 gave corresponding alcohol T7.1d (Scheme 49).   
 
 
 
 
 
 
 
 
 
 
Scheme 49. Highly enantioselective synthesis of alcohol T7.1d.  
 
 
The enatiomeric excess of the prepared alcohol T7.1d was determined by 
coupling it with selected chiral derivatizing agents.175 Initially, chiral (S)-2-acetoxy-2-
phenylacetic acid was used for this purpose. Diastereomeric esters S50.1 and S50.2 were 
obtained by coupling of alcohols S48.7 and T7.1d with chiral (S)-2-acetoxy-2-
phenylacetic acid, under Steglich esterification reaction conditions (DCC, DMAP in 
dichloromethane, Scheme 50). No distinctive signal separation could be seen in the 1H 
NMR spectrum of S50.2.  
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Scheme 50. Coupling of racemic and chiral alcohols with (S)-2-acetoxy-2-phenylacetic 
acid).175   
 
To overcome the issue in Scheme 50, it was envisioned to introduce new chiral 
center of the diastereomeric ester (S51.3) closer to the existing chiral center. The pure 
enantiomer of commercially available L-menthol was chosen to serve this purpose. To 
couple with L-menthol, it was necessary to convert racemic ester S48.6 and chiral ester 
S49.1 to their carboxylic acid derivatives S51.2 and S51.3. Hydrolysis of esters S48.6 and 
S49.1 gave their corresponding carboxylic acids, which were then reacted with L-
menthol to produce esters S51.2 and S51.3 (Scheme 51). Similarly to the previous 
example (Scheme 50), the L-menthol-coupled ester showed no resolved peaks in the 1H 
NMR spectrum.   
 
 
 
 
 
Scheme 51. Coupling of racemic and chiral carboxylic acids with (1R,2S,5R)-(−)-
menthol.  
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Since the chiral esters S50.2 and S51.3 could not provide NMR spectra 
appropriate for determination of de, the pure enantiomer of (S)-1-phenylethylamine was 
recognized as a suitable chiral derivatizing agent, because of its ability to form amides  
with carboxylic acids (Scheme 52). (S)-1-Phenylethylamine was coupled with racemic 
and chiral carboxylic acids S51.1 to obtain the corresponding racemic (S52.2) and chiral 
(S52.3) amides. The 1H NMRspectrum of the resulted chiral amide S52.3 displayed 
several distinct peaks from which an enatiomeric ratio could be discerned. The 
diastereomeric excess (88%) of amide S52.3 was found by considering the integrated 
area of the two peaks (at 4.46−4.46 ppm) assigned the benzyl protons (1H NMR spectrum 
is shown in appendix III, Figure 6).    
 
 
 
 
 
 
Scheme 52. Formation of amides with carboxylic acids and (S)-1-phenylethylamine. 
 
 
5.1.4 Preparation of diazosulfonates 
 The commercially available alcohols [(−)-isomenthol (T7.1a), (−)-borneol 
(T7.1c), isopentanol (T7.1e), (−)-citronellol (T7.1g), (−)-menthol (T7.1h)] and prepared 
alcohols (T7.1c, T7.1d and T7.1f) were used to furnish their corresponding 
diazosulfonates, following a two-step sequence as shown in Table 7. The corresponding 
alcohols were treated with ethyl chlorosulfonylacetate, T7.2 (prepared from ethyl 
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chloroacetate as described in reference49) to obtain sulfonates T7.3a−h.48, 158 Although 
triethylamine had previously been used as a base49 for the sulfonation step, imidazole has 
proven to be an excellent base for this reaction, and its use improved the yield of 
sulfonate T7.3 significantly. The obtained sulfonates were subjected to different diazo 
transfer conditions: a) MsN3, DBU, THF, −45 oC; b) MsN3, DIPEA, MeCN, 0 oC and c) 
NosN3, DIPEA, DMF, 0 oC. According to the reported work by John and Novikov,49 
NosN3 is a superior diazo transfer agent for this step. Nonetheless, use of MsN3 
simplified the purification process without affecting the yield of the desired diazo 
compound (T7.4). Hence, MsN3 was used as an efficient diazo transfer agent as shown in 
Table 7. In the presence of MsN3, DIPEA in MeCN at 0 oC, T7.3e and T7.3f were 
successfully converted to their corresponding diazo compounds T7.4e and T7.4f. Due to 
poor yields obtained under these conditions for some of the diazosulfonates, the reactions 
were repeated by replacing the base and the solvent with DBU and THF respectively. 
Under these conditions, the yields of diazo compounds T7.1a, T7.1b, T7.1g and T7.1h 
improved significantly. Even though purification was easily achieved when the reaction 
was carried out in the presence of MsN3, the preparation of diazo T7.1d was considerably 
more efficient with NosN3 than with MsN3. Unexpectedly, partial decomposition was 
observed with diazo T7.1c, resulting in very low yield. This step has yet to be optimized 
for this particular compound.   
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Table 7. Preparation of diazosulfonates.49, 167 
 
 
 
 
 
Entry R substituent Diazo compound, T7.4 
Yield (%) 
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Table 7. Cont. 
a
 Yield in the preparation of diazo compound using condition (a);  b: Yield in the preparation of diazo 
compound using condition (b);  c: Yield in the preparation of diazo compound using condition (c).  
 
 
5.1.5 C−H insertion of diazosulfones and diazosulfonates 
 According to the work reported by John and Novikov,49 diazosulfones and 
sulfonates undergo C−H insertion reactions to selectively form six-membered ring 
structures, despite the sterics at the tertiary carbon center.49 In addition, the authors found 
that the same influence is exerted in the presence of Rh2(pfb)4, with strong electron-
withdrawing ligands. This suggests that the electronic environment is another key aspect 
towards selectivity. Therefore, careful selection of the Rh(II) catalyst for intramolecular 
Entry R substituent Diazo compound, T7.4 
Yield (%) 
T7.3 T7.4 
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75 
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C−H insertion of diazosulfones and sulfonates should allow more control over the 
selectivity.166      
 Commercially available Rh2(OAc)4 has proven to be one of the most suitable 
catalysts for the C−H insertion reaction of carbethoxy sulfones and sulfonates.49, 166, 176 
Du Bois has recommended Rh2(esp)4  as a superior catalyst for particular intramolecular 
C−H insertion reactions,109 therefore, Rh2(esp)4 was used when appropriate. Preparation 
of Rh2(esp)4 was carried out in our lab utilizing readily available materials according to 
the synthetic procedure proposed by Du Bois,109 with few modifications (Scheme 53). 
The synthesis of the catalyst was initiated by dialkylation of ethyl isobutyrate S53.1 with 
freshly prepared LDA at −78 oC and with dibromo m-xylene S53.2 to obtain diester 
S53.3. Hydrolysis of resulted diester S53.3 to its corresponding dicarboxylate S53.4 
followed by metalation with Rh2(OAc)4 afforded the desired Rh2(esp)2 complex S53.5 in 
55% yield.  
 
 
 
 
 
 
 
 
 
 
Scheme 53. Preparation of Rh2(esp)4.    
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The previously obtained diazosulfones (T6.5a and T6.5b) had been converted 
into their six-membered cyclic sulfones (F5.1 and F5.2) in Dr. Novikov’s lab (Table 
8).167 
  
Table 8. C−H insertion of carbethoxy sulfones.49, 167 
 
 
 
 
 
 
 The previously obtained diazosulfonates (Table 7) were subjected to C−H 
insertion conditions with the aim of constructing δ-sultones under the influence of a 
suitable Rh(II) catalyst. Notably, the effective formation of new stereocenters in sultones 
T5.1a, T5.1b, T5.1g and T5.1h was observed. Due to this reason, these intermediates can 
serve as potential synthetic precursors to natural products.167 Synthesis of (+)-bakuchiol 
was achieved using T5.1g as the key intermediate providing a quaternary center, 
Substrate T6.5 Conditions Product T8.1 Yield (%) 
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demonstrating the utility of the C−H insertion methodology.157 The diazosulfonate T7.4d 
was subjected to C−H insertion conditions [2 mol% of Rh2(OAc)2] and unexpectedly it 
gave unidentified products. Modification of this step using Rh2(esp)2 led to the successful 
synthesis of the corresponding δ-sultone T5.1d.158 The resulted benzyl-protected 
diastereomers T5.1d, could be used to construct the five-membered lactone T5.2d, which 
is the key intermediate of the (−)-eburnamonine (S41.4) synthesis (Scheme 54).168 
Additionally, preparation of T5.1c was planned because of its viability in the synthesis of 
five-membered lactone T5.2c (Scheme 55), which would also serve as a precursor to (−)-
eburnamonine. Unexpectedly, exposure of substrate T7.4c to the diazo reaction 
conditions resulted in unidentified byproducts, with no desired cyclized products. The 
cyclization of (−)-menthol diazosulfonate T7.4h and (−)-isomenthol diazosulfonate 
T7.4a also provided useful synthetic intermediates T5.1h and T5.1a in considerably high 
yields. The diastereomeric ratio of δ-sultones T5.1h and T5.1a was erratically different 
from one experiment to the next. This behavior can be attributed to the changing nature 
of Rh2(OAc)4 catalyst during the reaction.49, 109 In the case of (−)-borneol diazosulfonate 
T7.4b, two products (T5.1b1 and T5.1b2) were formed unexpectedly. Greater amount of 
unexpected product T5.1b1 was formed by C−H insertion involving the methyl group, 
whereas the expected δ-sultone T5.1b2 was formed as the minor product by C−H 
insertion into the methylene bridge.   
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Table 9. C−H insertion of carbethoxy sulfonates.49, 167 
 
 
 
 
 
Substrate T7.4 Conditions Product T9.1 Yield (%)  
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Table 9. Cont. 
 
 
5.1.6 Oxidative conversion of δ-sultones to γ-butyrolactones 
According to the previous work done in Novikov’s research group,166 δ-sultones 
when exposed to TBHP in the presence of KHMDS or t-BuOK are oxidatively converted 
to γ-butyrolactone. Since low yields were obtained in many cases of the reaction, 
optimization of the conditions for desulfonation of each substrate was necessary.  
Optimization studies for the synthesis of γ-butyrolactone S44.6 from 
desulfonation of δ-sultone S44.5 are described in Table 10. The determined optimal 
conditions, shown in entries 7 and 8 produced γ-butyrolactone S44.6 with a satisfactory 
Substrate T7.4 Conditions Product T9.1 Yield (%)  
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yield (75%) using 5 eq of TBHP and 6 eq of t-BuOK in, DME or THF as a solvent at rt. 
According to the data shown in Table 10, the lesser amount of base and oxidizing agent 
are not sufficient to drive the reaction to its completion. Meanwhile, too many 
equivalents of base and oxidizing agent leads to reduction in the yield of the desired γ-
butyrolactone. Therefore, addition of 5 eq of the oxidizing agent, THBP, to the reaction 
mixture followed by the addition of 6 eq of the base, t-BuOK, in the presence of THF or 
DME as a solvent at room temperature were determined to be the optimized reaction 
conditions for oxidative desulfonation of δ-sultones to γ-butyrolactones.  
 
Table 10. TBHP oxidative desulfonation of δ-sultones to γ-butyrolactones. 
    
    
    
 
Entry Conditions Solvent Yield (%) 
1 First (3 eq)TBHP, then (4 eq) t-BuOK THF 42 
2 First (4 eq) t-BuOK , then (3 eq) TBHP THF 20 
3 Mixture of (3 eq)TBHP and (4 eq) t-BuOK THF SM 
4 First (3 eq)TBHP, then (2 eq) K2CO3 THF SM 
5 First (3 eq)TBHP, then (4 eq) t-BuOK DEE SM 
6 First (3 eq)TBHP, then (4 eq) t-BuOK DME 40 
O
O
TBHP, t-BuOK
Solvent, rt, 12h
O
SO
O COOEt
BnO
OBn
S44.5 S44.6
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Table 10. Cont. 
Entry Conditions Solvent Yield (%) 
7 First (5 eq)TBHP, then (6 eq) t-BuOK DME 75 
8 First (5 eq)TBHP, then (6 eq) t-BuOK THF 74 
9 First (10 eq)TBHP, then (12 eq) t-BuOK THF 50 
10 First (7 eq)TBHP, then (8 eq) t-BuOK THF 65 
SM=Starting material 
 
To demonstrate the application of the oxidative conversion of δ-sultones to γ-
butyrolactones using the above optimized conditions, δ-sultone substrates shown in Table 
9 were selected. The conversion of simple δ-sultones T5.1e and T5.1f to γ-butyrolactones 
T5.2e and T5.2f was carried out resulting in 54% and 60% yields of the products, 
respectively. These two δ-sultones T5.1e and T5.1f exhibited the viability of the 
optimized oxidative desulfonation conditions on simple substrates. These relatively low 
yields could be due to volatility and water solubility of these low molecular weight γ-
butyrolactones. To evaluate the extent of this problem, the lactones T5.2e and T5.2f were 
prepared using alternative routes as explained in Appendix II, Scheme 58. The volatility 
of T5.2e and T5.2f were assessed using a rotary evaporator. From this study, it was 
concluded that although lactones T5.2e and T5.2f are not extremely volatile, there is a 
high tendency to lose the product during the long exposure to vacuum and elevated 
temperatures (above 30 oC). Taking this information into account, lactones T5.2e and 
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T5.2f (Table 11) were treated carefully. In the case of δ-sultone T5.1b1, the product 
T5.2b1 was isolated with 70% yield. Surprisingly, the desired product T5.2b2 could not 
be obtained from T5.1b2. Instead, unidentified byproducts formed. The construction of γ-
butyrolactone T5.2d from δ-sultone T5.1d in the presence of both THF and DME 
resulted in compatible yields, confirming that these two solvents are suitable for the 
oxidative desulfonation step. To demonstrate the importance of these γ-butyrolactone 
precursors in the synthesis of natural product, a synthetic approach towards (−)-
eburnamonin,168 consuming γ-butyrolactone T5.2d as a key intermediate, will be 
discussed in Section 5.2.  
 
Table 11. TBHP oxidative desulfonation of δ-sultones to γ-butyrolactones.  
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Table 11. Cont. 
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Table 11. Cont. 
 
 
 
5.2 Studies towards the synthesis of (−)-eburnamonine  
(−)-Eburnamonine is a pentacyclic indole alkaloid isolated from Hunteria 
eburnea plant. This important alkaloid is a cerebrovascular agent and has received 
considerable and sustained attention from chemists due to their structural complexity and 
biological activities.177 Several total syntheses of (−)-eburnamonine have been carried out 
during the past four decades.168, 178−180 In the total synthesis of (−)-eburnamonine by Node 
et al.,168 the five-membered lactone S49.2 is a key intermediate from which (−)-
eburnamonine is obtained after an additional seven steps utilizing tryptamine S54.1 
(Scheme 54).168 Using the developed methodology, γ-butyrolactone S49.2 can be 
prepared from a δ-sultone T5.1d using oxidative desulfonation.  
 
 
 
 
 
Scheme 54. Synthesis of (−)-eburnamonine.168  
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It was envisioned that the chiral lactone T5.2c and T5.2d could provide potential 
synthetic intermediates in the approach towards γ-butyrolactone S49.2. Synthesis of both 
γ-butyrolactones T5.2c and T5.2d were carried out in parallel.  
 Our approach toward the synthesis of butyrolactone T5.2c (Scheme 55) was 
initiated with previously prepared enantiopure T7.1c (Scheme 47), which was then 
converted to diazo compound T7.4c via two steps (Table 7). The diazo substrate T7.4c 
was exposed to the C−H insertion reaction conditions (Table 9). The attempt was 
unsuccessful and no cyclized products were isolated. However, the synthesis of the key 
intermediate γ-butyrolactone S49.2 was successfully achieved via benzyl-protected γ-
butyrolactone T5.2d as shown in Schemes 56 and 57.   
   
 
 
 
 
 
 
Scheme 55. Approach towards the synthesis of γ-butyrolactone T5.2c.  
 
 
As shown in the retrosynthetic analysis (Scheme 56), total formal synthesis of 
(−)-eburnamonine can be achieved using commercially available 1,4-butanediol S48.1 as 
a low-cost and readily available starting material.  
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Scheme 56. Retrosynthetic analysis of (−)-eburnamonine.  
 
The chiral lactone T5.2d, which was synthesized from diol S48.1, was subjected 
to catalytic hydrogenolysis conditions to deprotect the benzyl group. The resulting 
lactone S49.2 can be a potential synthetic intermediate towards the synthesis of (−)-
eburnamonine (Scheme 57).168  
 
 
 
 
Scheme 57. Preparation of chiral key intermediate S49.2 to form (−)-eburnamonine. 
 
  
5.3   Conclusion 
In summary, new potentially useful synthetic intermediates were prepared by 
diazosulfonate and diazosulfone C−H insertion from easily available starting materials. 
Oxidative conversion of δ-sultones, which are the product of C−H insertion on 
diazosulfonates, to γ-butyrolactones by treatment with TBHP and t-BuOK was optimized 
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to provide consistently good yields of the lactone products. Using this methodology, the 
key intermediate in the synthesis of (−)-eburnamonine was prepared from commercially 
available 1,4-butane diol. 
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CHEPTER VI 
 
EXPERIMENTAL SECTION FOR RHODIUM-CATALYZED INTRAMOLECULAR 
C–H INSERTION STUDIES ON DIAZOSULFONATES 
 
6.1 General information and instrumentation 
 All reactions were carried out under an inert nitrogen atmosphere unless 
otherwise stated. 1H and 13C NMR spectra were recorded on a Bruker AVANCE 500 
NMR spectrometer. All spectra were obtained in deuterochloroform (CDCl3). Chemical 
shifts are reported in ppm relative to tetramethylsilane (TMS). Spin-spin coupling 
constants, J, are reported in hertz (Hz). Infrared (IR) spectra were acquired on a Perkin 
Elmer Spectrum 400 FT-IR/FT-FIR spectrometer. HRMS data were obtained on an 
Agilent 61969A TOF high resolution mass spectrometer using electrospray ionization 
(ESI). Melting points were determined on a MEL-TEMP melting point apparatus. 
Analytical thin layer chromatography (TLC) was performed on silica gel 60 F254  
(E. Merck no. 5715-7) pre-coated plates. Purification by column chromatography was 
performed using 40-63 µm silica gel (Merck, Geduran, no. 11567-1) as the stationary 
phase. THF was distilled over sodium-benzophenone under nitrogen before use. 
Dichloromethane was distilled over calcium hydride under nitrogen atmosphere. All 
other chemicals were used as purchased without further purification, unless mentioned. 
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6.2 Procedures and physical data for compounds from Table 6 
General procedure for tosylation (T6.2a−T6.2b) 
A solution of alcohol T6.1 (1 equiv) and tosyl chloride (3 equiv) in pyridine (10 
mL/mmol) was stirred at rt for 24 h. Upon completion of the reaction, the reaction 
mixture was diluted with 10 mL of ethyl acetate, washed with water (10 mL), a 1 N 
solution of hydrochloric acid (10 mL) and again with water (10 mL). The organic layer 
was then dried with anhydrous magnesium sulfate, filtered and volatiles were removed 
under reduced pressure. The crude product was purified by column chromatography on 
silica gel using petroleum ether. 
 
2-Methylpentyl 4-methylbenzenesulfonate (T6.2a). The 
compound was purified by column chromatography on silica gel  
(petroleum ether). Pale yellow oil (90%). Rf = 0.40 (petroleum ether). The physical data 
of T6.2a match with its previously reported data of the compound.49   
 
3-Methylpentyl 4-methylbenzenesulfonate (T6.2b). The 
compound was purified by column chromatography on silica gel  
(petroleum ether). Pale yellow oil (94%). Rf = 0.35 (petroleum ether). The physical data 
of T6.2b match with its previously reported data of the compound.49   
  
General procedure for sulfones (T6.4a−T6.4b)  
The corresponding tosylated compound T6.2 (1.0 equiv, 0.5 to 5 mmol) was dissolved in 
acetone (20 mL/mmol) under nitrogen atmosphere. K2CO3 (2.0 equiv) was then added to 
T6.2a
OTs
T6.2b
OTs
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the reaction mixture followed by ethyl mercaptoacetate (1.5 mmol). The reaction mixture 
was then stirred for 24 h at rt. The volatiles were removed under reduced pressure, and 
the resulted residue was partitioned between ethyl acetate (20 mL) and water (10 mL). 
After separating the organic layer, the aqueous layer was further washed with ethyl 
acetate (2 × 20 mL). The combined organic layers were dried with anhydrous magnesium 
sulfate and volatiles were removed under reduced pressure. The obtained crude sulphide 
T6.3 was dissolved in acetone (2 mL), then water was added (5 mL) followed by Oxone 
(4 mmol). The reaction mixture was stirred for 12 h at rt. Upon completion of the 
reaction, the product was extracted with ethyl acetate (20 mL). The separated aqueous 
layer was washed again with two additional portions of ethyl acetate (10 mL). The 
combined organic layers were dried with anhydrous magnesium sulfate, filtered and 
volatiles were removed under reduced pressure. The crude sulfone was purified by 
column chromatography on silica column (EtOAc-hexanes) to yield the pure product.  
 
Ethyl 2-(2-methylpentylsulfonyl)acetate (T6.4a). The 
compound was purified by column chromatography on 
silica gel (1:5, EtOAc-hexane). Pale yellow oil (88%). Rf =  
0.30 (1:5, EtOAc-hexane). 1H NMR (500 MHz, CDCl3): δ 0.91 (t, J = 7.0 Hz, 3H), 1.16 
(d, J = 6.5 Hz, 3H), 1.33 (t, J = 7.0 Hz, 3H), 1.29−1.39 (m, 4H), 1.46−1.55 (m, 1H), 3.09 
(dd, J = 14.0, 8.0 Hz, 1H), 3.32 (dd, J = 14.0, 4.5 Hz, 1H), 3.95 (s, 2H), 4.28 (q, J = 7.0 
Hz, 2H). 13C NMR (125 MHz, CDCl3): δ 14.1 (CH3), 14.4 (CH3), 19.8 (CH2), 20.0 
(CH3), 28.0 (CH), 39.1 (CH2), 58.9 (CH2), 59.8 (CH2), 62.8 (CH2), 163.4 (C). HRMS 
S
O
O
T6.4a
O O
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(ESI) calcd for C10H24NO4S [M+NH4]+ 254.1432, found 254.1425. Note: equivalence of 
the two CH3 groups is coincidental. 
  
Ethyl 2-(3-methylpentylsulfonyl)acetate (6.4b). The 
compound was purified by column chromatography on 
silica gel (1:5, EtOAc-hexane). Pale yellow oil (90%). Rf =  
0.30 (1:5, EtOAc-hexane). 1H NMR (500 MHz, CDCl3): δ 0.91 (t, J = 7.5 Hz, 3H), 0.94 
(d, J = 7.0 Hz, 3H), 1.20−1.28 (m, 1H), 1.33 (t, J = 7.0 Hz, 3H), 1.34−1.43 (m, 1H), 
1.49−1.56 (m, 1H), 1.64−1.73 (m, 1H), 1.85−1.94 (m, 1H), 3.19−3.33 (m, 2H), 3.92 (s, 
2H), 4.28 (q, J = 7.0 Hz, 2H). 13C NMR (125 MHz, CDCl3): δ 11.3 (CH3), 14.2 (CH3), 
18.9 (CH3), 28.3 (CH2), 29.1 (CH2), 33.8 (CH), 51.9 (CH2), 57.4 (CH2), 62.9 (CH2), 
163.3 (C). HRMS (ESI) calcd for C10H24NO4S [M+NH4]+ 254.1432, found 254.1421. 
 
General procedure for diazo compounds (T6.5a−T6.5b).  
The corresponding sulfone ester T6.4 (1 mmol) in THF (5mL/mmol) was cooled to     
−45 oC and to this solution mesyl azide was added (1.1 equiv). DBU (1.5 equiv) was then 
added dropwise over a 2−3 min period. After stirring at −45 oC for 1 h, the solution was 
warmed to 25 oC over a 15−20 min period, diluted with 20 mL of half-saturated aqueous 
solution of ammonium sulfate, and the aqueous layer was extracted with 3 × 10 mL of 
dichloromethane. The combine organic extracts were dried over anhydrous sodium 
sulfate, filtered, and concentrated under reduced pressure. Purification by column 
chromatography on silica gel (1:9−1:5, EtOAc-hexanes) yielded the pure product. 
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Note: All diazo compounds do not show the diazo carbon in their 13C spectra. IR (neat, 
cm-1, ν): 2130 (          ) 
 
Ethyl 2-(2-methylpentylsulfonyl)diazoacetate (6.5a). The 
compound was purified by column chromatography on 
silica gel (1:5, EtOAc-hexane). Colorless oil (80%). Rf =  
0.32 (1:5, EtOAc-hexane). 1H NMR (500 MHz, CDCl3): δ 0.92 (t, J = 7.0 Hz, 3H),  1.15 
(d, J = 7.0 Hz, 3H), 1.30 (t, J = 6.9 Hz, 3H), 1.34−1.41 (m, 4H), 2.15−2.25 (m, 1H), 3.21 
(dd, J = 14.0, 8.0 Hz, 1H), 3.45 (dd, J = 14.0, 4.5 Hz, 1H), 4.34 (q, J = 7.0 Hz, 2H). 13C 
NMR (125 MHz, CDCl3): δ 14.1 (CH3), 14.5 (CH3), 19.7 (CH2), 19.9 (CH3), 28.9 (CH), 
38.9 (CH2), 62.7 (CH2), 63.0 (CH2), 160.4 (C). IR (neat, cm-1, ν): 2129, 1714, 1333, 
1146. 
 
Ethyl 2-(3-methylpentylsulfonyl)diazoacetate (6.5b).  
The compound was purified by column chromatography on 
silica gel (1:5, EtOAc-hexane). Colorless oil (88%). Rf =  
0.32 (1:5, EtOAc-hexane). 1H NMR (500 MHz, CDCl3): δ 0.89 (t, J = 7.0 Hz, 3H),  0.91 
(d, J = 7.0 Hz, 3H), 1.18−1.26 (m, 1H), 1.34 (t, J = 7.0 Hz, 3H), 1.34−1.42 (m, 1H), 
1.46−1.54 (m, 1H), 1.60−1.68 (m, 1H), 1.80−1.88 (m, 1H), 3.32−3.46 (m, 2H), 4.34 (q, J 
= 7.0 Hz, 2H). 13C NMR (125 MHz, CDCl3): δ 11.3 (CH3), 14.5 (CH3), 19.0 (CH3), 29.0 
(CH2), 29.1 (CH2), 33.5 (CH), 54.9 (CH2), 62.7 (CH2), 160.3 (C). IR (neat, cm-1, ν): 
2129, 1711, 1333, 1146. 
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6.3 Procedures and physical data for compounds from Scheme 46 
1-[(1R,4S)-7,7-Dimethyl-2-oxobicyclo[2.2.1]hept-1- 
yl]methanesulfonamide (S46.2). Into a two-necked round- 
bottom flask, a reflux condenser was fitted with a bubbler for  
monitoring gas evolution. Camphorsulfonic acid S46.1 (3.00 g,  
12.9 mmol) and 50 mL of anhydrous chloroform were added to the flask. The suspension 
of camphorsulfonic acid was heated to reflux and freshly distilled thionyl chloride (1.5 
mL, 20 mmol) was then added dropwise over a 1 h period. Heating was continued for 
12−14 h until gas evolution (sulfur dioxide and hydrogen chloride) had ceased. The 
resultant solution of camphorsulfonyl chloride in chloroform was converted to 
camphorsulfonamide without further purification. A two-neck round-bottom flask was 
charged with 45 mL of ammonium hydroxide and the solution was cooled to 0 oC. The 
above-prepared crude camphorsulfonyl chloride solution was added dropwise to the 
ammonium hydroxide solution at 0−10°C over a period of 1 h. The reaction mixture was 
warmed to room temperature and stirred for 4 h. The organic layer was separated and the 
aqueous layer was washed with dichloromethane (3 × 25 mL). The combined organic 
layers were washed with brine (25 mL), dried over anhydrous magnesium sulfate and 
filtered. The volatiles were removed under reduced pressure yielding 2.99 g (92%) of 
crude camphorsulfonamide S46.2 as a white solid. The physical data of S46.2 match with 
its previously reported data of the compound.170   
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(1R,7S)-10,10-Dimethyl-3-thia-4-azatricyclo[5.2.1.01,5]dec-4-ene 3,3- 
dioxide (S46.3). 125 mL of a 1 N solution of HCl was added to crude 
camphorsulfonamide S46.2 (2.99 g, 12.9 mmol) and the reaction mixture 
was refluxed overnight.  Upon completion of the reaction, needle-like  
crystals were collected by filtering through a sintered funnel and crystals were washed 
with copious amounts of water. The product was dried under vacuum yielding 1.50 g 
(55%) of the cyclized compound S46.3 as white crystals. The physical data of S46.3 
match with its previously reported data of the compound.170   
 
(1R,7S)-10,10-Dimethyl-3-thia-4-azatricyclo[5.2.1.01,5]decane 3,3- 
dioxide (S46.4). The compound S46.3 (1.50 g, 7.00 mmol) was dissolved 
in 20 mL of anhydrous methanol and the mixture was cooled to 0 oC. 
Sodium borohydride (400 mg, 11.0 mmol) was then added to the reaction mixture and 
stirred for 4 h at 0 oC. Then 10 mL of a 0.1 N solution of HCl was added to the mixture 
and volatiles were removed under reduced pressure. The remaining aqueous layer was 
extracted with ethyl acetate (2 × 50 mL) followed by drying over anhydrous magnesium 
sulfate and filtration. Volatiles were removed under reduced pressure and 1.28 g (86%) of 
the crude product S46.4 was obtained as a white solid. The physical data of S46.4 match 
with its previously reported data of the compound.170   
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6.4 Procedures and physical data for compounds from Scheme 47 
(2E)-1-[(1R,7S)-10,10-dimethyl-3,3-dioxido-3-thia-4- 
azatricyclo[5.2.1.01,5]dec-4-yl]pent-2-en-1-one (S47.1). 
To the solution of (E)-pent-2-enoic acid (100 mg,  
1.00 mmol) and triethylamine (252 mg, 2.50 mmol) in 5 mL of THF, pivaloyl chloride 
(120 mg, 1.00 mmol) was added at −25 oC. The resulting mixture was stirred at −20 oC 
for 2 h. Lithium chloride (46.6 mg, 1.10 mmol) was then added, followed by camphor 
auxiliary S46.4 (215 mg, 1.00 mmol). The mixture was warmed to rt and stirred for 4h. 
THF was removed under reduced pressure, and the resulting residue was diluted with 10 
mL of ethyl acetate and 10 mL of a 5% solution of potassium hydrogen sulfate. The 
organic layer was further washed with a solution of potassium hydrogen sulfate (10 mL), 
brine (10 mL), a 1 M aqueous solution of sodium bicarbonate (2 × 10 mL) and again with 
brine (10 mL).The organic layer was dried over anhydrous magnesium sulfate, filtered 
and volatiles were removed under reduced pressure. Purification of the resulting residue 
by column chromatography on silica gel (1:7, EtOAc-hexane) afforded 2.60 g (64%) of 
compound S47.1 as a pale yellow oil. Rf = 0.25 (1:5, EtOAc-hexane). The physical data 
of S47.1 match with its previously reported data of the compound.181   
 
Allylated camphor auxiliary (S47.2). Copper(I) bromide 
(9.5 mg, 0.050 mmol) and lithium chloride (4.2 mg,  
0.10 mmol) were added to a dried round bottom flask. The  
flask was evacuated, heated with a heat gun and allowed to cool to rt under vacuum after 
which it was filled with nitrogen. THF (1.0 mL) was then added to the above mixture and 
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the reaction mixture was stirred for 10 min. The resulting homogeneous reaction mixture 
was cooled to 0 oC and ester S47.1 (73.4 mg, 0.250 mmol) in 1.0 mL of THF was added 
followed by trimethylsilyl chloride (38 µL, 0.30 mmol). The solution was stirred at 0 oC 
for 15 min. A 2.0 M solution of ethylmagnesium bromide in THF (185 µL, 0.370 mmol) 
was then added dropwise. The resulting reaction mixture was stirred for 1 h at 0 oC and 
poured into 10 mL of saturated aqueous solution of ammonium chloride. The mixture 
was extracted with diethyl ether (3 × 5 mL). The combined organic extracts were washed 
with brine, dried over anhydrous magnesium sulfate, filtered and volatiles were removed 
under reduced pressure. Purification of the resulting residue by column chromatography 
on silica gel (1:7, EtOAc-hexane) yielded 54 mg (62%) of compound S47.2 as a white 
solid. Rf = 0.35 (1:5, EtOAc-hexane). 1H NMR (CDCl3, 500 MHz): δ 0.85 (t, J = 7.0 Hz, 
3H), 0.99−1.15 (s, 6H), 1.30−1.50 (m, 11H), 1.90 (m, 1H), 2.10 (m, 3H), 2.50−2.70 (m, 
1H), 3.35 (q, J = 14.1 Hz, 2H), 3.90 (t, J = 6.0 Hz, 1H), 4.90 (dd, J = 16.6, 5.0 Hz, 2H), 
5.80 (m, 1H). 13C NMR (CDCl3, 125 MHz): δ 10.1 (CH2), 19.2 (CH3), 20.1 (CH3), 25.7 
(CH2), 29.6 (CH2), 30.2 (CH2), 32.1 (CH2), 34.9 (CH2), 35.3 (CH2), 37.9 (CH2), 39.0 
(CH), 43.7 (C), 47.1 (CH), 47.6 (C),  52.3 (CH2), 64.6 (CH), 113.7 (CH2), 138.1 (CH), 
171.1 (C).   
 
(S)-3-Ethylhept-6-enoic acid (S47.3). 1:4 mixture of THF and  
water (3 mL) was added to compound S47.2 (54.0 mg,  
0.160 mmol) and the reaction mixture was cooled to 0 oC.  
Hydrogen peroxide (18 µL from a 30% aqueous solution of hydrogen peroxide, 0.63 
mmol) was then added followed by lithium hydroxide (9.9 mg, 0.24 mmol) and the 
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reaction mixture was stirred for 5 h.  Upon completion, the reaction was quenched with 
saturated aqueous solution of sodium sulfite
 
(3 mL), THF was removed under reduced 
pressure and the auxiliary was removed by extracting the aqueous layer to 
dichloromethane (3 × 10 mL). The aqueous layer was cooled to 0 oC and the mixture was 
brought to pH=1 with a 6 N solution of HCl and phosphoric buffer. The acidified 
aqueous layer was then extracted with ethyl acetate (5 × 10 mL), the combined extracts 
were dried with anhydrous magnesium sulfate, filtered and volatiles were removed under 
reduced pressure yielding 24 mg (99%) of the crude carboxylic acid S47.3 as a colorless 
oil. Rf = 0.20 (1:5, EtOAc-hexane). 1H NMR (CDCl3, 500 MHz): δ 0.80 (t, J = 12.8 Hz, 
3H), 1.25−1.40 (m, 4H), 1.80 (m, 1H), 2.0 (m, 2H), 2.20 (d, J = 11.1 Hz, 2H), 4.38 (dd, J 
= 12.5, 4.5 Hz, 2H), 5.75 (m, 1H), 10.21−10.55 (s, 1H). 13C NMR (CDCl3, 125 MHz): δ 
11.1 (CH3), 26.5 (CH2), 32. 9 (CH2), 36.0 (CH), 36.1 (CH2), 38.8 (CH2), 115.0 (CH2), 
139.0 (CH), 180.4 (C).  
 
3-Ethylhept-6-en-1-ol (T7.1c). Lithium aluminum hydride  
(25.5 mg, 0.670 mmol) was added to a solution of carboxylic acid 
S47.3 (42.0 mg, 0.270 mmol) at 0 oC. The reaction mixture  
was refluxed for 12 h under nitrogen at rt. Upon completion, the reaction mixture was 
cooled to 0 oC and quenched with deionized water, a solution of 15% potassium 
hydroxide followed by additional amount of deionized water. The resulting mixture was 
stirred for 1 h with anhydrous magnesium sulfate. The resulting reaction mixture was 
filtered through a celite plug and volatiles were removed under reduced pressure. 
Purification of the crude product by column chromatography on silica gel (1:3, EtOAc-
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hexane) afforded 13.8 mg (72%) of alcohol T7.1c as a colorless oil. 1H NMR (CDCl3, 
500 MHz): δ 0.90 (t, J = 11.8 Hz, 3H), 1.70 (s, 1H), 3.40 (t, J = 12.5 Hz, 2H), 1.20−1.40 
(m, 5H), 1.55 (m, 2H), 2.05 (m, 2H), 4.95 (dd, J = 12.1, 2.8 Hz, 2H), 5.80 (m, 1H).  
 
6.5 Procedures and physical data for compounds from Scheme 48 
4-(Benzyloxy)butan-1-ol (S48.2). Butane-1,4-diol (5.00 g,  
55.5 mmol) in DMF (5 mL) was added dropwise at 0 oC to a  
stirred suspension of sodium hydride (882 mg, 22.2 mmol). After stirring for 30 min, 
NBu4I (21 mg, 0.055 mmol) was added. Benzyl chloride (2.88 g, 22.8 mmol) in DMF (5 
mL) was then added to the reaction mixture dropwise at 0 oC. After stirring the reaction 
mixture at rt for 14 h, water (25 mL) was added and the product was extracted with 
diethyl ether (50 mL). The organic layer was washed with brine and dried with anhydrous 
magnesium sulfate, filtered and volatiles were evaporated under reduced pressure. 
Purification of the resulting residue by column chromatography on silica gel (1:7, 
EtOAc-hexane) yielded 2.60 g (70%) of compound S48.2 as a pale yellow oil. Rf = 0.35 
(1:5, EtOAc-hexane). The physical data of S48.2 match with its previously reported data 
of the compound.182   
 
4-(Benzyloxy)butanal (S48.3). To a solution of oxalyl chloride 
(1.3 mL, 15 mmol) in 5 mL of dichloromethane, dimethyl  
sulfoxide (2.4 mL, 34 mmol) was added at −78 oC and stirred for 15 min. Alcohol S48.2 
(2.43 g, 13.5 mmol) in 5 mL of dichloromethane was added dropwise to the reaction 
mixture and stirred for 30 min at −78 oC followed by the addition of N,N-ethyl-
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diidopropylamine (11.1 mL, 67.4 mmol). The mixture was warmed to −60 oC over 30 
min and diluted with water (10 mL) at 0 oC. The reaction mixture was extracted with 
diethyl ether (15 mL), and the organic layer was washed with a solution of 2 N 
hydrochloric acid, saturated aqueous solution of sodium bicarbonate (10 mL) and brine 
followed by drying with anhydrous magnesium sulfate
 
and filtration. Volatiles were 
removed under reduced pressure. Purification of the resulting residue by column 
chromatography (1:5, EtOAc-hexane) afforded 2.30 g (95%) of compound S48.3 as a 
colorless oil. Rf = 0.38 (1:5, EtOAc-hexane). The physical data of S48.3 match with its 
previously reported data of the compound.183   
 
(E)-Ethyl 6-(benzyloxy)hex-2-enoate (S48.5). To a 
solution of sodium hydride (92.5 mg, 2.32 mmol, 60%  
dispersion in mineral oil, washed free of oil with anhydrous THF) triethyl 
phosphonoacetate (380 mg, 1.70 mmol) in 2 mL of THF was added at 0 oC. The mixture 
was stirred for 30 min at 0 oC and a solution of aldehyde S48.3 (275 mg, 1.54 mmol) was 
added dropwise under nitrogen. The resulting reaction mixture was left to stir for 30 min 
at 0 oC, and quenched with saturated aqueous solution of ammonium chloride (15 mL). 
The reaction mixture was allowed to warm up to rt and the product was extracted with 
ethyl acetate (2 × 15 mL) and the combined organic extracts were dried over anhydrous 
magnesium sulfate and filtered. Volatiles were removed under reduced pressure. 
Purification of the resulting residue by column chromatography on silica gel (1:9, 
EtOAc-hexane) afforded 268 mg (70%) of unsaturated ester S48.5 as a colorless oil. Rf = 
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0.40 (1:7, EtOAc-hexane): The physical data of S48.5 match with its previously reported 
data of the compound.182   
Ethyl 6-(benzyloxy)-3-ethylhexanoate (S48.6). Copper(I) 
bromide (14.5 mg, 0.100 mmol) and lithium chloride  
(8.5 mg, 0.20 mmol) were added to a round bottom  
flask. The flask was evacuated, heated with a heat gun, allowed to cool to rt under 
vacuum and then filled with nitrogen. THF (3 mL) was then added and the reaction 
mixture was stirred for 10 min. The mixture was cooled to 0 oC and ester S48.5 (250 mg, 
1.01 mmol) in 2 mL of THF was added followed by trimethylsilyl chloride (140 µL, 1.11 
mmol). The solution was stirred at 0 oC for 15 min and 2.0 M ethylmagnesium bromide 
in THF (0.8 mL, 1 mmol) was added dropwise. The resulting reaction mixture was stirred 
for 1 h at 0 oC and poured into 10 mL of saturated aqueous solution of ammonium 
chloride. The mixture was extracted with diethyl ether (3 × 10 mL). The combined 
organic layers were washed with brine, dried over anhydrous magnesium sulfate and 
filtered. Volatiles were removed under reduced pressure. Purification of the crude 
product by column chromatography on silica gel (1:5, EtOAc-hexane) provided 275 mg 
(90%) of pure ester S48.6 as a pale yellow oil. Rf = 0.40 (1:3, EtOAc-hexane). 1H NMR 
(CDCl3, 500 MHz): δ 0.75 (t, J = 7.4 Hz, 3H), 1.10 (t, J = 7.2 Hz, 3H), 1.15−1.30 (m, 
4H), 1.48 (m, 2H), 1.70 (m, 1H), 2.10 (dd, J = 13.6, 6.9 Hz, 2H), 3.20 (t, J = 7.4 Hz, 2H), 
3.98 (q, J = 6.9 Hz, 2H), 4.35 (s, 2H), 7.10−7.30 (m, 5H). 13C NMR (CDCl3, 125 MHz): 
δ 11.2 (CH3), 14.7 (CH3), 26.7 (CH2), 27.2 (CH2), 30.2 (CH2), 36.7 (CH), 39.2 (CH2), 
60.6 (CH2), 71.0 (CH2), 73.3 (CH2), 127.9 (CH), 128.04 (CH), 128.8 (C), 139.0 (C), 
174.0 (C). HRMS (ESI) calcd for C17H26O3Na [M+Na]+ 301.1774, found 301.1743.    
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6-(Benzyloxy)-3-ethylhexan-1-ol (S48.7). A round bottom 
flask was charged with ester S48.6 (275 mg, 0.990 mmol)  
and flushed with nitrogen followed by the addition of 
anhydrous diethyl ether (5 mL). The solution was cooled to 0 oC and lithium aluminum 
hydride (45.0 mg, 1.18 mmol) was added. The reaction mixture was stirred for 24 h at rt. 
Upon the completion of the reaction, the mixture was cooled to 0 oC and quenched with 
water (50 µL) followed by addition of 50 µL of a solution of 15% potassium hydroxide 
and 150 µL of water. The resulting mixture was stirred for 1 h and dried with anhydrous 
magnesium sulfate. The mixture was filtered through a Celite plug and the Celite plug 
was rinsed with excess diethyl ether. Volatiles were removed under vacuum yielding 216 
mg (95%) of alcohol S48.7 as a colorless oil. Rf = 0.20 (1:5, EtOAc-hexane). 1H NMR 
(CDCl3, 500 MHz): δ 0.75 (t, J = 8.1 Hz, 3H), 1.25 (m, 2H), 1.25 (m, 2H), 1.50 (m, 2H), 
1.35 (m, 1H), 2.17 (m, 2H), 3.50 (t, J = 6.7 Hz, 2H), 2.50 (s, 1H), 3.50 (t, J = 6.7 Hz, 
2H), 4.40 (s, 2H), 7.20−7.40 (m, 5H). 13C NMR (CDCl3, 125 MHz): δ 11.1 (CH3), 26.4 
(CH2), 27.2 (CH2), 29.9 (CH2), 35.9 (CH), 36.7 (CH2), 61.20 (CH2), 71.30 (CH2), 73.35 
(CH2), 127.95 (CH), 128.11 (CH), 128.8 (CH), 139.0 (C). HRMS (ESI) calcd for 
C17H26O3Na [M+H]+ 237.1849, found 237.1853.    
 
6.6 Procedures and physical data for compounds from Scheme 49 
(R)-Ethyl 6-(benzyloxy)-3-ethylhexanoate (S49.1). (R)- 
tol-BINAP (10.2 mg, 0.0150 mmol) and CuI (1.9 mg,  
0.010 mmol) was dissolved in methyl tert-butyl ether   
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(1.0 mL) in a round bottom flask and stirred under nitrogen at rt until a yellow suspension 
was observed. The mixture was then cooled to −78 oC and ethylmagnesium bromide (2.0 
M in diethyl ether, 0.5 mL) was added. After stirring for 10 min, a solution of unsaturated 
ester S49.5 (50.0 mg, 0.200 mmol) in methyl tert-butyl ether (250 µL) was added 
dropwise over 1 h by syringe pump. After stirring at −78 oC for 3 h, methanol (0.5 mL) 
and a solution of saturated ammonium chloride (2 mL) were sequentially added, and the 
mixture was warmed to rt. After extracting with diethyl ether (3 × 5 mL), the combined 
organic layers were dried over anhydrous sodium sulfate and concentrated under high 
vacuum to obtain a crude product as a yellow oil. Purification of the resulting crude 
mixture by column chromatography on silica gel (1:4, EtOAc-hexane) afforded 48.0 mg 
(89%) of ester S49.1 as a pale yellow oil. Rf = 0.40 (1:3, EtOAc-hexane).  = +10.8 
(c 0.120, CHCl3). The physical data of S49.1 match with the data reported for racemic 
ester S48.6.  
 
(R)-6-(Benzyloxy)-3-ethylhexan-1-ol (T7.1d). The 
compound T7.1d was obtained using the procedure 
described for compound S48.7 in Scheme 48. 216 mg  
(92%) of the compound T7.1d was isolated as a colorless viscous oil. Rf = 0.200 (1:5, 
EtOAc-hexane).  = +10.2 (c 0.20, CHCl3). The physical data of T7.1d match with 
the data reported for racemic alcohol S48.7.    
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6.7 Procedures and physical data for compounds from Scheme 50 
(S)-6-(Benzyloxy)-3-ethylhexyl 2-acetoxy-2- 
phenylacetate (S50.1). A round bottom flask was 
charged with (S)-2-acetoxy-2-phenylacetic acid  
(12.3 mg, 0.0600 mmol), N,N'-Dicyclohexylcarbodiimide (13.1 mg, 0.0640 mmol) 
followed by 1 mL of dichloromethane. The resulting solution was stirred for 30 min, after 
which alcohol S48.7 (10.0 mg, 0.0400 mmol) dissolved in dichloromethane (0.5 mL) was 
added to it, followed by 4-dimethylaminopyridine (2.6 mg, 0.020 mmol). The reaction 
mixture was stirred overnight at rt under nitrogen. Upon completion of the reaction, the 
mixture was taken up in ethyl acetate (5 mL), washed with a 1 N solution of hydrochloric 
acid (3 × 5 mL), saturated aqueous solution of sodium bicarbonate (5 mL) and brine. The 
organic layer was dried over anhydrous magnesium sulfate, filtered and volatiles were 
removed under reduced pressure. Purification of the resulting residue by column 
chromatography on silica gel (1:7, EtOAc-hexane) afforded 15 mg (86%) of compound 
S50.1 as a colorless oil. Rf = 0.45 (1:5, EtOAc-hexane). 1H NMR (CDCl3, 500 MHz): δ 
0.70 (t, J = 7.5 Hz, 3H), 1.20 (m, 4H), 1.40−1.50 (m, 5H), 2.10 (s, 3H), 3.35 (t, J = 7.3 
Hz, 2H), 4.40 (s, 2H), 4.50 (t, J = 6.5 Hz, 2H), 6.80 (s, 1H), 7.20−7.40 (m, 10H).    
 
Note: The compound S50.2 was obtained using the 
procedure described for compound S50.1. The  
physical data of S50.2 match with the data reported  
for S50.1.    
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6.8 Procedures and physical data for compounds from Scheme 51 
(R)-6-(Benzyloxy)-3-ethylhexanoic acid (S51.1). A round 
bottm flask was charged with ester S49.1 (56.0 mg,  
0.200 mmol), potassium hydroxide (90.4 mg, 1.60 mmol)   
and methanol (2.5 mL). The reaction mixture was refluxed over night at 70−80 oC. Upon 
completion of the reaction, the volatiles were removed under reduced prssure. The 
remaining residue was dissolved in 10 mL of water and organic impurities were extracted 
using a 1:1 mixture od etheyl acetate and hexane (15 mL). The aqeuous layer was 
acidified with a 1 N solution of hydrochloric acid and the carboxylic acid was extracted 
with ethyl acetate (2 × 10 mL). The combined organic layers were then dried with 
anhydrous magnesium sulfate and filtered. Volatiles were removed under reduced 
pressure resulting 49.8 mg (98%) of pure product S51.1 as a colourless liquid. Rf = 0.25 
(1:5, EtOAc-hexane).  = +8.9 (c 0.025, CHCl3). 1H NMR (CDCl3, 500 MHz): δ 0.80 
(t, J = 7.5 Hz, 3H), 1.20 (m, 2H), 1.20−1.30 (m, 4H), 1.70−1.80 (m, 1H), 2.00 (dd, J = 
14.05, 7.5 Hz, 1H), 2.20 (dd, J = 13.57, 6.9 Hz, 1H), 3.50 (t, J = 6.8 Hz, 2H), 4.40 (s, 
2H), 7.20−7.30 (m, 5H), 9.87−10.20 (s, 1H).   
 
     (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 6- 
     (benzyloxy)-3-ethylhexanoate (S51.2).  The 
     compound S51.2 was obtained using the procedure 
described for compound S50.1 in Scheme 50. Purification with column chromatography 
on silica gel (1:9, EtOAc-hexane) afforded 30 mg (71%) of compound S51.2 as a 
colorless viscous liquid. Rf = 0.50 (1:7, EtOAc-hexane). 1H NMR (CDCl3, 500 MHz): δ 
BnO
OH
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0.78−0.83 (m, 12H), 1.25−1.35 (m, 6H), 1.55−1.60 (m, 6H), 1.80 (m, 2H), 1.90 (m, 2H), 
2.15 (dt, J = 12.5, 6.5 Hz, 1H), 3.40 (t, J = 13.0 Hz, 3H), 3.90 (m, 1H), 4.40 (s, 2H), 
7.20−7.30 (m, 5H).     
 
Note: The compound S51.3 was obtained using the 
procedure described for compound S50.1 in  
Scheme 50. The physical data of S51.3 match   
with the data of compound S51.2.    
 
6.9 Procedures and physical data for compounds from Scheme 52 
6-(Benzyloxy)-3-ethyl-N-[(S)-1-phenylethyl]hexanamide 
(S52.2). A solution of carboxylic acid (5.0 mg,  
0.020 mmol) in 0.5 mL dichloromethane was cooled to  
0 oC and oxalyl chloride (5.1 mg, 0.040 mmol) was added dropwise. The reaction was 
stirred at 0 oC for 1 h and the volatiles were removed under reduced pressure. The residue 
was dissolved in 0.1 mL dichloromethane followed by the addition of (S)-1-
phenylethylamine (2.9 mg, 0.024 mmol) and triethylamine (3.1 mg, 0.030 mmol). Then 
the reaction mixture was stirred for 2 h at 0 oC. Upon completion, the reaction was 
quenched with water. The product was extracted with dicholoromethane (4 × 5 mL). The 
combined extracts were washed with a 1 N solution of hydrochloric acid (5 mL) followed 
by saturated aqueous solution of sodium bicarbonate (5 mL). The resulting organic layer 
was dried over anhydrous magnesium sulfate and volatiles were removed under vacuum. 
Purification of the resulting residue by column chromatography on silica gel (1:5−3:1, 
BnO
O
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EtOAc-hexane) afforded 6 mg (85%) of amide S52.2 as a colorless oil. Rf = 0.10 (1:5, 
EtOAc-hexane)  = −26 (c 0.034, CHCl3). 1H NMR (CDCl3, 500 MHz): δ 0.77 (t, J = 
7.5 Hz, 3H), 1.25−1.29 (m, 4H), 1.40 (d, J = 6.9 Hz, 3H), 1.50−1.60 (m, 2H), 1.80 (m, 
1H), 2.20 (m, 2H), 3.35 (t, J = 6.9 Hz, 2H), 4.40 (s, 2H), 5.59 (q, J = 7.2 Hz,  2H), 
7.20−7.30 (m, 10H).     
 
Note: The compound S52.3 was obtained using the  
procedure described for compound S52.2. The physical 
data of S52.3 match with the data reported for S52.2. The  
compound showed two significant peaks around 4.30−4.50 ppm as a proof of enatiomeric 
excess (Appendix III, Figure 6)  
 
6.10 Procedures and physical data for compounds from Table 7 
Ethyl chlorosulfonylacetate (T7.2). A solution of ethyl  
chloroacetate (8.8 mL, 71 mmol) in 40 mL of ethanol was added to  
a solution of sodium sulfite (6.00 g, 47.6 mmol) in 40 mL of water. The mixture was 
reflux for 6 h and volatiles were then removed under reduced pressure. The concentrated 
materials were azeotropically dried with toluene (3 × 40 mL) to afford a white solid. The 
product was allowed to stand under vacuum at 100 oC for 12 h. The flask was then fitted 
with a reflux condenser and flushed with nitrogen. To the resulting white solid, 
succession of 50 mL toluene, DMF (348 mg, 4.76 mmol), and oxalyl chloride (12.08 g, 
95.20 mmol) was added. The white suspension was heated at 100 oC for 3 h. The 
resulting turbid solution was cooled to 25 oC and filtered through a small pad of Celite. 
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The flask and filter cake were washed with an additional 200 mL of toluene. The filtrate 
was concentrated under reduced pressure, and the resulting yellow residue was purified 
by distillation under high vacuum at 170−180 oC to afford 3.25 g (50%) the sulfonyl 
chloride as a pale yellow oil, which was stored under nitrogen. The physical data of T7.2 
match with its previously reported data of the compound.184   
 
General procedure for Sulfonates (T7.3a−T7.3h)  
A solution of ethyl chlorosulfonylacetate S7.2 (355 mg, 1.80 mmol) in 2.5 mL of THF 
was added dropwise to a mixture of corresponding alcohol S7.1 (355 mg, 1.50 mmol) and 
imidazole (123 mg, 1.80 mmol) in 2.5 mL of THF. Upon completion of the reaction after 
16 h, the mixture was diluted with 20 mL of water, and the aqueous layer was extracted 
with dichloromethane (3 × 10 mL). The combined dichloromethane layers were washed 
with a 1 N solution of hydrochloric acid, saturated aqueous solution of sodium 
bicarbonate and brine. The organic layer was then dried over anhydrous sodium sulfate 
and volatiles were removed under reduced pressure. The resulting crude product was 
purified by column chromatography on silica gel (1:7, EtOAc-hexane) affording the pure 
sulfonate S7.3.  
 
 (1S,2R,5R)-Ethyl-2-{[5-methyl-2-(1-
methylethyl)cyclohexyl]oxy}sulfonyl acetate (T7.3a).  
The compound was purified by column chromatography on 
silica gel (1:3, EtOAc-hexane). Colorless solid (98%). Rf =  
O
S
O
O
T7.3a
O O
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0.40 (1:5, EtOAc-hexane). 1H NMR (500 MHz, CDCl3): δ 0.91 (d, J = 6.5 Hz, 6H), 0.96 
(d, J = 6.5 Hz, 3H), 1.10−1.20 (m, 1H), 1.32 (t, J = 7.0 Hz, 3H), 1.44−1.62 (m, 4H), 
1.65−1.80 (m, 2H), 1.85−1.94 (m, 2H), 4.28 (q, J = 7.0 Hz, 2H), 4.05 (s, 2H), 5.05−5.09 
(m, 1H). 13C NMR (125 MHz, CDCl3): δ 14.2(CH3), 19.8 (CH3), 19.8 (CH3), 21.1 (CH2), 
21.2 (CH3), 26.3 (CH), 27.2(CH), 29.3 (CH2), 36.3 (CH2), 46.0 (CH), 56.1 (CH2), 62.8 
(CH2), 84.5(CH), 162.3(C), HRMS (ESI) calcd for C14H30NO5S [M+NH4]+ 324.1850, 
found 324.1820. 
 
Ethyl (1S,2R,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2- 
oxysulfonylacetate (T7.3b). The compound was purified 
by column chromatography on silica gel (1:3, EtOAc- 
hexane). Colorless solid (90%). Rf = 0.40 (1:5, EtOAc- 
hexane). 1H NMR (500 MHz, CDCl3): δ 0.89 (s,3H), 0.90 (s, 3H), 0.94 (s, 3H), 
1.29−1.37 (m, 5 H), 1.40 (dd, J = 14.0, 3.0 Hz, 1H), 1.73−1.82 (m, 2H), 1.87−1.94 (m, 
1H), 2.34−2.42 (m, 1H), 4.07 (s, 2H), 4.29 (q, J = 7.0 Hz, 2H), 4.92 (ddd, J = 10.0, 3.0, 
2.0 Hz, 1H). 13C NMR (125 MHz, CDCl3): δ 13.3 (CH3), 14.2 (CH3), 19.0 (CH3), 20.0 
(CH3), 26.8 (CH2), 28.0 (CH2), 36.5 (CH2), 44.8 (CH), 48.0 (C), 50.0 (C), 55.6 (CH2), 
62.8 (CH2), 90.2 (CH), 162.2 (C). HRMS (ESI) calcd for C14H28NO5S [M+NH4]+ 
322.1683, found 322.1675.  
 
Ethyl ({[(3R)-3-ethylhept-6-en-1-
yl]oxy}sulfonyl)acetate (T7.3c). The compound 
was purified by column chromatography on silica  
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gel (1:5, EtOAc-hexane). Colorless oil (74%). Rf = 0.35 (1:5, EtOAc-hexane). 1H NMR 
(CDCl3, 500 MHz): δ 0.80 (t, J = 6.9 Hz, 3H), 0.85 (t, J = 6.9 Hz, 3H), 1.34 (m, 4H), 1.48 
(m, 1H), 1.75 (m, 2H),2.05 (m, 2H), 4.15 (s, 2H), 4.27 (q, J = 7.3 Hz, 2H), 4.35 (t, J = 
11.6 Hz, 2H), 4.99 (dd, J = 17.3, 6.5 Hz, 2H), 5.80 (m, 1H). 13C NMR (CDCl3, 125 
MHz): δ 10.8 (CH3), 14.7 (CH3), 25. 7 (CH2), 32. 4 (CH2), 32. 8 (CH), 35.2 (CH2), 54.00 
(CH2), 55.3 (CH2), 63.1 (CH2), 71.4 (CH2), 115.0 (CH2), 139.1 (CH), 162.5 (C).  
 
 (R)-Ethyl 2-(6-(benzyloxy)-3- 
ethylhexyloxysulfonyl)acetate (T7.3d). The 
compound was purified by column chromatography  
on silica gel (1:7, EtOAc-hexane). Pale yellow oil (90%). Rf = 0.30 (1:5, EtOAc-hexane). 


 = +14.78 (c 0.115, CHCl3). 1H NMR (CDCl3, 500 MHz): δ 0.90 (t, J = 7.4 Hz, 3H), 
1.30 (t, J = 6.9 Hz, 3H), 1.35−1.40 (m, 4H), 1.50 (m, 1H), 1.62 (m, 1H), 1.75 (m, 2H), 
3.50 (t, J = 6.4 Hz, 2H), 4.08 (s, 2H), 4.28 (q, J = 7.1 Hz, 2H), 4.38 (t, J = 6.9 Hz, 2H), 
4.55 (s, 2H), 7.30−7.50 (m, 5H). 13C NMR (CDCl3, 125 MHz): δ 10.9 (CH3), 14.3 (CH3), 
25.1 (CH2), 27.02 (CH2), 29.6 (CH2), 32.9 (CH), 35.6 (CH2), 52.0 (CH2), 60.1 (CH2), 
69.0 (CH2), 71.3 (CH2), 73.3 (CH2), 127.9 (CH), 128.02 (CH), 128.8 (CH), 139.0 (C), 
162.5 (C). HRMS (ESI) calcd for C19H21O6S [M+H]+ 387.1836, found 387.1792. 
 
    Ethyl-2-[(3-methylbutoxy)sulfonyl]acetate (T7.3e). 
The compound was purified by column chromatography on 
silica gel (1:5, EtOAc-hexane). Colorless oil (73%). Rf =  
O
S
OEt
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0.40 (1:5, EtOAc-hexane). The physical data of T7.3e match with its previously reported 
data of the compound.49      
 
Ethyl-2-[(1,3-dimethylbutoxy)sulfonyl]acetate (T7.3f). 
The compound was purified by column chromatography on 
silica gel (1:5, EtOAc-hexane). Colorless oil (75%). Rf =  
0.45 (1:5, EtOAc-hexane). The physical data of T7.3f match with its previously reported 
data of the compound.49      
 
(S)-Ethyl 2-(3,7-dimethyloct-6-enyloxysulfonyl)acetate 
(T7.3g). The compound was purified by column 
chromatography on silica gel (1:5, EtOAc-hexane).  
Colorless oil (98%). Rf = 0.30 (1:3, EtOAc-hexane). The physical data of T7.3g match 
with its previously reported data of the compound.157      
 
 (1R,2S,5R)-Ethyl-2-[5-methyl-2-(1-
methylethyl)cyclohexyl)oxy]sulfonyl acetate (T7.3h)).  
The compound was purified by column chromatography on 
silica gel (1:3, EtOAc-hexane). Colorless solid (95%). Rf =  
0.40 (1:5, EtOAc-hexane). The physical data of T7.3h match with its previously reported 
data for the compound.49      
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General procedure for diazosulfonates (T7.4a−T7.4h).  
Procedure with nosyl azide: The corresponding sulfonate (1 equiv) was dissolved in 
DMF (5 mL/mmol) and stirred under nitrogen at 0 oC. Nosyl azide (1.2 equiv) and N,N-
diisopropylethylamine (2 equiv) were then added sequentially. The resulting reaction 
mixture was stirred at 0 oC for 7−8 h. Upon completion of the reaction, the reaction 
mixture was taken up in ethyl acetate (10 mL) and the organic layer was washed with 
water (2 × 10 mL) followed by the saturated brine solution (2 × 10 mL). The organic 
phase was then dried with anhydrous sodium sulfate. The volatiles were evaporated under 
reduced pressure to yield the crude product that was purified using column 
chromatography on silica column (1:5−1:3, EtOAc-hexanes) to yield the desired pure 
product.  
 
Procedure with mesyl azide: The same procedure described for preparation of diazo 
sulfones T6.5a and T6.5b was followed.   
Note: all diazocompounds do not show the diazo carbon in 13C spectra. IR data are 
provided, showing the diazo stretch at ~ 2130 cm-1. 
 
 (1S,2R,5R)-Ethyl-2-diazo-2-{[5-methyl-2-(1- 
methylethyl)cyclohexyl]oxy}sulfonyl acetate (T7.3a). 
The compound was purified by column chromatography on 
silica gel (1:3, EtOAc-hexane). Colorless solid (81%). Rf =  
0.50 (1:5, EtOAc-hexane). 1H NMR (500 MHz, CDCl3): δ 0.91 (d, J = 6.5 Hz, 3H), 0.92 
(d, J = 6.5 Hz, 3H), 0.96 (d, J = 6.5 Hz, 3H), 1.10−1.18 (m, 1H), 1.33 (t, J = 7.0 Hz, 3H), 
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1.42−1.62 (m, 4H), 1.64−1.79 (m, 2H), 1.80−1.98 (m, 2H), 4.34 (q, J = 7.0 Hz, 2H), 
5.04−5.08 (m, 1H). 13C NMR (125 MHz, CDCl3): δ 14.5 (CH3), 19.8 (CH3), 21.0(CH3), 
21.1 (CH2), 21.2 (CH3), 26.2 (CH), 27.2 (CH), 29.2 (CH2), 36.2 (CH2), 46.0 (CH), 62.8 
(CH2), 86.0 (CH), 159.8 (C). IR (neat, cm-1, ν): 2137, 1723, 1383, 1183. 
 
Ethyl (1S,2R,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2- 
oxysulfonyldiazoacetate (T7.4b). The compound was 
purified by column chromatography on silica gel (1:3,  
EtOAc-hexane). Colorless oil (95%). Rf = 0.40 (1:5,  
EtOAc-hexane). 1H NMR (500 MHz, CDCl3): δ 0.90 (s, 3H), 0.91 (s, 3H), 0.92 (s, 3H), 
1.28−1.40 (m, 6H), 1.73−1.80 (m, 2H), 1.89−1.96 (m, 1H), 2.33−2.41 (m, 1H), 4.34 (q, J 
= 7.0 Hz, 2H), 4.92 (dt, J = 10.0, 2.5 Hz, 1H), 13C NMR (125 MHz, CDCl3): δ 13.2 
(CH3), 14.5 (CH3), 19.0 (CH3), 19.9 (CH3), 26.8 (CH2), 28.0 (CH2), 36.2 (CH2), 44.8 
(CH), 48.0 (C), 50.0 (C), 62.8 (CH2), 62.8 (CH2), 91.6 (CH), 159.8 (C). IR (neat, cm-1, 
ν): 2138, 1723, 1381, 1182. 
 
Ethyl diazo({[(3R)-3-ethylhept-6-en-1- 
yl]oxy}sulfonyl)acetate (T7.4c). The compound 
was purified by column chromatography on silica  
gel (1:3, EtOAc-hexane). Colorless oil (27%). Rf = 0.50 (1:5, EtOAc-hexane). 1H NMR 
(CDCl3, 500 MHz): δ 0.80 (t, J = 6.9 Hz, 3H), 0.85 (t, J = 6.9 Hz, 3H), 1.30−1.40 (m, 
5H), 1.5 (m, 1H), 1.70 (m, 1H), 2.05 (m, 2H), 4.30 (q, J = 7.3 Hz, 2H), 4.38 (t, J = 11.6 
Hz, 2H), 4.98 (dd, J = 17.3, 2.5 Hz, 2H), 5.80 (m, 1H). 13C NMR (CDCl3, 125 MHz): δ 
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10.8 (CH3), 14.7 (CH3), 25. 7 (CH2), 32. 4 (CH2), 32. 6 (CH), 35.2 (CH2), 54.0 (CH2), 
63.1 (CH2), 72.6 (CH2), 115.0 (CH2), 139.1 (CH), 159.9 (C). IR (CH2Cl2, cm-1, ν): 2135. 
3, 1724.42.  
 
 (R)-Ethyl 2-[6-(benzyloxy)-3- 
ethylhexyloxysulfonyl]-2-diazoacetate (T7.4d). 
The compound was purified by column  
chromatography on silica gel (1:3, EtOAc-hexane). Colorless oil (80%). Rf = 0.30 (1:3, 
EtOAc-hexane). 1H NMR (CDCl3, 500 MHz): δ 0.75 (t, J = 7.4 Hz, 3H), 1.25 (t, J = 6.8 
Hz, 3H), 1.20−1.30 (m, 4H), 1.40 (m, 1H), 1.52 (m, 2H), 1.65 (m, 2H), 3.35 (t, J = 6.7 
Hz, 2H), 4.25 (q, J = 7.0 Hz, 2H), 4.30 (t, J = 6.8 Hz, 2H), 4.43 (s, 2H), 7.20−7.40 (m, 
5H). 13C NMR (125 MHz, CDCl3): δ 8.84 (CH3), 11.9 (CH3), 24.85 (CH2), 28.94 (CH2), 
31.78 (CH2), 32.46 (CH2), 46.31 (CH), 60.0 (CH2), 65.33 (CH2), 70.32 (CH2), 73.10 
(CH2), 127.76 (CH), 127.81 (CH), 128.55 (CH), 138.52 (C), 181.40 (C). IR (CH2Cl2, cm-
1
, ν): 2135.74, 1722.51. 
 
Ethyl-2-diazo-2-[(3-methylbutoxy)sulfonyl]acetate 
(T7.4e). The compound was purified by column 
chromatography on silica gel (1:3, EtOAc-hexane).  
Colorless oil (68%). Rf = 0.40 (1:3, EtOAc-hexane). The physical data of T7.4e match 
with its previously reported data of the compound.49      
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Ethyl-2-diazo-2-[(1,3-dimethylbutoxy)sulfonyl]acetate 
(T7.4f). The compound was purified by column 
chromatography on silica gel (1:3, EtOAc-hexane).  
Colorless oil (70%). Rf = 0.40 (1:3, EtOAc-hexane). The physical data of T7.4f matches 
with its previously reported data of the compound.49      
 
(S)-Ethyl 2-diazo-2-(3,7-dimethyloct-6-
enyloxysulfonyl)acetate T7.4g. The compound was 
purified by column chromatography on silica gel (1:3,  
EtOAc-hexane). Colorless oil (74%). Rf = 0.30 (1:3, EtOAc-hexane). The physical data of 
T7.4g matches with its previously reported data of the compound.157      
 
 (1R,2S,5R)-Ethyl-2-diazo-2-{[5-methyl-2-(1- 
methylethyl)cyclohexyl]oxy}sulfonyl acetate (T7.4h). 
The compound was purified by column chromatography on 
silica gel (1:3, EtOAc-hexane). Colorless oil (75%). Rf =  
0.50 (1:5, EtOAc-hexane).  = +24.05 (c 0.05, CHCl3). The physical data of T7.4h 
match with its previously reported data of the compound.49      
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6.11 Procedures and physical data for compounds from Scheme 53 
α,α,α',α'-Tetramethyl-1,3-benzenediethyldipropionate 
(S53.3). n-Butyllithium (1.9 mL of a 2.5 M solution in 
hexanes, 4.7 mmol) was added slowly to a solution of 
diisopropylamine (0.7 mL, 5 mmol) in 1 mL of THF at  
−78 oC. The mixture was stirred for 30 min followed by the dropwise addition of 
ethylisobuterate, S53.1 (549 mg, 4.73 mmol). The reaction was stirred at 0 oC for an 
additional 1.5 h. A solution of a α,α’-bromo-m-xylene (500 mg, 1.89 mmol) in 4 mL of 
THF was slowly added to the reaction flask. The resulting reaction mixture was warmed 
to rt and stirred for another 10 h. The reaction was quenched with 10 mL of water and the 
product was extracted with ethyl acetate (15 mL). The organic layer was further washed 
with 10 mL brine, dried over anhydrous sodium sulfate and volatiles were removed under 
reduced pressure. Purification of the oily residue by column chromatography on silica gel 
(2.5−5%, DEE-petroleum ether) yielded 215 mg (50%) of the desired diester S53.3 as a 
semi-solid. Rf = 0.30 (0.5:9.5, DEE-petroleum ether). 1H NMR (CDCl3, 500 MHz): δ 1.15 
(s, 12H), 1.20 (t, J = 6.8 Hz, 6H), 2.80 (s, 4H), 4.10 (q, 4H), 6.90 (s, 1H), 6.95 (d, J = 7.9 
Hz, 2H), 7.15 (t, J = 7.8 Hz, 1H). 13C NMR (125 MHz, CDCl3): δ 14.57 (CH3), 25.34 
(CH3), 43.82 (C), 46.54 (CH2), 60.74 (CH2), 127.91 (CH), 128.65 (CH), 132.64 (CH), 
137.94 (C), 177.82 (C).  
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α,α,α',α'-Tetramethyl-1,3-benzenedipropionic acid 
(S53.4). The compound S53.4 was obtained using the 
procedure described for compound S51.1 in Scheme 51. 
The product was isolated (172 mg, 96%) as a colorless  
solid. The physical data of S53.4 match with its previously reported data of the same 
diacid.109     
 
Rh2(esp)2 (S53.5). A 15 mL round bottom flask was 
charged with Rh2(OAc)4 (137 mg, 0.310 mmol), α,α,α',α'- 
tetramethyl-1,3-benzenedipropionic acid (17.0 mg,  
0.0620 mmol), and 3.0 mL of 1,2-dichloroethane. The 
reaction mixture was refluxed under nitrogen. After twenty  
minutes, the flask was removed from the heating bath and the contents slowly cooled (5 
min) to 23 °C. The vessel was charged with 17.0 mg (0.2 equiv) of the diacid, sealed, and 
heating at 125 °C was resumed. This process was repeated an additional three times at 
twenty minutes intervals, following which the reaction was stirred at 125 °C for 5 h. 
Within this period, the reaction mixture slowly became turbid. A second equivalent of 
dicarboxylic acid was then introduced in a similar fashion (5 portions of 17.0 mg at 20 
minute intervals). Once again, the mixture was stirred at 125 °C for an additional 5 h, 
during which time the reaction became homogenous. The deep green solution was cooled 
to 23 °C and volatiles were removed under reduced pressure. Purification of the resulting 
deep green residue by column chromatography on silica gel using gradient elution 
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(1:15−1:10, EtOAc-hexane) furnished 122 mg (55%) of the catalyst Rh2(esp)2 as a green 
microcrystalline solid. Rf = 0.43 (20:1, DCM-EtOAc). The physical data of S53.5 match 
with its previously reported data of the catalyst.109      
 
6.12 Procedures and physical data for compounds from Table 9 
General procudeure for cyclization through C−H insertion (T9.1a−T9.1h). 
To the suspension of a rhodium catalyst (Rh2(OAc)4 or Rh2(esp)4) (2 mol %) in 
dichloromethane (4 mL/mmol) a solution of the corresponding diazo compound (1 equiv, 
0.1−1 mmol) in dichloromethane (2 mL/mmol) was added at rt over a period of 1 h using 
a syringe pump. Upon completion of the addition, the reaction mixture was stirred at rt 
for an additional 15 h. The volatiles were removed under reduced pressure and the crude 
reaction mixture was purified using column chromatography on silica column (1:5−1:3, 
EtOAc-hexanes). In many cases, additional purification on a silica gel column (1:9−1:10, 
DEE-petroleum ether) was required to yield the pure product. 
 
Ethyl (4aR,7R,8aS)-4,4,7-trimethyloctahydro-1,2-benzoxathiine-3- 
carboxylate 2,2-dioxide (T5.1a). Less polar isomer of T5.1a. The 
compound was purified by column chromatography on silica gel (1:4, 
DEE-petroleum ether). Colorless oil (88%). Rf = 0.30 (1:4, DEE- 
petroleum ether). 1H NMR (500 MHz, CDCl3): δ 1.02 (d, J = 7.5 Hz, 3H), 1.11 (s, 3H), 
1.33 (t, J = 7.0 Hz, 3H), 1.35 (s, 3H), 1.55−1.65 (m, 3H), 1.88 (td, J = 12.0, 5.0 Hz, 1H), 
1.97−2.03 (m, 2H), 2.22−2.29 (m, 2H), 3.78 (s, 1H), 4.27 (qd, J = 7.0, 2.0 Hz, 2H), 4.77 
(td, J = 11.0, 4.5 Hz, 1H). 13C NMR (125 MHz, CDCl3): δ 14.2 (CH3), 18.2 (CH3), 19.0 
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(CH2), 22.7 (CH3), 26.9 (CH3), 28.4 (CH), 30.9 (CH2), 37.8 (CH2), 38.9 (C), 44.2 (CH), 
62.5 (CH2), 71.7 (CH), 81.9 (CH), 165.3 (C), HRMS (ESI) calcd for C14H28NO5S 
[M+NH4]+ 322.1683, found 322.1667. More polar isomer of T5.1a. 1H NMR (500 
MHz, CDCl3): δ 1.02 (d, J = 7.5 Hz, 3H), 1.14 (s, 3H), 1.33 (s, 3H), 1.34 (t, J = 7.0 Hz, 
3H), 1.51−1.64 (m, 3H), 1.67−1.79 (m, 2H), 1.96−2.01 (m, 1H), 2.21−2.29 (m, 2H), 3.87 
(s, 1H), 4.32 (q, J = 7.0 Hz, 2H), 4.78 (td, J = 11.0, 4.5 Hz, 1H). 13C NMR (125 MHz, 
CDCl3): δ  14.3 (CH3), 16.3 (CH3), 18.1 (CH3), 19.2 (CH2), 27.4 (CH3), 28.3 (CH), 30.8 
(CH2), 37.8 (CH2), 40.5 (C), 51.4 (CH), 62.6 (CH2), 72.3 (CH), 81.2 (CH), 163.8 (C). 
HRMS (ESI) calcd for C14H28NO5S [M+NH4]+ 322.1683, found 322.1705. 
 
Borneol sulfonate ethylester (T5.1b) 
     Ethyl 11,11-dimethyl-5-oxa-4-thiatricyclo[6.2.1.01,6]undecane- 
     3-carboxylate 4,4-dioxide (T5.1b1). The compound was ppurified by 
     column chromatography on silica gel (1:5, DEE-petroleum ether). 
     Colorless oil (88%). Rf = 0.25 (1:5, DEE-petroleum ether).  
1H NMR (500 MHz, CDCl3): δ 0.95 (s, 3H), 0.97 (s, 3H), 1.28 (dd, J = 14.0, 5.0 Hz, 1H), 
1.32 (t, J = 7.0 Hz, 3H), 1.34−1.47 (m, 2H), 1.78−1.99 (m, 2H), 2.00 (dd, J = 14.0, 4.5 
Hz, 1H), 2.15−2.21 (m, 1H), 2.25−2.35 (m, 2H), 3.95 (dd, J = 13.0, 5.0 Hz, 1H), 
4.25−4.34 (m, 2H), 5.00 (ddd, J = 11.0, 5.0, 2.0 Hz, 1H). 13C NMR (125 MHz, CDCl3): δ 
14.1 (CH3), 18.7 (CH3), 19.8 (CH3), 24.7 (CH2), 28.0 (CH2), 28.8 (CH2), 32.5 (CH2), 45.7 
(CH), 46.7 (C), 47.5 (C), 61.0 (CH), 63.1 (CH2), 88.5 (CH), 164.7 (C). HRMS (ESI) 
calcd for C14H23O5S [M+H]+ 303.1266, found 303.1261.  
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     Ethyl 8,9,9-trimethyl-4-oxa-5-thiatricyclo[5.2.1.03,8]decane-6- 
     carboxylate 5,5-dioxide (T5.1b2). 1H NMR (500 MHz, CDCl3):  
    δ 0.92 (s, 3H), 0.98 (s, 3H), 1.08 (s, 3H), 1.35 (t, J = 7.0 Hz, 3H), 
     1.88 (t, J = 4.0 Hz, 1H), 2.11 (dd, J = 13.0, 5.0 Hz, 1H), 2.14−2.23  
(m, 2H), 2.45 (dd, J = 14.0, 4.0 Hz, 1H), 2.73−2.78 (m, 1H), 4.15 (d, J = 4.0 Hz, 1H), 
4.30−4.38 (m, 2H), 4.80 (dt, J = 10.0, 3.0 Hz, 1H). 13C NMR (125 MHz, CDCl3): 11.9 
(CH3), 14.2 (CH3), 18.90 (CH3), 18.92 (CH3), 28.4 (CH2), 30.2 (CH2), 42.3 (CH), 43.5 
(CH), 47.9 (C), 49.7 (C), 60.8 (CH), 63.1 (CH2), 95.3 (CH), δ 164.7 (C). HRMS (ESI) 
calcd for C14H23O5S [M+H]+ 303.1266, found 303.1293.     
      
Benzyl protected sulfonate ethylester (T5.1d). The 
compound was purified by column chromatography on 
silica gel (1:5, EtOAc-hexane). Colorless oil (80%). Rf =  
0.30 (1:5, EtOAc-hexane).  = +13 (c 0.018, CHCl3). 1H NMR (CDCl3, 500 MHz): δ 
0.80 (t, J = 7.5 Hz, 3H), 1.20 (m, 7H), 1.40−1.50 (m, 4H), 2.50 (dd, J = 10.9, 6.0 Hz, 
1H), 3.32 (dd, J = 11.8, 5.9 Hz, 1H), 3.40 (dd, J = 10.8, 5.9 Hz, 1H), 3.60 (dd, J = 11.5, 
6.9 Hz, 1H), 4.28 (q, J = 7.1 Hz, 2H), 4.40 (s, 1H), 4.55 (s, 2H), 7.20−7.30 (m, 5H). 13C 
NMR (CDCl3, 125 MHz): δ 7.84 (CH3), 14.3 (CH3), 23.30 (CH2), 25.1 (CH2), 27.4 (C), 
29.7 (CH2), 32.8 (CH2), 41.9 (CH2), 62.8 (CH2), 68.4 (CH2), 75.0 (CH2), 75.8 (CH), 
127.5 (CH), 128.7 (CH), 128.7 (CH), 138.0 (C), 165.0 (C). HRMS (ESI) calcd for 
C19H29O6S [M+H]+ 385.1685, found 385.1639.     
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Ethyl-4,4-dimethyl-1,2-oxathiane-2,2-dioxide-3-carboxylate 
(T5.1e). The compound was purified by column chromatography 
on silica gel (1:6, EtOAc-hexane). Colorless oil (60%). Rf = 0.20  
(1:5, EtOAc-hexane). The physical data of T5.1e matches with its previously reported 
data of the compound.49      
 
Ethyl-4,4,6-trimethyl-1,2-oxathiane-2,2-dioxide-3-carboxylate 
(T5.1f). The compound was purified by column chromatography 
on silica gel (1:5, EtOAc-hexane). Colorless oil (75%). Rf = 0.30  
(1:5, EtOAc-hexane). The physical data of T5.1f matches with its previously reported 
data of the compound.49      
 
Ethyl (4R)-4-methyl-4-(4-methylpent-3-en-1-yl)-1,2-oxathiane- 
3-carboxylate 2,2-dioxide (T5.1g). The compound was purified 
by column chromatography on silica gel (1:5, EtOAc-hexane).  
Colorless oil (85%). Rf = 0.3 (1:1, EtOAc-hexane). The physical data of T5.1g matches 
with its previously reported data of the compound.157      
 
Ethyl (4aS,7R,8aR)-4,4,7-trimethyloctahydro-1,2-benzoxathiine-3- 
carboxylate 2,2-dioxide (T5.1h). The compound was purified by column 
chromatography on silica gel (1:4, DEE-petroleum ether). Colorless oil 
(80%). Rf = 0.30 (1:4, DEE-petroleum ether). The physical data of T5.1h  
match with its previously reported data of the compound.49 
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6.13 Procedures and physical data for compounds from Table 11 
General procedure for oxidation of δ-sultones with TBHP/t-BuOK 
To a solution of δ-sultone in THF (2.5 mL/mmol) was added potassium tert-butoxide (10 
equiv.) or KHMDS (10 equiv.) followed by tert-butyl hydroperoxide (4 equiv.). After 
stirring at rt for 16 h, sodium sulfite was added and the resulting suspension stirred for 15 
min to destroy excess tert-butyl hydroperoxide. This was followed by the addition of 20 
mL of 1 N solution of hydrochloric acid and the resulting mixture was extracted with 
diethyl ether, washed with brine, dried over anhydrous magnesium sulfate and evaporated 
to afford a crude product, which was purified by flash chromatography. 
 
 (3aR,6R,7aS)-Hexahydro-3,3,6-trimethylbenzofuran-2(3H)-one 
(T5.2a). The compound was purified by column chromatography on silica 
gel (1:4, DEE-petroleum ether). Colorless solid (90%). Rf = 0.30 (1:4,  
DEE-petroleum ether). 1H NMR (CDCl3, 500 MHz): δ 1.04−1.08 (d, J =  
7.5 Hz, 3H), 1.08 (s, 3H), 1.20 (s, 3H), 1.40−1.50 (m, 1H), 1.55−1.70 (m, 5H), 2.10 (m, 
1H), 2.30 (m, 1H), 4.10 (m, 1H). 13C NMR (CDCl3, 125 MHz): δ 17.77 (CH3), 19.59 
(CH3), 23.84 (CH2), 28.61 (CH), 31.40 (CH2), 36.55 (CH2), 42.67 (C), 55.35 (CH), 77.2 
(CH), 182.98 (C). HRMS (ESI) calcd for C11H18O2 [M+H]+ 183.1379, found 183.1423.  
 
7,8,8-Trimethyl-4-oxatricyclo[4.2.1.03,7]nonan-5-one (T5.2b1). The 
compound was purified by column chromatography on silica gel (1:4,  
DEE-petroleum ether). Colorless oil (70%). Rf = 0.30 (1:4, DEE- 
petroleum ether). 1H NMR (CDCl3, 500 MHz): δ 0.86 (s, 3H), 0.88 (s,  
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3H), 1.05 (s, 3H), 1.39 (d, J = 14.2, 1H), 1.5 (d, J = 12.6, 1H), 1.87 (m, 1H), 2.12−2.30 
(m, 3H), 4.35 (d, 1H). 13C{1H} NMR (CDCl3, 125 MHz): δ 11.6 (CH3), 19.4 (CH3), 20.5 
(CH3), 33.4 (CH2), 36.8 (CH2), 46.3 (CH), 46.6 (CH), 49.2 (C), 58.8 (C), 87.1 (CH), 
181.5 (C).  
 
 (S)-3-(3-(Benzyloxy)propyl)-3-ethyl-dihydrofuran-2(3H)-one 
(T5.2d). The compound was purified by column chromatography 
on silica gel (1:5, EtOAc-hexane). Colorless oil (75%). Rf = 0.40  
(1:5, EtOAc-hexane).  = +11 (c 0.010, CHCl3). 1H NMR (CDCl3, 500 MHz): δ 0.85 
(t, J = 7.5 Hz, 3H), 1.50−1.70 (m, 6H), 2.00 (t, J = 7.0 Hz, 2H), 3.50 (m, 2H), 4.20 (t, J = 
7.6 Hz, 2H), 4.55 (s, 2H), 7.20−7.30 (m, 5H). 13C NMR (CDCl3, 125 MHz): δ 8.84 
(CH3), 24.83 (CH2), 28.94 (CH2), 31.78 (CH2), 32.46 (CH2), 46.31(C), 65.6 (CH2), 70.6 
(CH2), 73.4 (CH2), 128.7 (CH), 128.8 (CH), 130.0 (CH), 138.8 (C), 181.0 (C). HRMS 
(ESI) calcd for C16H23O3 [M+H]+ 263.1647, found 263.1623  
 
Dihydro-3,3-dimethylfuran-2(3H)-one (T5.2e). The compound was 
purified by column chromatography on silica gel (1:9−1:3, DEE- 
petroleum ether). Colorless oil (54%). The physical data of T5.2e match  
with its previously reported data of the compound.185  
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      Dihydro-3,3,5-trimethylfuran-2(3H)-one (T5.2f). The compound was 
purified by column chromatography on silica gel (1:9−1:3, DEE- 
petroleum ether). Colorless oil (60%). The physical data of T5.2f match  
with its previously reported data of the compound.185      
 
3-Methyl-3-(4-methyl-3-pentenyl)dihydrofuran-2-one (T5.2g). 
The compound was purified by column chromatography on silica 
gel (1:1, DCM-pentane). Pale yellow oil (72%). Rf = 0.30 (1:1,  
DCM-pentane). 1H NMR (CDCl3, 500 MHz): δ 1.20−1.30 (s, 3H), 1.55 1.65 (m, 5H), 
1.65 (s, 3H), 1.87−2.10 (m, 3H), 2.20−2.30 (m, 1H), 4.25 (m, 2H), 5.10 (m, 1H). 13C 
{
1H} NMR (CDCl3, 125 MHz): δ 17.87 (CH3), 22.70 (CH2), 23.32 (CH3), 25.56 (CH3), 
34.69 (CH2), 37.42 (CH2), 42.37 (C), 65.16 (CH2), 123.40 (CH), 132.65 (C), 182.11 (C).  
 
 (3aS,6R,7aR)-Hexahydro-3,3,6-trimethylbenzofuran-2(3H)-one 
(T5.2h). The compound was purified by column chromatography on silica 
gel (1:4, DEE-petroleum ether). Colorless solid (93%). Rf = 0.30 (1:4, 
DEE-petroleum ether). The physical data of T5.2h match with its  
previously reported data of the compound.186   
 
6.14 Procedures and physical data for compounds from Scheme 57 
(S)-3-Ethyl-dihydro-3-(3-hydroxypropyl)furan-2(3H)-one 
(S49.2). The benzyl protected T5.2d (20.0 mg, 0.0760 mmol) was 
stirred with 2 mL of methanol, followed by the addition of  
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palladium on carbon (8.1 mg, 0.0076 mmol) for 12 h under a hydrogen atmosphere. Upon 
completion of the reaction, the resulting reaction mixture was filtered through a silica 
plug, and the solid was further washed with 15 mL of dichloromethane. The combined 
rganic layers were concentrated under reduced pressure. Purification of the resulting 
residue by column chromatography on silica gel (1:3, EtOAc-hexane) afforded 13.0 mg 
(99%) as colorless oil. Rf = 0.30 (3:1, EtOAc-hexane).  = +9.25 (c 0.005, CHCl3).  
The physical data of S49.2 match with its previously reported data of the compound.168       
  
6.15 Procedures and physical data for compounds from Scheme 58 
Ethyl 2,2-dimethylpent-4-enoate (S58.2). The compound S58.2 
was prepared using the procedure described for compound S53.3 in 
Scheme 53. 290 mg (86%) of the compound S58.2 was isolated as 
a colorless liquid. The physical data of S58.2 match with its previously reported data of 
the compound.187        
  
Ethyl 2-(formylmethyl)-2-methylpropanoate (S58.3). A solution 
of alkene S58.2 (100 mg, 0.640 mmol) in 20 mL of 
dichloromethane was cooled to −78 oC and ozone was bubbled  
through the solution for 2−3 h until the reaction mixture turned to a light blue color. Then 
dimethyl sulfide (141 µL, 1.09 mmol) was added to the mixture at −78 oC and the 
mixture was stirred overnight at rt.  Volatiles were removed under reduced pressure 
affording the crude aldehyde as a colorless liquid. The physical data of S58.3 match with 
its previously reported data of the compound.188       
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Dihydro-3,3-dimethylfuran-2(3H)-one (T5.1e). The aldehyde S58.3 
(300 mg, 1.90 mmol) was dissolved in 5 mL of methanol and the solution 
was cooled to 0 oC followed by the addition of sodium borohydride  
(78.9 mg, 2.09 mmol). The resulting reaction mixture was stirred overnight at rt.  Then 
the reaction was quenched with 5 mL of saturated aqueous solution of sodium 
bicarbonate (10 mL). The product was extracted with dichloromethane (2 × 10 mL) 
followed by washing the organic extracts with water (2 × 10 mL) and brine. The resulting 
organic layer was dried with anhydrous magnesium sulfate, filtered. Removal of volatiles 
under reduced pressure afforded 13.0 mg (25%) (over three steps from the staring ester 
S58.1) of lactone ST5.2e as a colorless oil. The physical data of T5.2e match with its 
previously reported data of the compound.185   
 
Dihydro-5-(iodomethyl)-3,3-dimethylfuran-2(3H)-one (S58.4). 
Alkene S58.2 (100 mg, 0.640 mmol) was stirred in THF-water 
(2:1) and an iodine crystal was added (243 mg, 1.92 mmol). The  
resulted reaction mixture was stirred 5 h at rt. Upon completion of the reaction, the 
product was extracted with dichloromethane and the organic layer was washed with water 
(2 × 10 mL) followed by 10 mL of saturated brine solution. The organic layer was then 
dried with anhydrus sodium sulfate and volatiles were removed under reduced pressure. 
Purification of the resulting crude mixture by column chromatography on silica gel (1:5, 
EtOAc-hexane) afforded 139 mg (85%) of the iodolactone S58.4 as a colorless oil. The 
physical data of S58.4 match with its previously reported data of the compound.        
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Dihydro-3,3,5-trimethylfuran-2(3H)-one (T5.2f). Iodolacone S58.4 
(70.0 mg, 0.280 mmol) was refluxed in a stirred suspension of Raney 
nickel (700 mg) in isopropanal (3 mL) for 15 min. Upon completion of the  
reaction, the mixture was cooled to rt, the organic layer was decanted from the Raney 
nicke, and the catalyst was washed with dichloromethane (3 × 5 mL). The combined 
organic layers were fileted through a Celite plug, which was washed with an additional 5 
mL of dichloromethane. Removal of volatiles under reduced pressure afforded 27.0 mg 
(77%) of lactone S58.4 as a colourless liquid. The physical data of T5.2f match with its 
previously reported data of the compound.185   
 
 
 
T5.2f
O
O
143 
 
APENDIX I 
 
LIST OF ABBREVIATIONS AND ACRONYMS 
 
abs.  absolute 
 
Ac  acetyl 
AD  asymmetric dihydroxylation 
AIBN  azobis(isobutyronitrile) 
acac  acetylacetone 
ATP  adenosine triphosphate 
9-BBN  9-borabicyclo[3.3.1]nonane 
B3LYP Becke,3-parameter, Lee-Yang-Parr 
Bn  benzyl 
Bu  butyl 
Bz  benzoyl 
CAN  cerium(IV) ammonium nitrate 
CSA  camphorsulfonic acid  
DBU  1,8-diazabicyclo[5.4.0]undec-7-ene 
DCC  N,N’-dicyclohexylcarbodiimide 
DCM  dichloromethane 
DEAD  diethyl azodicarboxylate 
DEE  diethyl ether 
DEPT  distortionless enhancement by polarization transfer
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DET  diethyltryptamine 
DIAD  diisopropyl azodicarboxylate 
DIBAL-H diisobutylaluminum hydride 
DIPEA/DIEA N,N-diisoropylethylamine 
DMAP  dimethylaminopyridine 
DME  1,2-dimethoxyethane 
DMF  N,N-dimethylformamide 
DMPU  1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone 
DMS  dimethyl sulfide 
DMSO  dimethyl sulfoxide 
dr  diastereomeric ratio 
EDG  electron-donating group 
ee  enatiomeric excess 
Et  ethyl 
equiv.  equivalent 
EWG  electron-withdrawing group 
FT-IR  fourier transform infrared spectroscopy 
h  hour 
HMPA  hexamethylphosphoramide 
HOBT  hydroxybenzotriazole 
HPLC  high-performance liquid chromatography 
HRMS  high-resolution mass spectrometry 
IBX  iodoxy benzoic acid 
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Im-H  imidazole 
i-Pr  isopropyl 
KHMDS potassium hexamethyldisilazane 
LAH  lithium aluminum hydride 
LD50  lethal dose, 50% 
LDA  lithium diisopropylamide 
LiHMDS lithium hexamethyldisilazane 
m-CPBA meta-chloroperoxybenzoic acid 
Me  methyl 
MeOH  methanol 
MeCN  acetonitrile 
MEOX 4(S)-methyl 2-oxooxazolidinecarboxylate 
MPPIM 4(S)-methyl 1-(3-phenylpropanoyl)-2-oxaimidazolidinecarboxylate 
MS  molecular sieves 
Ms  mesyl 
MTPA  α-methoxy-α-trifluoromethylphenylacetic acid 
NaHMDS sodium hexamethyldisilazane 
NMO  N-methylmorpholine-N-oxide 
NMR  nuclear magnetic resonance 
NOE  nuclear Overhauser effect 
Nos  Nosyl 
Pd  palladium 
Pet   petroleum 
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Pfb  perfluorobutyrate 
PGME  phenylglycine methyl ester 
Ph  phenyl 
Piv  pivaloyl  
PMB  para-methoxybenzyl 
PMP  para-methoxyphenyl 
PNB  propylene glycol butyl ether 
Pr  propyl 
PTLC  preparative thin layer chromatography 
PTSA  para-toluenesulfonic acid 
Py  pyridine 
PyBOP (benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate 
RCM  ring-closing metathesis 
rt  room temperature 
TBAF  tetrabutylammonium fluoride  
TBAI  tetrabutylammonium iodide 
TBDPS tert-butyldiphenylsilyl 
TBDS  (S)-2-(tert-butylamino)-3-hydroxypropanoic acid 
TBHP  tert-butyl hydroperoxide 
TBS  tert-butyldimethylsilyl  
TEA  triethylamine 
Tf  trifluoromethanesulfyl 
TFA  trifluoroacetate 
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THF  tetrahydrofuran 
TLC  thin layer chromatography 
TMS  tetramethylsilane 
TOF  time of flight 
tol-BINAP 2,2′-bis(di-p-tolylphosphino)-1,1′-binaphthyl 
TPAP  tetrapropylammonium perruthenate 
Tr  trityl 
p-Ts  para-toluenesulfonyl  
TS  transition state 
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APENDIX II 
 
SCHEMES FOR THE ALTERNATIVE SYNTHESIS OF  
T5.2e AND T5.2f 
 
Ethyl isobutyrate S51.1 was obtained via Fischer esterification of isobutyric acid 
S58.1. Ethyl isobutyrate was allylated189 with freshly prepared LDA at −78 oC, followed 
by ozonolysis with reductive work-up with dimethyl sulfide to produce aldehyde S58.3.55 
Reduction of aldehyde S58.3 to its corresponding alcohol and cyclization of the alcohol 
to five-membered lactone T5.2e occurred within a single pot in the presence of sodium 
borohydride and methanol at 0 oC. Lactone T5.2e was obtained in 25% yield from 
starting acid S58.1, over three steps. Iodolactonization of ester S58.2 followed by 
hydrogenolysis of iodolactone S58.4 resulted the desired lactone T5.2f.    
 
 
 
 
 
 
 
 
 
 
Scheme 58. Alternative synthetic routes for the preparation of T5.2e and T5.2f.  
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APENDIX III 
SELECTED SPECTRA 
FIGURES 6−22 
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Figure 6. 1H NMR (500 MHz) spectrum of 6-(benzyloxy)-3-ethyl-N-((S)-1- 
phenylethyl)hexanamide (S52.3) in CDCl3. 
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Figure 7. 1H NMR (500 MHz) spectrum of (3aR,6R,7aS)-hexahydro-3,3,6- 
trimethylbenzofuran-2(3H)-one (T5.2a) in CDCl3. 
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Figure 8. 13C{1H} NMR (125 MHz) spectrum of (3aR,6R,7aS)-hexahydro-3,3,6-
trimethylbenzofuran-2(3H)-one (T5.2a) in CDCl3. 
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Figure 9. 1H NMR (500 MHz) spectrum of 7,8,8-trimethyl-4-oxatricyclo 
[4.2.1.03,7]nonan-5-one (T5.2b1)in CDCl3. 
154 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. 13C{1H} NMR (125 MHz) spectrum of 7,8,8-trimethyl-4-oxatricyclo 
[4.2.1.03,7]nonan-5-one (T5.2b1)in CDCl3. 
155 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. 1H NMR (500 MHz) spectrum of (S)-3-(3-(benzyloxy)propyl) 
-3-ethyl-dihydrofuran-2(3H)-one (T5.2d) in CDCl3. 
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Figure 12. 13C{1H} NMR (125 MHz) spectrum of (S)-3-(3-(benzyloxy)propyl) 
-3-ethyl-dihydrofuran-2(3H)-one (T5.2d) in CDCl3. 
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Figure 13. 1H NMR (500 MHz) spectrum of dihydro-3,3-dimethylfuran- 
2(3H)-one (T5.2e) in CDCl3. 
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Figure 14. 13C{1H} NMR (125 MHz) spectrum of dihydro-3,3-dimethylfuran- 
2(3H)-one (T5.2e) in CDCl3. 
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Figure 15. 1H NMR (500 MHz) spectrum of dihydro-3,3,5-trimethylfuran- 
2(3H)-one (T5.2f) in CDCl3. 
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Figure 16. 13C{1H} NMR (125 MHz) spectrum of dihydro-3,3,5-trimethylfuran- 
2(3H)-one (T5.2f) in CDCl3. 
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Figure 17. 1H NMR (500 MHz) spectrum of 3-methyl-3-(4-methyl-3-pentenyl) 
dihydrofuran-2-one (T5.2g) in CDCl3. 
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Figure 18. 13C{1H} NMR (125 MHz) spectrum of 3-methyl-3-(4-methyl-3- 
pentenyl)dihydrofuran-2-one (T5.2g) in CDCl3. 
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Figure 19. 1H NMR (500 MHz) spectrum of (3aS,6R,7aR)-hexahydro- 
3,3,6-trimethylbenzofuran-2(3H)-one (T5.2h).  in CDCl3. 
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Figure 20. 13C{1H} NMR (125 MHz) spectrum of (3aS,6R,7aR)-hexahydro- 
3,3,6-trimethylbenzofuran-2(3H)-one (T5.2h).  in CDCl3. 
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Figure 21. 1H NMR (500 MHz) spectrum of (S)-3-ethyl-dihydro-3-(3-hydroxypropyl) 
furan-2(3H)-one (S49.2). 
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Figure 22. 13C{1H} NMR (125 MHz) spectrum of (S)-3-ethyl-dihydro-3- 
(3-hydroxypropyl)furan-2(3H)-one (S49.2) 
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